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„Science is a game we play with God 
to find out what his rules are.“ 
 
(Krasel, Cornelius)
Summary 
Against the background of an ongoing demand on faster, more cost-effective and more 
sensitive analysis methods particularly in the area of DNA analytics, innovative analytic 
developments are necessary. Miniaturized laboratories on electrically driven chip devices 
present an example of such sophisticated technologies. Their application gains increasing 
importance in medical diagnostics as well as in the forensics field of research, most notably as 
often only a small amount of sample material is available which in addition requires to be 
analyzed free of contamination. In this work a multifunctional lab-on-a-chip system is 
presented, that is generally applicable to a wide variety of small-scale sample material. The 
lab-on-a-chip is characterized by a modular design. The single working units used for sample 
retrieval, processing and detection were optimized concerning their capacity. The 
applicability of the lab-on-a-chip in forensic DNA analytics was exemplified on several actual 
scientific problems. After contamination-free microdissection retrieved sample material was 
analyzed on a chip-based DNA amplification unit. On a chemically structured planar chip 
surface virtual reaction tubes were built in form of small droplets, that were stabilized by the 
liquid’s surface tension. The facilitated miniaturization of the reaction volume to just 1 µl in 
total enabled analyses of smallest amounts of sample material free of contamination. In that 
manner, a higher sensitivity than in voluminous plastic tube-based reactions could be 
achieved. The miniaturized reaction volume permitted a decrease of analysis time to  
15 seconds per PCR cycle. The required amount of starting material for a significant genetic 
analysis could be reduced to a minimum of 25 pg. 
Based on reliable, reproducible and highly sensitive analyses using purified standard DNA the 
applicability of the lab-on-a-chip was tested on various samples of forensic relevant materials, 
liquid ones as well as solid ones. (1) Using just 1% (v/v) of unpurified whole blood in PCR-
based analysis, full allelic DNA profiles for the generation of genetic fingerprints could be 
determined. (2) Dried blood spots were analyzed over a specific period of time ranging from 
several minutes up to three months of age. In dependence on the status of the drying and 
coagulation process, up to 92% full detectable DNA profiles could be attained. (3) 
Microdissected tissue particles of pathological relevant tissues could directly be subjected to 
PCR-based gender determining analysis and related to male and female individuals, while no 
additional DNA extraction steps were needed prior to analysis. (4) The self-posted demand on 
performing highly sensitive and contamination-free analyses was demonstrated using ancient 
bone tissue material derived from Egyptian mummy material. After laser microdissection 
 DNA fragments of up to 297 bp in length could be amplified in PCR-based analyses using 
just 60 pg of ancient DNA starting material. The authenticity of amplified fragments could be 
verified when compared to sequences recalled from current genome databases, showing 
identities of up to 98% concerning the DNA sequence. (5) This innovative laser 
microdissection-based nanotechnological approach for ancient DNA analysis of bone material 
could after all be highlighted versus a conventionally performed pathological technique for 
sample retrieval. The traditional method was based on pulverization of bone material. In using 
the novel technology considerably more authentic ancient DNA molecules could be isolated 
while simultaneously impacts of destructive factors could be eliminated.  
 Zusammenfassung 
Vor dem Hintergrund eines ständig wachsenden Bedarfs an schnelleren, kostengünstigeren 
und sensitiveren Nachweisverfahren, insbesondere im Bereich der DNA Analytik, sind 
innovative Entwicklungen unerlässlich. Miniaturisierte Labore auf elektrischen Chips sind ein 
Beispiel solcher hochentwickelten Technologien. Ihr Einsatz gewinnt sowohl in der 
medizinischen Diagnostik als auch in der Forensik zunehmend an Bedeutung, vor allem 
deshalb, weil häufig nur sehr geringe Probenmengen zur Verfügung stehen und diese zudem 
kontaminationsfrei analysiert werden müssen. In dieser Arbeit wird ein multifunktionales 
Chiplabor vorgestellt, das zur Analyse kleinster Mengen sehr unterschiedlicher 
Probenmaterialien eingesetzt werden kann. Das Chiplabor zeichnet sich durch einen 
modularen Charakter aus. Die einzelnen Einheiten zur Probengewinnung, Prozessierung und 
Detektion wurden hinsichtlich ihrer Leistungsfähigkeit optimiert. Die Anwendbarkeit des 
Chiplabors in der forensischen DNA-Analytik wurde am Beispiel mehrerer aktueller 
wissenschaftlicher Fragestellungen demonstriert. Nach kontaminationsfreier 
Lasermikrodissektion wurden die gewonnenen Proben auf einer chip-basierten DNA-
Vervielfältigungseinheit verarbeitet. Auf einer chemisch strukturierten planaren 
Chipoberfläche wurden virtuelle, durch Oberflächenspannung stabilisierte Reaktionsgefäße in 
Form kleiner Flüssigkeitströpfchen gebildet. Die dadurch ermöglichte Miniaturisierung des 
Reaktionsvolumens auf nur 1 µl ermöglichte kontaminationsfreie Analysen geringster 
Mengen von Probenmaterial. Auf diese Weise konnte eine höhere Sensitivität als in 
großvolumigen Plastikgefäß-basierten Reaktionen erzielt werden. Das miniaturisierte 
Reaktionsvolumen erlaubte eine Reduktion der PCR-Zykluszeiten auf 15 Sekunden pro 
Zyklus. Die für aussagekräftige genetische Analysen benötigte Menge an Ausgangsmaterial 
ließ sich auf eine minimale Menge von 25 pg DNA reduzieren. 
Ausgehend von verlässlichen, reproduzierbaren und hoch sensitiven Analysen mit gereinigter 
Standard DNA, wurde die Anwendbarkeit des Chiplabors auf verschiedenartige, flüssige 
sowie feste Proben von forensisch relevantem Material getestet. (1) Bei Einsatz von nur 1% 
(v/v) ungereinigtem Vollblut konnten in PCR-basierter Analyse vollständige DNA-Profile zur 
Generierung genetischer Fingerabdrucke ermittelt werden. (2) Getrocknete Blutstropfen 
wurden über einen Zeitraum von mehreren Minuten bis zu drei Monaten untersucht. In 
Abhängigkeit vom Status des Trocknungs- und Koagulationsprozesses ließen sich bis zu 92% 
vollständig nachweisbare DNA-Profile gewinnen. (3) Mikrodissektierte Gewebepartikel aus 
pathologisch relevanten Geweben konnten direkt in PCR-basierter 
 Geschlechtsbestimmungsanalyse ohne vorherige DNA Extraktion männlichen und weiblichen 
Individuen zugeordnet werden. (4) Der selbst gestellte Anspruch, hochsensitive, 
kontaminationsfreie Analysen durchführen zu können, wurde an sehr altem Knochengewebe 
aus ägyptischem Mumienmaterial demonstriert. Nach Lasermikrodissektion konnten aus einer 
Startmenge von nur 60 pg historischen DNA Materials in PCR-basierten Analysen DNA-
Fragmente von bis zu einer Länge von 297 bp vervielfältigt werden. Die Authentizität der 
vervielfältigten Fragmente konnte in Vergleichen mit gängigen Genom-Datenbanken 
bewiesen werden, mit einer Übereinstimmung hinsichtlich der DNA-Sequenzen bis zu 98%. 
(5) Die Vorzüge dieses innovativen, auf Lasermikrodissektion basierenden, 
nanotechnologischen Ansatzes zur DNA-Analyse aus Knochenmaterial wurden schließlich 
durch Vergleich mit Untersuchungen belegt, bei denen eine herkömmliche pathologische 
Technik zur Probengewinnung eingesetzt wurde. Die konventionelle Technik basierte auf 
einer Pulverisierung des Knochenmaterials. Mit der neuen Technologie konnten deutlich 
mehr authentische alte DNA Moleküle isoliert und gleichzeitig Einflüsse von schädlichen 
Faktoren vermieden werden. 
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1.  Introduction 
During the past decade, molecular biologic genetic analysis tended to be performed at a high-
resolution level, where only microscopically small amounts of sample material were needed 
for analysis. In this way, the handling of such small samples needs sophisticated miniaturized 
tools. The field of developing miniaturized and specified sample processing platforms has a 
highly interdisciplinary character. A convergence of several disciplines at the nanoscale must 
be achieved, namely engineering, electronics, informatics, biology, chemistry and physics. In 
order to find a way for adapting all necessary operations for sample handling onto a small 
device, one needs to combine technical skills with biological know-how. While a variety of 
sample materials need to be considered for application, they all need to be tracked down to 
the basic material used for analysis, which is the DNA molecule. The following paragraphs 
outline some fundamental knowledge of genetics and DNA analysis. Afterwards an overview 
is given over the present status of the efforts undertaken to integrate sample-processing steps, 
in particular the polymerase chain reaction, in microfluidic structures. 
1.1  DNA analysis 
Over the past years DNA analysis became one of the most fascinating fields of research and 
gained enormous importance in all areas of life: in ancestry research, prenatal diagnosis and 
criminalistics, diagnosis of diseases as well as in determination of paternity or natural 
abilities. Due to the great efforts, which had been made during 1990 and 2003 by the 
international Human Genome Project (HGP), the information kept in the DNA molecule 
became especially accessible and usable for well-directed analysis. The primary goal of the 
HGP was to determine the sequence of the three billion chemical base pairs, which make up 
human DNA and to identify approximately 30,000-35,000 genes in human DNA 
(http://ornl.gov/sci/techresources/Human_Genome/home.shtml). 
The DNA, which stands for deoxyribonucleic acid (DNA), represents the unique molecule 
housing the total construction plan of living organisms. Together with structural proteins 
DNA is organized in complex structures called chromosomes, which are stored in the nucleus, 
the biggest cellular organelle in eukaryotic cells. Each human cell contains exactly 46 
chromosomal DNA molecules differing in size and in their informational content. From the 
molecular side the DNA molecule is composed of two complementary strands described as 
double-helix (figure 1 A), each consisting of a sugar-phosphate backbone (blue strands in 
1. Introduction 
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figure 1 A) carrying a definite sequence of four nucleotide bases adenine (A), guanine (G), 
thymine (T) and cytosine (C) (green and violet pairs in figure 1 A). These nucleotides, and 
thus both DNA strands, are connected via hydrogen bonds, while A and T form a dual bond 
and C and G a triple bond. Solely via the defined sequence of these four nucleotide bases, 
having a fixed order within three billion base pairs in total, the biologic information of 
approximately 30,000-35,000 genes is encoded. Genes are defined as domains of the genome 
that encode specific structural information for building polypeptide chains for the assembly of 
proteins. Among humans, the nucleotide sequence of each gene is fixed. However, areas 
encompassing genes coding for proteins comprise just 2% of the whole DNA genome. The 
information stored in the remaining non-coding 98% of the DNA, also called “junk DNA” 
(Venter JC et al., 2001), provides no genetic information, does not code for proteins, but 
contains useful marker loci for DNA profiling, linkage information and recognition sequences 
for the DNA polymerase enzyme to start replication. The four nucleotides A, T, G and C in 
these non-coding parts of the DNA are organized in sequences of repeated tandem array 
modules. Several non-coding elements are known to be located there, for instance 
pseudogenes, transposons like Alu repeats, as well as microsatellite and minisatellite modules, 
which are simple sequence repeats also known as short tandem repeats (STRs). The number 
of these repeating units is highly variable among individuals as they inherited differing 
numbers of these allelic repeat units from their parents. 
 
Figure 1. The structure of DNA and the principle of PCR analysis. A) The DNA is a macromolecule shaped 
in form of a twisted step-ladder named double-helix, which is 2 nm in width. Four nucleotide bases A, T, G, C 
are arrayed along two complementary strands (blue), bound via hydrogen bonds (two between A and T, three 
between C and G) and house genomic information. The DNA double helix is further coiled around nucleosomes 
and then twisted several times in a helical way to pack the amount of information into a single compact molecule 
(from Mange EJ and Mange AP, 1999). B) Schematic principle of the polymerase chain reaction. One PCR 
cycle is shown characterized via three particular temperatures effecting amplification. The three important steps 
are 1) DNA denaturation at 94°C to convert a double- into a single-stranded molecule, 2) primer annealing at 
50°C and 3) primer extension to a complementary strand at 72°C by the action of a thermostable DNA 
polymerase. Repeated cycling for 30-45 times results in an exponential increase in the amount of DNA material 
that is supposed to be amplified. 
1. Introduction 
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Thus, nowadays, these STR fragments provide the standard method for DNA profiling via a 
PCR-based method called STR fragment length analysis. DNA profiling kits generally test for 
10-16 STR markers and a sex marker. The probability of a stochastical match between 
unrelated individuals is on average less than one in a billion, which makes DNA profiling 
very reliable. 
There is a wide spectrum of procedures that have been established up to now to analyze 
genomic DNA, and all these procedures basically follow the same elementary steps. As DNA 
is stored in the cells of biological sample material, DNA molecules need to be made 
accessible and must be extracted, purified from cell debris and often concentrated prior to 
genetic analysis. As usually the amount of isolated DNA is not sufficient for direct detection, 
an amplification step is mandatory, like e.g. via the polymerase chain reaction. 
The technique of polymerase chain reaction (PCR) was one of the greatest scientific 
discoveries in the last century. It is nowadays one of the most commonly used standard 
methods applied in modern biomolecular analytics to amplify segments of double-stranded 
DNA when only a small amount is available. Since its development in 1983 by Kary Mullis, 
who was honored with a Nobel prize in chemistry in 1993 for that, the PCR has 
revolutionized molecular biology (Saiki RK et al., 1985; Mullis KB et al., 1994). The PCR is 
an enzyme-catalyzed process, which makes use of the DNA polymerase, an enzyme 
catalyzing DNA replication within cells for purposes of DNA duplication and cell division. 
For performing PCR, besides enzymatic activity also a pair of primers is needed, that flank 
the DNA fragment that is to be amplified. Primers are short oligonucleotides that are designed 
to comprise a sequence complementary to the end parts of the DNA segment going to be 
amplified (Saiki RK et al., 1988). The PCR is a temperature-dependent process, where three 
steps are mandatory to amplify a template DNA sample, namely denaturation, annealing and 
extension (figure 1 B). As the DNA polymerase can only work on single-stranded molecules, 
in the denaturation step both DNA strands are separated by overcoming binding forces and 
breaking the hydrogen bonds between base pairs at 94°C. After denaturation, temperatures 
between 50-65°C facilitate primer binding for bordering the target sequence. The specific 
annealing temperature is dependent on the primer length and its composition. This generated 
short double-stranded sequence provides the fundament for the DNA polymerase to start 
primer extension at a temperature of about 72°C, synthesizing a complementary DNA 
segment. Due to the high temperatures especially during the denaturation step, heat-stable 
variants of the DNA polymerase are utilized, originating from thermophile bacteria, like e.g. 
the Taq DNA polymerase from Thermus aquaticus (Saiki RK et al., 1988). Repeated cycling 
1. Introduction 
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through these three temperatures, each doubling the amount of DNA theoretically, results in 
an exponential increase in the number of copies of a specific DNA sequence, relative to the 
original number of DNA template copies. Due to this exponential duplication, PCR is highly 
sensitive as theoretically one single DNA strand is sufficient to produce up to 1012 identical 
molecules. Sometimes the annealing and extension steps are combined into one step and 
performed at the annealing temperature comprising a 2-step PCR procedure in contrast to the 
generally performed 3-step protocols. During PCR, transition times between temperatures 
should be kept as short as possible to avoid formation of non-specific byproducts and to 
reduce the thermal stress on the DNA polymerase. Thus, fast cooling and heating times are 
mandatory. Since its conception, the PCR has become one of the main laboratory tools in the 
life sciences, and has revolutionized many applications including molecular biological-, 
clinical diagnostic-, medical-, biomedical-, forensic-, or agricultural-related analysis (Auroux 
PA et al., 2002; Auroux PA et al., 2004; Vilkner T et al., 2004; Chen L et al., 2007).  
1.2  Micro total analysis systems 
During the last decade, the miniaturization of bioanalytical processes has become a broad 
field of research due to the related enormous advantages. For instance, scaling down analyte 
volumes saves costs. Improving sample throughput through parallelization and automation is 
a further major advantage. 
Miniaturization became possible by the development of microfabrication technology for 
generating micro-electro-mechanical-systems (MEMS), which was acquired from the rapidly 
evolving electronics industry in the early 1990s. This technology allowed the production of 
microfluidic devices that are capable of handling, manipulating and processing small amounts 
of liquid. An envisioned integration of all sample-processing steps to one single microdevice 
established growing interest in this field of research. In the 1990s the term “micro total 
analysis system (µTAS)” was introduced describing the idea to operate whole processes on 
microfluidic platforms serving as a “lab-on-a-chip” (Manz A et al., 1990; Auroux PA et al., 
2002; Reyes DR et al., 2002; Vilkner T et al., 2004; Dittrich PS et al., 2006). A µTAS device 
was projected being capable of incorporating many macroscale techniques like sample 
handling, analysis, and detection altogether onto just one single miniature microfluidic 
instrument. These µTAS-related features were envisioned to enhance selectivity and 
sensitivity of analytical performances as well as enabling a more economical consumption of 
sample material, reagents, chemicals and reaction volumes. Within the last decade, the area of 
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microfluidic technology associated with µTAS has been a rapidly developing field (Craighead 
H, 2006; deMello AJ, 2006; El-Ali J et al., 2006; Janasek D et al., 2006, Whitesides GM, 
2006; Yager P et al., 2006). A huge variety of excellent publications concerning µTAS can be 
found in literature (for a broad overview see reviews of Reyes DR et al., 2002; Auroux PA et 
al., 2002; Roper MG et al., 2005; Dittrich PS et al., 2006; Zhang CS et al., 2006; Horsman 
KM et al., 2007; Zhang C and Xing D, 2007; Chen L et al., 2007; Zhang Y and Ozdemir P, 
2009). Almost day after day novel articles concerning miniaturized analysis systems are 
published online and the area of micro total analysis systems is still growing rapidly. 
The rapid development of microdevices over the past decade has pioneered the interest for 
their application in forensic genetic analysis (Jin LJ et al., 2001; Huang Y et al., 2002; for a 
broad overview see Horsman KM et al., 2007). In improving the particular macroscale sample 
processing steps, like e.g. sample preparation, yielding, cell sorting, DNA extraction, DNA 
quantitation, PCR amplification and DNA separation, microdevices are envisioned to become 
“the” technology in future forensic DNA laboratories. In this way, microdevices have the 
potential to revolutionize even forensic DNA testing with state-of-the-art analytical 
technology. In particular, great effort has been put into the miniaturization of genetic tests 
(Auroux PA et al., 2004; Kricka LJ and Wilding P, 2003; Zhang C and Xing D, 2007), 
especially with regard to the miniaturization of the polymerase chain reaction. As the original 
cellular material available for genetic analysis is often extremely limited, miniaturized PCR 
gives the advantage of low reagent and sample consumption. Besides microchip PCR, 
miniaturizing labor-intensive preparative steps of biological material has brought some 
advancement as well, but still remains a delicate task due to complexity of methods and 
variety of target sample materials. Comparable efforts have been made in miniaturizing post-
PCR product detection methods, like the size-dependent separation of DNA fragments in 
restriction fragment length polymorphism (RFLP) or STR analysis for purposes like DNA 
fingerprinting or DNA profiling.  
Modular, single-process devices as well as totally integrated microfluidic systems are in 
development to fill both high-throughput batched and complete single-sample analysis niches. 
However, the standardization, commercialization and final manifestation of microdevices in 
forensics will surely take another decade.  
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1.2.1  Miniaturization of PCR technology 
Enormous efforts have been undertaken to integrate the polymerase chain reaction in fluidic 
microdevices due to its universal importance for fast gene-based analytics and the advantages 
of miniaturization.  
Conventionally, PCR is performed in thin-walled plastic tubes comprising reaction volumes 
in the range of 2-50 µl, which are inserted into a chambered temperature-controlled metal 
block for performing material amplification. This setup bears a number of issues being 
disadvantageous for a fast analysis performance. As not only the PCR mixture needs to be 
heated up and cooled down, but also the whole chambers, traditional PCR systems are 
characterized by a large thermal mass, leading to slow heating and cooling rates and lengthy 
PCR reactions. The key to faster thermocycling was either increasing the heat transfer rate or 
decreasing the thermal mass, or both. The long transition times and the high power 
consumption of these conventional bulky systems eliminate the possibility of making a 
battery-operated and portable PCR system. In addition, the reaction tubes are large and the 
required amount of PCR reagents makes the whole process expensive. As the detection of 
PCR products has generally to be done off-line, i.e. in another instrument, additional costs can 
be listed. 
In comparison, the miniaturization of PCR devices offers numerous remarkable advantages 
over current conventional macroscopic technologies. First, the volume of PCR mixture 
thermocycled is reduced by several orders of magnitude, having PCR chambers with reaction 
volumes on the order of microliters to nanoliters. For microchip PCR this means a low 
reagent as well as sample consumption, decreasing the costs for genetic analysis dramatically. 
Second, due to the small dimension of microfluidic technology much faster analysis times can 
be achieved. As just the microchip substrate or the reaction solution undergoes heating and 
cooling procedures, the thermal mass is reduced massively providing a rapid heat transfer. As 
cycling rates depend on rapid heating and cooling rates of the device, microdevice PCR 
benefits with increased speed of thermocycling. Microchip PCR not only affords much 
shorter assay times, but also favors less power consumption and a great potential of 
integrating multiple processing modules for high-throughput purposes. High-throughput is 
one of the most important issues in fabricating PCR microdevices. As most conventional 
thermocyclers hold 24 to 96 polypropylene tubes, multiple PCR chambers for simultaneous 
reactions (most importantly positive and negative controls) and multiplex amplifications must 
also be integrated into microchip PCR devices. 
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Besides these quantitative advantages, analytical microchips offer further significant benefits 
over existing methods concerning quality of analysis. Due to the dramatic decrease in reaction 
volumes, these include enhanced analysis sensitivity and efficiency as well as increased 
quality of assays with respect to sample tracking and reproducibility due to the potential of 
automation (Auroux PA et al., 2002; Reyes DR et al., 2002; Vilkner T et al., 2004; Dittrich 
PS et al., 2006). Decreased sample handling due to automation of nearly all necessary 
processes, from sample preparation to outcome of analysis results, is also a remarkable 
attribute. This is a key feature particularly for the forensics community, providing less facility 
for sample contamination during processing steps. In order to eliminate cross-contamination 
between samples, the safest way is by using a disposable system (as reported and realized by 
Neuzil P et al., 2006 (a+b)), while at the very least the part of the device, which comes into 
contact with the sample, should be disposable. A further attractive feature of miniaturized 
PCR is its portability, making it useful for in-the-field analysis.  
Despite an enormous number of published and patented PCR microchips and miniaturization 
methods for integrating PCR into microdevices, only a few of them have been 
commercialized (Kricka LJ and Wilding P, 2003). One example is the miniature analytical 
thermal cycling instrument (MATCHI) (Ibrahim MS et al., 1998; Northrup MA et al., 1998). 
However, the market for PCR-on-chip systems is still triggered by the increasing demand for 
such systems in molecular diagnostics, for applications such as blood screening for infectious 
diseases, but also for forensics, paternity, food-safety, agri-diagnostics and veterinary 
applications. 
1.2.2  Modes of microchip-based PCR 
Numerous designs of PCR microdevices became popular varying in basic chip substrates 
(Reyes DR et al., 2002), surface treatments to prevent sticking of biomolecules, chip 
architectures and purposes of being modular systems or integrated ones. The architecture of a 
microdevice is certainly the most important feature as it defines its function, reaction speed, 
reaction volume and the sequence of actions taking place on the device. Some devices were 
just concentrating on on-chip preparative steps, while PCR analysis of sample material was 
performed off-chip. Others just focused on on-chip PCR followed by on-chip detection 
methods like e.g. capillary electrophoresis or microarray, while applying pre-purified DNA 
sample material. The technically most challenging lab-on-a-chip devices integrated all sample 
processing steps. A review about these features was provided by Zhang C and Xing D (2007). 
Concerning the architecture, three modes of microchip PCR technologies have been 
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established for fitting to a small chip. 3-dimensional approaches were realized as a) stationary 
cavity-based or b) continuous flow-through devices, while a 2-dimensional solution was 
provided in c) virtual reaction chamber-based ones. All three methods comprise special 
developed chip architectures, including various designs of PCR chambers and heating 
technologies (figure 2). The three modes of microchip-based PCR technology are described 
in brief in the following paragraphs. 
 
Figure 2. Modes of performing microchip PCR. A) Stationary chamber-based PCR. The PCR sample is 
thermocycled via heating the whole chamber. B) Continuous-flow or flow-through PCR. The PCR sample is 
thermocycled via being pumped along an unidirectional channel system through different temperature zones. C) 
Virtual reaction chamber PCR. The PCR sample is thermocycled via heating the chip surface locally. Figures 
were adapted from Thalhammer S (2009). 
a) Stationary cavity- or chamber-based PCR microdevices. Stationary cavity-based PCR is 
performed in single or multiple miniaturized PCR chambers. The PCR solution is kept 
stationary within the cavity, while the temperature of the reaction chamber is cycled between 
PCR relevant temperatures. The first chamber-based PCR microdevice was presented by 
Northrup MA et al. (1993), followed by several similar approaches (Wilding PJ et al., 1994; 
Waters LC et al., 1998; Lagally ET et al., 2001). In the following years, simple functions on 
microfabricated devices have been reported that can perform analysis of nucleic acids (Yang J 
et al., 2002; Sethu P and Mastrangelo CH, 2004; Chung YC et al., 2004) as well as detection 
of pathogenic bacteria and genotyping (Liu RH and Grodzinski P, 2003; Liu RH et al., 2004; 
Liu Y et al., 2003; Lagally ET et al., 2004; Lagally ET et al., 2001). The most straightforward 
stationary cavity-based PCR approaches fabricated integrate an array of reaction chambers of 
micro-, nano- or even picoliter volumes for parallel PCR reactions (Burns MA et al., 1998; 
Krishnan M et al., 2004; Lee DS et al., 2004; Liu J et al., 2003; Northrup MA et al., 1998; 
Woolley AT et al., 1996). Recently, a channel-based three-dimensional arrayed micro 
droplet-in-oil microfluidic easy-to-handle PCR platform was introduced by Zhang Y et al. 
(2009). It was used as efficient tool for DNA analysis, performing 108 reactions in parallel.  
A distinct advantage of stationary systems is the fact that only the temperature of the chamber 
needs to be cycled in order to modify the temperature of the PCR solution, while an external 
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pumping system or other means to move the PCR sample around are not required. However, 
due to complex architectures, very complicated microfluidic control modules were usually 
incorporated. These require experienced operational skills and thus are difficult to handle as 
well as difficult to fit into routine biological laboratories and clinical settings. Additionally, 
heating the whole chamber is quite disadvantageous, as that attributes a large total thermal 
mass to these PCR chips and heat transfer from the heater to the sample is a limiting factor for 
fast systems.  
b) Continuous flow-through PCR microdevices. This mode of microchip PCR features a 
dynamic process, where the solution is continuously pumped through a microfluidic channel 
system into differently heated temperature zones. The first flow-through PCR device was 
introduced in 1994 (Nakano H et al., 1994) and has been refined in subsequent approaches 
(Kopp MU et al., 1998; Köhler JM et al., 1998; Chiou J et al., 2001; Liu J et al., 2002; Chen 
ZY et al., 2004; Hashimoto M et al., 2004; Wang H et al., 2006; Mohr S et al., 2007). The 
latest developments of continuous-flow microfluidic PCR are summarized in a review of 
Zhang Y and Ozdemir P (2009).  
The prominent advantage of flow-through systems is that they typically comprise zones at 
three constant temperatures, so that only the sample needs to change temperature by moving 
between zones. In this way the thermal mass is reduced to a minimum and cycling can be 
performed at high speeds. Based on this principle, an elegant solution was provided by 
infrared radiation (IR) as heat source (Oda RP et al., 1998; Hühmer AFR and Landers JP, 
2000; Giordano BC et al., 2001 (a)). The IR light source was used to selectively heat the 
water in solution rather than the microdevice substrate, resulting in extremely rapid cycling 
times. The type of flow-through PCR is faster than the first one, but it requires an 
implementation of a mechanism to move the sample around. In both cases, the heaters are 
integrated with the PCR system, so it is not economical to dispose the device to avoid cross-
contamination after performing only a single test. Another prominent disadvantage is the 
requirement of an external bulky syringe pump for moving the fluid, which negatively affects 
the development of compact, portable and integrated continuous-flow PCR chips. 
Additionally, high fabrication cost and difficulties controlling the continuous liquid flow have 
been reported, and parallelization cannot easily be realized as it complicates chip architecture. 
c) Virtual reaction chamber PCR microdevices. In virtual reaction chamber (VRC) PCR 
devices, miniaturization is realized by performing PCR in free micro droplets on chemically 
modified surfaces. Using a hydrophobic and oleophobic structured planar surface providing 
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fluid confinement, small-scale droplets themselves function as virtual test tubes held together 
by surface tension of the liquid and surface chemistry of the substrate. To prevent evaporation 
and cross-contamination, droplets are covered by mineral oil in an old-fashioned way. The 
first virtual reaction chamber PCR device was introduced in 2005 (Guttenberg Z et al., 2005), 
which has been advanced in several ways (Neuzil P et al., 2006 (a); Neuzil P et al., 2006 (b); 
Pipper J et al., 2007; Pipper J et al., 2008). Actuating droplets on the planar surface rely on 
electrowetting (Srinivasan V et al., 2004), dielectrophoresis (Gascoyne PRC et al., 2004), 
(electro-)magnetic forces in combination with superparamagnetic particles (Lehmann U et al., 
2006), or surface acoustic waves (Guttenberg Z et al., 2005).  
An open and planar PCR microdevice excels a lot of advantages over conventional 3-
dimensionally fabricated devices, following practicability issues. 1) While stationary chamber 
and flow-through PCR devices have complex three-dimensional architectures and are based 
on complicated MEMS processes, a planar VRC PCR device can be fabricated much simpler. 
2) Especially the manipulation of individual droplets on a planar surface offers an attractive 
option for µTAS devices with regard to flexibility purposes. The open chamber design 
provides easy access to surface modification and post-PCR sample retrieval for downstream 
analysis.  3) As the majority of micro PCR chips comprise closed chamber systems, requiring 
filling up the entire reaction chamber with reaction mixture, the reaction volume is 
indispensable defined by the chamber size once the device is fabricated. In open, planar, 
virtual reaction chamber devices, the reaction volume can be further reduced using the same 
device (Guttenberg Z et al., 2005). 4) As reaction droplets are completely isolated from 
contaminating environmental influences due to hydrophobic coverage, the chance of 
contamination is minimized. 5) The temperature control box can be physically separated from 
the PCR reaction chip and reused, so that just the microchip needs to be replaced for each new 
reaction (Neuzil P et al., 2006). Such kinds of disposable PCR chips are the most 
straightforward approach in order to eliminate sample-to-sample cross-contaminations in PCR 
microdevices. Since 2005, this slide-based virtual reaction chamber microPCR technology 
has been optimized for parallel processing, and became also known as low-volume PCR. Via 
chemical surface treatment 48-60 hydrophilic PCR reaction spots were generated on one 
single glass slide and arranged in an array-like manner. Several applications of this low-
volume PCR based devices were reported, mostly employed in the forensics field of research 
(Proff C et al., 2006; Schmidt U et al., 2006; Lutz-Bonengel S et al., 2007; Schmidt U et al., 
2008).  
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1.3  Scope of this work 
When starting this work the presented lab-on-a-chip comprised two stand-alone units, a laser 
microdissection module for sample retrieval and a planar chip-based DNA amplification unit 
operating the virtual reaction chamber PCR technology. In course of this thesis, the two basic 
modules were combined to a whole modular lab-on-a-chip system by adding three more units 
(in collaboration with cooperative project partners). The implemented modules include a 
transfer system for loading the analysis chips of the DNA amplification unit with 
microdissected sample material, a PCR product detection unit and an automatic fluid 
dispensing device serving the planar analysis chip. 
After integration, the aim of the presented work was to test the developed modular lab-on-a-
chip system for its use in forensic genetic DNA analysis. The focus was to identify the 
smallest amount of sample material allowing for a fast, reliable and sensitive analysis. 
Furthermore, the analytical procedures for operating at the minimum level of contamination 
had to be explored. These features are especially important in forensic genetic DNA analysis, 
in which case the amount of available sample material is often very small. The approach 
described here also serves to minimize the time and cost of analyses.  
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2.  Materials and Methods 
2.1  Sample materials and preparation 
In the following short paragraphs all kinds of sample materials utilized for genetic analyses 
are summarized. The particular procedures of sample preparation prior to analysis are 
described as well. 
2.1.1  Male and female human genomic reference DNA 
Male and female control DNA was extracted using the peqGOLD Tissue DNA Mini Kit 
(PeqLab Biotechnologie GmbH, Erlangen, Germany) to provide purified DNA material 
serving as reference samples. Female DNA was extracted from HeLa cells (cultivated in 
DMEM medium and kindly provided by a collaborative laboratory of the Ludwig-
Maximilians-University, Munich, Germany), while male DNA was extracted from a fresh 
heparin-treated male blood sample originating from a laboratory member. DNA extraction 
was performed according to the respective protocols for blood or cultured cells, recommended 
by the manufacturer. Concentration of purified eluates was measured via UV 
spectrophotometry (NanoDrop ND-1000, PeqLab Biotechnologie GmbH, Erlangen, 
Germany) and reached values from 291.1 ng/µl to 459.5 ng/µl concerning the female 
reference sample and values from 5 ng/µl to 10 ng/µl concerning the male reference sample. 
Using sterile water for dilution (Ampuwa, Fresenius, Bad Homburg, Germany), small 
aliquots of male and female reference DNA were prepared to known concentrations of  
100 ng/µl, 10 ng/µl, 5 ng/µl and 1 ng/µl and stored in sterile 0.5 ml PCR-tubes (Eppendorf 
AG, Hamburg, Germany). 
2.1.2  Paraffin-embedded human intestine, mamma and bladder tissue 
Eight tissue samples of three human tissues were examined and were derived from male and 
female individuals. Tissues originated in one case from bladder tissue (named tissue3), in one 
case from mamma tissue (named tissue6) and in 6 cases from intestine tissue of individuals 
(named tissue1, tissue2, tissue4, tissue5, tissue7 and tissue8). Tissue pieces of about 2x2 cm 
in diameter were embedded into square paraffin blocks. Microtome-cut tissue sections of  
2-4 µm were placed on an ultra thin 2 µm polyethylene-naphthalate laser supporting carrier 
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membrane (PEN), mounted on 1.00 mm thick standard microscope object slides 
(MicroDissect GmbH, Herborn, Germany). These paraffin-embedded tissue sample slides 
were kindly provided by the Institute of Pathology (Klinikum Bogenhausen, Munich, 
Germany). Deparaffinization was achieved by xylene incubation (Merck KGaA, Darmstadt, 
Germany) for 30 min and subsequent decreasing alcohol series (100% EtOH for 5 min, 90% 
EtOH for 2 min and 70% EtOH for 2 min; Merck KGaA, Darmstadt, Germany) at room 
temperature. After drying, tissue material, fixed on 2 µm PEN carrier membrane coated 
slides, was used for laser microdissection. 
2.1.3  Anticoagulant treated whole blood 
Whole blood samples from four individuals were examined, two male (named 1 and 2) and 
two female ones (named 3 and 4). Blood specimens were collected into EDTA K treated 
blood collection tubes (Monovettes, SARSTEDT AG & Co., Nümbrecht, Germany), to 
inhibit blood clotting and coagulation. Small 100 µl aliquots of 100% whole blood and 10% 
blood (v/v), diluted with sterile water (Ampuwa, Fresenius, Bad Homburg, Germany), were 
stored in sterile 0.5 ml PCR-tubes (Eppendorf AG, Hamburg, Germany). Consistently 0.1 µl 
of 100% and diluted 10% whole unpurified blood samples was used per 1 µl LV-PCR 
reaction volume, resulting in final dilutions of 10% and 1% blood (v/v) per reaction. 
2.1.4  Time dependant setup of degrading dried blood spots 
Whole blood specimens from a female individual were collected into conventional plastic 
syringes (Becton Dickinson GmbH, Heidelberg, Germany), without adding anticoagulants. 
Immediately after extraction, several blood spots of 1 µl of volume were spread onto pre-
cleaned and decontaminated object slides (Carl Roth GmbH, Karlsruhe, Germany) and dried 
at room temperature. Before use, object slides were cleaned with 70% EtOH (Merck KGaA, 
Darmstadt, Germany) and decontaminated using a UVC light source (PCR Workstation, 
PeqLab Biotechnologie GmbH, Erlangen, Germany) for at least 60 min. For analysis, samples 
of dried blood spots were taken after 0 min, 30 min, 60 min, 120 min, 6 h, 24 h, 2 days, 4 
days, 7 days, 2 weeks, 3 weeks, 4 weeks and 3 months. For sample take-up, single dried blood 
spots of 1 µl were resolved in 10 µl of sterile water (Ampuwa, Fresenius, Bad Homburg, 
Germany) on the surface of the object slide. Final dilutions of 10% blood (v/v) were 
transferred into sterile 0.2 ml PCR-tubes for storage (Eppendorf AG, Hamburg, Germany). 
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Using consistently 0.1 µl of this diluted 10% blood samples for analysis resulted in a final 
dilution of 1% blood (v/v) per 1 µl LV-PCR reaction volume. 
2.1.5  Ancient bone tissue material 
Bone tissue samples from four ancient Egyptian mummies of the ‘Mummy Collection of 
Munich’ were examined and derived from an independent laboratory after anthropological 
and archaeological study. The mummies originally originated from the so-called ‘Tombs of 
the Nobles’, the huge necropolis of Thebes-West that had been mainly built during the New 
Kingdom (NK) (c. 1550 – 1070 BC) and which had been used during the Third Intermediate 
Period (TIP) until the Late Period (LP) (ca. 500 BC). According to the collection records, the 
long bones originated from mummies found in four different tombs of the necropolis of 
Thebes-West. The four specimens were all long bone samples and comprised of a fibula 
(named mummy1), a distal part of a tibia (named mummy2), a distal part of a humerus 
(named mummy3) and a tibia diaphysis (named mummy4).  
Paraffin-embedded ancient bone tissue material. Bones were first cleaned with sodium 
hypochlorite (0.5% solution) and subsequently the outer surface was removed mechanically 
with appropriate sterile tools. To avoid external contamination, several tissue samples were 
taken exclusively from the inner parts of the bones in a nested way using sterile blades. A 
tissue block from each of the four bone samples was removed and subsequently rehydrated 
(Parsche F and Nerlich A, 1997). For paraffin-embedding procedures, decalcification of bone 
particles was achieved by 0.1 M EDTA-solution, pH 7.4, followed by post-fixation with 4% 
buffered formaldehyde. After paraffin-embedding of nested isolated tissue blocks, sections of 
3-5 µm in size were cut via microtome and placed on a 2 µm ultra thin polyethylene-
naphthalate (PEN) laser supporting carrier membrane, mounted on 0.17 mm thin microscope 
cover glass slides (MicroDissect GmbH, Herborn, Germany). Prepared paraffin-embedded 
bone tissue sample slides were kindly provided by the Institute of Pathology (Klinikum 
Bogenhausen, Munich, Germany). Deparaffinization was achieved by xylene (Merck KGaA, 
Darmstadt, Germany) incubation for 30 min and subsequent decreasing alcohol series (100% 
for 5 min, 90% EtOH for 2 min and 70% EtOH for 2 min; Merck KGaA, Darmstadt, 
Germany) at room temperature. After drying, sample material, fixed on 2 µm PEN carrier 
membrane coated slides, was used for laser microdissection. 
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DNA extracts from pulverized ancient bone tissue material. Bones were first cleaned with 
sodium hypochlorite (0.5% solution) and subsequently the outer surface was removed 
mechanically with appropriate sterile tools. Bone particles of the four bone samples were 
pulverized using a mixer mill (MM200, Retsch, Haan, Germany). Pulverized bone specimens 
were subjected to conventional pathological DNA extraction (Zink A et al., 2003). DNA 
extraction was tested by UV spectrophotometry (NanoDrop ND-1000, PeqLab 
Biotechnologie GmbH, Erlangen, Germany), measuring the DNA concentration of extracted 
mummy DNA material. DNA amounts of 2.1 to 10.0 ng/µl were measured from 1 g of 
pulverized bone tissue. Amounts of 50 pg respectively 100 pg of this conventionally extracted 
mummy DNA material were used for LV-PCR analysis. 
2.1.6  Genomic sample material of individuals 
Genomic sample material was extracted from scientific staff for DNA profiling purposes in 
anticipation of introduced external contaminating events, in particular in regard to ancient 
sample materials. Saliva samples were taken from archaeologist/excavator of Egyptian 
mummy material, technical assistance staff, laboratory members and involved scientists, 
simply all people who have been knowingly in contact with laboratory equipment and 
consumables and any kind of mummy material used. In the following these individuals are 
termed ‘scientific staff’. Sample material of scientific staff as potential contaminators was 
extracted from saliva via sterile cotton buds (Nuova Aptaca, Canelli (AT), Italy) and dried for 
20 min at 37°C. To isolate DNA out of dried saliva samples the First-DNA All-tissue DNA 
kit (Gen-ial, Troisdorf, Germany) was used according to the manufacturer’s protocol. To 
release saliva cell material from cotton buds, tips of cotton buds were transferred into 450 µl 
of lysis solution. Finally, pellets were diluted with sterile water (Ampuwa, Fresenius, Bad 
Homburg, Germany) to a final volume of 20 µl. For DNA typing reactions of scientific staff, 
1 µl of these DNA extracts was used in LV-PCR analysis. 
2.2  Experimental techniques 
The following sections summarize all techniques that were used for processing sample 
materials. Pre-PCR and post-PCR applications are described as well as all kinds of hardware 
devices utilized. 
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2.2.1  Temperature measurement 
Temperature measurements were performed on the CytoCycler PCR module of the lab-on-a-
chip system to test for heat transfer capabilities. The CytoCycler and its components were 
fabricated by the company Advalytix AG/Beckman Coulter Biomedical GmbH (Munich, 
Germany). It was a module of the lab-on-a-chip (LOC) system and provided the basis for 
performing PCR analysis. It comprised a chip-holder including a cavity for installing LOC 
chips, a temperature control device, a high frequency (HF) generator (FC 1201 HF) serving as 
SAW control device as well as particular software for programming PCR protocols. 
Temperatures for thermal cycling were provided by a Peltier element, controlled via the 
appropriate software “CytoCycler” (Advalytix AG/Beckman Coulter Biomedical GmbH, 
Munich, Germany). To validate the temperature transfer from the Peltier element to LOC chip 
surface, temperature measurements were carried out using an adapted measurement LOC 
chip. The measurement LOC chip comprised a Pt100 temperature sensor fixed on the LOC 
chip surface, exactly positioned on reaction center B, centered to the middle of the Peltier 
element when implemented into the chip-holder. Connected to a temperature measurement 
device (Präzisionsthermometer GMH 3710, Greisinger electronic GmbH, Regenstauf, 
Germany), the heat transfer from the Peltier element through the glass substrate to the surface 
of the measurement LOC chip was analyzed. On the one hand, increasing temperatures steps 
comprising a temperature increment of +5°C per step were measured, starting from 25°C to 
105°C. Each temperature was kept for a hold time of 30 sec, before raised to the next 
temperature level. On the other hand, temperature steps and hold time of each temperature 
were measured in a way relevant for PCR analysis, simulating repeated PCR temperature 
cycling. Starting at 95°C for 10 min, the measurements were continued by 3 to 5 cycles of the 
representative temperatures 94°C, 60°C and 72°C, each kept for a hold time of 30 sec. The 
duration of temperature steps was controlled using an alarm timer in parallel. Comparing 
input temperature of the software and output temperature of the temperature measurement 
device, differing temperatures were adapted in the software to fit the output. Data was 
evaluated by using graphically software (OriginPro 7.5 SR0, OriginLab Corporation, 
Northhampton, MA, USA). The latter measurements simulating thermal PCR cycling were 
performed on the AmpliSpeed slide cycler as well (Advalytix AG/Beckman Coulter 
Biomedical GmbH, Munich, Germany). In all applications of the lab-on-a-chip system, the 
AmpliSpeed slide cycler was used as reference LV-PCR device, validating the results of the 
LOC CytoCycler as providing reference, negative and positive controls. Measurements were 
repeated several times for validation. 
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2.2.2  Laser-based microdissection 
Recovery and isolation of sample material out of paraffin-embedded fixed biological material 
was achieved by laser-based microdissection using a modified UVA-laser system (CryLaS 
GmbH, Berlin, Germany) integrated into an inverted optical microscope (Axio Obsever.Z1, 
Carl Zeiss GmbH, Jena, Germany), based on the basic principle reported by Thalhammer S et 
al. (2003) and Thalhammer S et al. (2004). 
Specimens and biological material destined for laser microdissection were applied directly 
onto a 2 µm ultra thin polyethylene-naphthalate (PEN) laser supporting carrier membrane. 
The PEN membrane was mounted on 0.17 mm thin microscope cover glass slides or on  
1.00 mm thick standard microscope object slides (MicroDissect GmbH, Herborn, Germany) 
serving as supporting backbone for cutting and isolation of material while lowering adhesion 
forces. Before utilization, PEN membrane coated slides were decontaminated in a sterile 
environment by treatment with ultraviolet light using a UVC light source (PCR Workstation, 
PeqLab Biotechnologie GmbH, Erlangen, Germany) for at least 30 min, in order to exclude 
DNA contamination. Microdissection operations were optically controlled by either a color 
firewire camera (PixeLINK, BFI Optilas, Munich, Germany) or a black & white CCD camera 
(Rolera-XR, QImaging, Surrey BC, Canada) and appropriated software (QCapture Pro 6.0, 
QImaging, Surrey BC, Canada). The laser energy as well as the laser focus was regulated 
exactly to the focal plane of the PEN carrier membrane, providing a thin and sharp cutting 
line without scattering. When 0.17 mm thin microscope cover glass slides were used, the 
numerical aperture of the objective was adjusted to 1.5 for tuning the laser focus to the 
focused object plane. The numerical aperture was set to 1.0 when 1.00 mm thick standard 
microscope object slides were used. Biological material of interest was visualized using 5x, 
10x, 40x or 63x magnifying objectives. For microdissection, the pulsed laser beam was 
directed from below through the objective lens and the microscope glass slide to the PEN 
membrane, on which the sample resided. Using 0.5-0.6 µJ/pulse laser energy, sample material 
of interest was separated from its surrounding by moving the microscope XY-stage and 
ablating unwanted material. Extraction blanks, microdissecting PEN carrier membrane devoid 
of sample material, were always included in every procedure. 
After laser microdissection isolated material was extracted and transferred via a low-pressure 
operated transfer device named SPATS (single particle adsorbing transfer system) (XYZ High 
Precision, Darmstadt, Germany), integrated at the microscope. The SPATS provided a totally 
new approach for controlled horizontal material transfer after laser microdissection directly 
onto any planar microdevice (Woide D et al., 2009; EU patent 08150662.8). The SPATS 
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device consisted of a copper collection grid, having a diameter of 500 µm. The grid was 
attached to a transparent glass capillary tube, comprising the adsorbing head. The glass 
capillary tube was fixed to a carrier device, providing both a connection to a micrometer step 
motor for XY-directed movements and a connection to a pressure-supplying pneumatic 
picopump (PLI-100 pressure control unit, Harvard Apparatus, Holliston, US). For 
contamination reasons, adsorbing heads were exchanged for every single isolation procedure, 
when sample material was diverse. Otherwise, grids were cleaned by 70% EtOH (Merck 
KGaA, Darmstadt, Germany) treatment and decontaminated using a UVC light source (PCR 
Workstation, PeqLab Biotechnologie GmbH, Erlangen, Germany) for at least 30 min when a 
new procedure on the same sample material was started. Via the micrometer step motor the 
low-pressure transfer device SPATS was fixed to the inverted optical microscope used for 
microdissection purposes (Axio Obsever.Z1, Carl Zeiss GmbH, Jena, Germany). 
Biological material destined for SPATS transfer was mounted on 2 µm ultra thin PEN carrier 
membrane mounted glass slides (MicroDissect GmbH, Herborn, Germany), as already 
described for laser microdissection. The PEN carrier membrane served as carrier substrate, 
favoring SPATS-mediated particle transfer out of surrounding material while keeping 
adhesion forces of the subjacent glass slide at a minimum. For sample uptake, the adsorbing 
head was approached to the sample surface keeping a distance of about 100 µm or less. The 
collection grid was centered to the sample shape for optimal sample uptake. Applying low-
pressure (0–0.75 kPa) adsorbed single particles to the collection grid, while grid-directed low-
pressure suction needed to surpass adhesion forces of the glass slide surface. Dissected 
particles in the range of 5–500 mm were selectively be adsorbed under optical control. 
Smaller particles fell below the diameter of the grid meshes, and larger ones exceeded the 
visible adsorption zone. For transfer, the adsorbing head was raised up again and moved 
vertically and horizontally to a desired, predefined unloading position. During material 
transfer low-pressure was maintained to avoid loosing the sample. Release of sample material 
was controlled with µm-precision either onto the surface of any planar analysis microdevice 
or into a tube. Release was managed by approaching the grid to about 100 µm to the surface 
predefined for sample release and simply switching from low-pressure operation to a short 
high-pressure impulse (413 kPa, 2 milliseconds). After release, sample material was available 
for further biochemical processing. Optimally, sample unloading was performed into a small 
volume of fluid, prepared on the surface supposed for sample release. Droplet volumes on 
planar chip surfaces for sample uptake ranged between 0.2-1.0 µl, while sterile water as well 
as directly PCR reaction mix was used. By this means sample material was adsorbed, 
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transferred and released in a highly precise, safe, reliable and gentle way at a predefined, 
designated position on a planar surface. 
Laser microdissection and transfer of human intestine, mamma and bladder tissue 
material. Small tissue particles of about 500 µm in diameter were microdissected and then 
isolated out of tissue sections and transferred via the SPATS device. Sample material was 
transferred onto a planar multi LV-PCR microdevice comprising 48 hydrophilic reaction sites 
for performing virtual reaction chamber PCR (AmpliGrid AG480F, Advalytix 
AG/Beckman Coulter Biomedical GmbH, Munich, Germany). Sample material was released 
directly into 0.5 µl of sterile water (Ampuwa, Fresenius, Bad Homburg, Germany) prepared 
on hydrophilic reaction sites and dried at room temperature for subsequent LV-PCR analysis. 
In an analogous manner, sample material was applied to the hydrophilic reaction center B of 
LOC chips and directly released into 1.0 µl of LV-PCR master mix.  
Laser microdissection, particle transfer and DNA extraction from ancient Egyptian 
mummy bone tissue material. Single osteon areas in the range of 350 µm in diameter were 
microdissected, and then isolated out of bone tissue material and transferred via the SPATS 
device. Osteon bone particles were released directly into a sterile 0.5 ml PCR-tube 
(Eppendorf AG, Hamburg, Germany) containing 112.5 µl of lysis solution for subsequent 
DNA extraction using the First-DNA All-tissue DNA kit (Gen-ial, Troisdorf, Germany) 
according to the manufacturer’s protocol. In a final step, extracted DNA was pelleted and 
resolved in 10 µl of sterile water (Ampuwa, Fresenius, Bad Homburg, Germany) serving as 
total extraction solution. Concentration of extracted ancient DNA was about 60 pg/µl as 
measured using real-time PCR (chapter 2.3.2). Amounts of 60 pg of the extracted mummy 
DNA material were used for LV-PCR analysis. 
2.2.3  Polyacrylamide gelelectrophoresis and DNA silver staining 
Horizontal polyacrylamide gelelectrophoresis (PAAGE) followed by DNA silver staining was 
used for standard detection of PCR products. Via polyacrylamide gelelectrophoresis, charged 
molecules were separated according to their size. Due to their charge these molecules were 
forced to migrate through the polyacrylamide gel, serving as support medium, in an electric 
field under controlled conditions of temperature, pH, voltage, and time. As PCR products 
were negatively charged due to the sugar-phosphate backbone of DNA, migration happened 
towards the anode and PCR fragments were separated according to their size-dependant 
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charge. For PAAGE precast 10% polyacrylamide DNA gels (CleanGel 10% or CleanGel 
HyRes, ETC GmbH, Kirchentellinsfurt, Germany) were utilized. Before use, gels were 
rehydrated in appropriate buffers: 10% CleanGels for 1.5 h in Delect Gel Buffer and HyRes 
CleanGels for 2.0 h in DNA HyRes Buffer (ETC GmbH, Kirchentellinsfurt, Germany). 
PAAGE was performed using a horizontal gel electrophoresis device (GenePhor 
electrophoresis unit, Amersham Biosciences Europe GmbH, Freiburg, Germany), a power 
supply (Electrophoresis Power Supply EPS 601, Amersham Biosciences Europe GmbH, 
Freiburg, Germany) and appropriated anode and kathode buffers, provided with the 
CleanGels by the manufacturer: (-) Delect Cathode Buffer and (+) Delect Anode Buffer for 
10% CleanGels and (+/-) DNA HyRes Buffer for HyRes CleanGels. Using 10% CleanGels 
electrophoretic separation was performed using 580 V for about 60 min. Settings for HyRes 
CleanGels were 180 V for 40 min followed by 360 V for about 60 min. 
For DNA staining via silver nitrate a prepared silver staining system was used (DNA silver 
staining kit, GE Healthcare, Uppsala, Sweden). According to the manufacturer’s protocol, 
CleanGels were first incubated in 1x Fixing Solution (35 min for 10% CleanGels, 45 min for 
HyRes CleanGels), washed 3x for 10 min in H2Odd, incubated in 1x Staining Solution (35 min 
for 10% CleanGels, 45 min for HyRes CleanGels), washed 2x for 1 min in H2Odd, followed 
by applying 1x Developing Solution (time depended on the staining grade) and final 
incubation for 30 min in 1x Stopping & Preserving Solution. Stained CleanGels were scanned 
for documentation and sealed in plastic bags for long time storage. 
2.2.4  Capillary electrophoresis and STR fragment length analysis 
Fully automated capillary electrophoresis (CE) was used for fast and sensitive separation of 
PCR amplified STR fragments for genetic profiling purposes. Short tandem repeats (STRs), 
located in non-coding DNA domains, are short sequences of DNA which are repeated in 
tandem several times, while the number of repeats varies between complementary DNA 
strands and between individuals. In CE, small-diameter capillaries, a little larger than the 
width of a human hair and about 20 centimeters in length, are used to separate the various 
STR fragments due to electroosmotic flow. The surface of the capillary contains negatively 
charged functional groups, while positively charged ions migrate towards the negative 
electrode and carry solvent molecules in the same direction. Positively charged ions move 
faster and negatively-charged ones slower, thus separation of PCR products happens via their 
size-dependant charge. Due to fluorescently labeled STR primers amplified DNA fragments 
are fluorescently tagged and excited by a laser beam. As data analysis is performed by a 
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computer with appropriate software, capillary electrophoresis allows a higher resolution than 
gel electrophoresis, a greater sensitivity and on-line detection of PCR products, displayed as 
electropherograms. 
PCR reactions of amplified STR fragments were diluted 1:5 with sterile water (Ampuwa, 
Fresenius, Bad Homburg, Germany). An aliquot of 1 µl of this dilution was mixed with  
12.7 µl of Hi-Di Formamide (Applied Biosystems GmbH, Darmstadt, Germany) and 0.3 µl 
of GeneScan-500LIZ size standard (Applied Biosystems GmbH, Darmstadt, Germany) in 
a 96-well plate (ABgene PCR Plates, Thermo Scientific, Epsom, Surrey, UK). In 
experimental setups using the AmpF/STR SEfiler PCR amplification kit, 1 µl of the 
AmpF/STR SEfiler Allelic Ladder (Applied Biosystems GmbH, Darmstadt, Germany) 
was run in parallel. Amplified STR fragments were analyzed via a 3130xL Genetic Analyzer 
(Applied Biosystems GmbH, Darmstadt, Germany). Data was either interpreted using 
GeneScan 3.7 software in combination with Genotyper 3.7 software for EDTA K treated 
blood samples, Egyptian mummy and scientific staff samples, or using GeneMapper ID 
v.3.2 software for dried blood spot analysis (Applied Biosystems GmbH, Darmstadt, 
Germany). The signals of the fluorescent dyes incorporated into each amplicon through a 5’-
end labeled oligonucleotide primer, was a measure of quantity of the amplified target. Sample 
peak heights, in relative fluorescent units (rfu), of all true alleles were used for quantitative 
analysis and heterozygous peak ration calculations. The minimum peak height threshold was 
set at 50 rfu to allow for detection of all peaks clearly above background. This mode of data 
analysis, that signals below 50 rfu were not evaluated, is accepted as general accreditation-
threshold, validating authentic marker peaks. 
2.3  Molecular biological methods 
In the following sections utilized molecular biological reactions are summarized. All kinds of 
PCR analyses performed, especially the application of low-volume PCR, are described as 
well as real-time PCR, array-based approaches and general precautions, which were taken to 
eliminate risks of contamination. 
2.3.1  Polymerase chain reaction 
Conventional polymerase chain reaction (PCR) was performed as well as low-volume PCR. 
The technique of low-volume PCR (LV-PCR, also “virtual reaction chamber PCR (VRC 
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PCR)”, Guttenberg Z et al., 2005), performed on microdevices, is based on a chemically 
structured surface providing hydrophilic reaction sites surrounded by hydrophobic 
background. LV-PCR was performed on two microfabricated devices, in fact a multi LV-PCR 
microdevice (AmpliGrid AG480F, Advalytix AG/Beckman Coulter Biomedical GmbH, 
Munich, Germany) and LOC chips designed for the lab-on-a-chip system (Advalytix 
AG/Beckman Coulter Biomedical GmbH, Munich, Germany). The AmpliGrid AG480F is a 
commercially available multi LV-PCR microdevice, offering 48 hydrophilic reaction sites 
with 1.6 mm in diameter, each surrounded by a hydrophobic circle to hold 1 µl of aqueous 
PCR master mixes in place. A short-distanced hydrophilic ring comprising 3 mm in diameter 
and surrounding the hydrophilic reaction site, centers 5 µl of mineral oil cover solution 
(Sealing Solution, Advalytix AG/Beckman Coulter Biomedical GmbH, Munich, Germany) to 
the aqueous droplet. For performing thermal reactions, the AmpliGrid AG480F slide was 
placed on a corresponding thermal cycler (AmpliSpeed slide cycler, Advalytix AG/Beckman 
Coulter Biomedical GmbH, Munich, Germany). LOC chips present a single LV-PCR 
microdevice. For PCR performance, these chips offer one hydrophilic reaction site with 500 
µm in diameter, surrounded by a hydrophobic circle to keep 1 µl aqueous PCR master mixes 
in place (named reaction center B). A short-distanced intermitted hydrophilic ring comprising 
3 mm in diameter and surrounding the hydrophilic reaction site, centers 5 µl of mineral oil 
cover solution (Sealing Solution, Advalytix AG/Beckman Coulter Biomedical GmbH, 
Munich, Germany) to the aqueous droplet. For performing thermal cycling reactions, LOC 
chips were installed into the LOC CytoCycler. For all experiments, LOC chips of the Cyto3 
design were used. 
Setup of LV-PCR reactions. LOC chips and multi LV-PCR microdevices were 
decontaminated for 15-20 min using a UVC light source prior to use (PCR Workstation, 
PeqLab Biotechnologie GmbH, Erlangen, Germany). Additionally, LOC chips were 
preheated for 15 min at 95°C prior to PCR for adapting the material to heat and to eliminate 
material stress when starting the initial denaturation step of a PCR. LV-PCR reactions were 
setup in the following way: after master mixes were mixed thoroughly, 1 µl of prepared 
master mix was placed on reaction center B of LOC chips or on reaction sites of the multi 
LV-PCR microdevice and was immediately covered with 5 µl of Sealing Solution to prevent 
evaporation and external cross-contamination. Evaporation might inhibit LV-PCR due to loss 
of reactants, loss of volume and increase of salt concentrations present in the reaction mix. As 
LOC chips offer only one reaction site for performing VRC PCR, reactions were run on the 
multi LV-PCR microdevices in parallel for validation and as a reference system. In addition, 
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positive and negative controls were included. When using fluorescently tagged primers like 
D7S1824, D9S302, D10S2325, AmpF/STR SEfiler Primer Set, Amel1-f-Cy3 or SYBR 
Green I-based LV-PCR setups, reactions were performed in darkness by capping PCR cyclers 
with light impermeable stuff to exclude ambient light and to inhibit bleaching effects. 
Amelogenin and β-actin LV-PCR on reference DNA for evaluating the minimum amount 
of target material needed for cycling on the lab-on-a-chip integrated CytoCycler. To test the 
sensitivity and to analyze the product detection limit of the LOC CytoCycler PCR 
amplification device, LV-PCR was performed on purified human genomic male and female 
reference DNA. PCR reactions were performed using the QuantiFast SYBR Green I PCR 
kit for 2-step PCR (QIAGEN GmbH, Hilden, Germany) according to the protocol 
recommended by the manufacturer, but reaction volumes were adapted to low-volume PCR 
applications. 1 µl total PCR reaction mix contained 0.5 µl of 2x QuantiFast SYBR Green I 
PCR Master Mix (final 1x), 0.1 µl of 10 µM primer solutions β-Actin up and β-Actin down or 
Amel1 and Amel2 respectively (final 1 µM per primer), 0.2 µl of sterile water (Ampuwa, 
Fresenius, Bad Homburg, Germany) as well as 0.1 µl of 10x concentrated input DNA (final 
1x). Primer sequences were listed in the appendix, chapter 9.2. For input target DNA 
concentrations of 10 ng/µl, 5 ng/µl, 1 ng/µl, 500 pg/µl, 250 pg/µl, 125 pg/µl and 100 pg/µl 
were used, resulting in final concentrations of 1 ng, 500 pg, 100 pg, 50 pg, 25 pg, 12.5 pg and 
10 pg present in 1 µl total reaction mix. 1 µl of prepared master mix was placed on reaction 
center B of LOC chips or on reaction sites of a multi LV-PCR microdevice and was 
immediately covered with 5 µl of Sealing Solution to prevent evaporation and external cross-
contamination. 2-step PCR cycling conditions recommended by the manufacturer’s protocol 
were slightly changed concerning temperature hold times: 5 min initial denaturation at 95°C, 
followed by 40 cycles of 95°C for 30 sec and 60°C for 60 sec (instead of 95°C for 10 sec and 
60°C for 30 sec). PCR products were analyzed on polyacrylamide gels (CleanGel 10% or 
CleanGel HyRes, ETC GmbH, Kirchentellinsfurt, Germany) and subsequent DNA silver 
staining (DNA silver staining kit, GE Healthcare, Uppsala, Sweden) (chapter 2.2.3). Blank 
and negative controls (containing no DNA) were included in every reaction batch and all 
experiments were performed in multiplicates. 
Amelogenin and β-actin LV-PCR on reference DNA for cycling efficiency tests of the lab-
on-a-chip integrated CytoCycler. To test the cycling efficiency of the LOC CytoCycler PCR 
amplification device, LV-PCR was performed on purified human genomic male reference 
DNA. PCR reactions were performed using the QuantiFast SYBR Green I PCR kit for 2-
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step PCR (QIAGEN GmbH, Hilden, Germany) as well as the QIAGEN Fast Cycling PCR 
kit for 3-step PCR (QIAGEN GmbH, Hilden, Germany). Kits were used according to the 
protocol recommended by the manufacturer, but reaction volumes were adapted to low-
volume PCR applications. Furthermore, temperature hold-times were scaled down, speeding 
up cycling times to amplification limits. 
Using the QuantiFast SYBR Green I PCR kit, 1 µl of total PCR reaction mix contained  
0.5 µl of 2x QuantiFast SYBR Green I PCR Master Mix (final 1x), 0.1 µl of 10 µM primer 
solutions β-Actin up and β-Actin down or Amel1 and Amel2 respectively (final 1 µM per 
primer), 0.2 µl of sterile water (Ampuwa, Fresenius, Bad Homburg, Germany) and 0.1 µl of 
10x concentrated input DNA (final 1x). Primer sequences were listed in the appendix, 
chapter 9.2. For input target DNA 5 ng/µl male reference DNA was used, resulting in a final 
concentration of 500 pg present in 1 µl total reaction mix. 1 µl of prepared master mix was 
placed on reaction center B of LOC chips or on reaction sites of a multi LV-PCR microdevice 
and was immediately covered with 5 µl of Sealing Solution to prevent evaporation and 
external cross-contamination. The 2-step PCR protocol was adapted to shorter cycling times, 
starting with 95°C for 5 min, 40 cycles of 95°C for 30 sec and 60°C for 60 sec to 95°C for  
5 min, 40 cycles of 95°C for 10 sec and 60°C for 30 sec.  
Using the QIAGEN Fast Cycling PCR kit, 1 µl of total PCR reaction mix contained 0.5 µl of 
2x QIAGEN Fast Cycling PCR Master Mix (final 1x), 0.06 µl of 5x Q-Solution (final 0.3x), 
0.1 µl of 10 µM primer solutions β-Actin up and β-Actin down or Amel1 and Amel2 
respectively (final 1 µM per primer), 0.14 µl of sterile water (Ampuwa, Fresenius, Bad 
Homburg, Germany) and 0.1 µl of 10x concentrated input DNA. Primer sequences were listed 
in the appendix, chapter 9.2. For input target DNA 5 ng/µl, 1 ng/µl, 500 pg/µl and 250 pg/µl 
male reference DNA was used, resulting in final concentrations of 500 pg, 100 pg, 50 pg and 
25 pg present in 1 µl total reaction mix. 1 µl of prepared master mix was placed on reaction 
center B of LOC chips or on reaction sites of a multi LV-PCR microdevice and was 
immediately covered with 5 µl of Sealing Solution to prevent evaporation and external cross-
contamination. The 3-step PCR protocol was adapted to shorter cycling times, starting with a) 
95°C for 5 min, 30 cycles of 94°C for 30 sec, 60°C for 30 sec, 72°C for 30 sec, and 1 min 
final extension at 72°C, to b) 95°C for 5 min, 30 cycles of 94°C for 10 sec, 60°C for 10 sec, 
72°C for 10 sec, and final extension for 1 min at 72°C and finally c) 95°C for 5 min, 30 cycles 
of 94°C for 5 sec, 60°C for 5 sec, 72°C for 5 sec, and final extension for 30 sec at 72°C.  
PCR products were analyzed on polyacrylamide gels (CleanGel 10%, ETC GmbH, 
Kirchentellinsfurt, Germany) and subsequent DNA silver staining (DNA silver staining kit, 
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GE Healthcare, Uppsala, Sweden) (chapter 2.2.3). Blank and negative controls (containing 
no DNA) were included in every reaction batch and all experiments were performed in 
multiplicates. 
Amelogenin LV-PCR on human intestine, mamma and bladder tissue material. For LV-
PCR analysis of tissue material, performed on a multi LV-PCR microdevice, the QIAGEN 
Fast Cycling PCR kit was used for 3-step PCR (QIAGEN GmbH, Hilden, Germany) 
according to the protocol recommended by the manufacturer, but reaction volumes were 
adapted to low-volume PCR applications. Dried tissue fragments, fixed on reaction sites of a 
multi LV-PCR microdevice, were covered with 1 µl of PCR reaction mix. 1 µl of total PCR 
reaction mix contained 0.5 µl of 2x QIAGEN Fast Cycling PCR Master Mix (final 1x),  
0.2 µl of 5x QIAGEN Q-Solution (final 1x), 0.1 µl of 10 µM primer solutions Amel1 and 
Amel2 (final 1 µM per primer) and 0.1 µl of sterile water (Ampuwa, Fresenius, Bad 
Homburg, Germany). Primer sequences were listed in the appendix, chapter 9.2. 1 µl of 
positioned master mix was immediately covered with 5 µl of Sealing Solution to prevent 
evaporation and external cross-contamination. 3-step PCR cycling conditions recommended 
by the manufacturer’s protocol were slightly changed concerning temperature hold times: 20 
min initial denaturation and cell lysis at 97°C, followed by 40 cycles of 94°C for 30 sec, 60°C 
for 30 sec and 72°C for 30 sec, and final product extension at 72°C for 1 min. PCR products 
were analyzed on polyacrylamide gels (CleanGel HyRes, ETC GmbH, Kirchentellinsfurt, 
Germany) and subsequent DNA silver staining (DNA silver staining kit, GE Healthcare, 
Uppsala, Sweden) (chapter 2.2.3). Blank and negative controls (containing no DNA) were 
included in every reaction batch and all experiments were performed in multiplicates. Positive 
controls comprising male and female reference DNA were included as well. 
For LV-PCR analysis of tissue5, performed on a LOC chip, the QIAGEN Fast Cycling PCR 
kit was used for 3-step PCR (QIAGEN GmbH, Hilden, Germany) according to the protocol 
recommended by the manufacturer, but reaction volumes were adapted to low-volume PCR 
applications. Fragments of tissue5 were released directly into 1 µl of LV-PCR master mix on 
reaction center B of LOC chips after microdissection. 1 µl of total PCR reaction mix 
contained 0.5 µl of 2x QIAGEN Fast Cycling PCR Master Mix (final 1x), 0.06 µl of 5x Q-
Solution (final 0.3x), 0.1 µl of 10 µM primer solutions Amel1 and Amel2 (final 1 µM per 
primer) and 0.24 µl of sterile water (Ampuwa, Fresenius, Bad Homburg, Germany). Primer 
sequences were listed in the appendix, chapter 9.2. 1 µl of sample-loaded master mix was 
immediately covered with 5 µl of Sealing Solution to prevent evaporation and external cross-
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contamination. Adding volumes of 1 µl of master mix and 5 µl of Sealing Solution was 
performed using the automatic dispensing device BioSpot and appropriate software 
“BioSpot” (BioFluidix GmbH, Freiburg, Germany). PipeJet1 was used for applying the 
master mix, while PipeJet3 provided the oil coverage just by dispensing the liquid onto the 
chip surface. 3-step PCR cycling conditions recommended by the manufacturer’s protocol 
were slightly changed concerning temperature hold times: 20 min initial denaturation and cell 
lysis at 97°C, followed by 40 cycles of 94°C for 30 sec, 60°C for 30 sec and 72°C for 30 sec, 
and final product extension at 72°C for 1 min. PCR products were analyzed on 
polyacrylamide gels (CleanGel 10%, ETC GmbH, Kirchentellinsfurt, Germany) and 
subsequent DNA silver staining (DNA silver staining kit, GE Healthcare, Uppsala, Sweden) 
(chapter 2.2.3). Blank and negative controls (containing no DNA) were included in every 
reaction batch and experiment was performed in triplicate. 
Amelogenin and β-actin LV-PCR on ancient Egyptian mummy bone tissue material. For 
LV-PCR analysis of extracted mummy DNA samples, microdissected as well as 
conventionally extracted ones, the QIAGEN Fast Cycling PCR kit (QIAGEN GmbH, 
Hilden, Germany) was used for 3-step PCR according to the protocol recommended by the 
manufacturer, but reaction volumes were adapted to low-volume PCR applications. 1 µl of 
extracted mummy DNA sample solution was dried up either on reaction center B of LOC 
chips or on reaction sites of a multi LV-PCR microdevice at 30°C for 10 min. Dried input 
DNA sample material, comprising 60 pg of microdissected mummy DNA or 50-100 pg of 
pulverized mummy DNA, was covered with 1 µl of PCR reaction mix. 1 µl of total PCR 
reaction mix contained 0.5 µl of 2x QIAGEN Fast Cycling PCR Master Mix (final 1x),  
0.2 µl of 5x QIAGEN Q-Solution (final 1x), 0.1 µl of 10 µM primer solutions β-Actin up 
and β-Actin down, or Amel1 and Amel2 respectively (final 1 µM per primer) and 0.1 µl of 
sterile water (Ampuwa, Fresenius, Bad Homburg, Germany). Primer sequences were listed 
in the appendix, chapter 9.2. 1 µl of positioned master mix was immediately covered with 5 
µl of Sealing Solution to prevent evaporation and external cross-contamination. 3-step PCR 
cycling was performed as recommended by the manufacturer’s protocol: 5 min initial 
denaturation at 95°C, followed by 40 cycles of 94°C for 30 sec, 60°C for 30 sec and 72°C for 
30 sec, and final product extension at 72°C for 1 min. PCR products were analyzed on 
polyacrylamide gels (CleanGel 10% and CleanGel HyRes, ETC GmbH, Kirchentellinsfurt, 
Germany) and subsequent DNA silver staining (DNA silver staining kit, GE Healthcare, 
Uppsala, Sweden) (chapter 2.2.3). Blank and negative controls (containing no DNA) were 
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included in every reaction batch and all experiments were performed in multiplicates. Positive 
controls comprising male and female reference DNA were included as well. 
Multiplex STR PCR on ancient Egyptian mummy bone tissue material and DNA of 
scientific staff. For DNA profiling analysis on extracted mummy material as well as on 
extracted genomic material of scientific staff, PCR typing reactions were performed using two 
PCR setups amplifying distinct STR marker combinations. The QIAGEN Multiplex PCR kit 
(QIAGEN GmbH, Hilden, Germany) was used for 3-step PCR amplifying STR markers 
D7S1824, D9S302 and D10S2325. The AmpF/STR SEfiler PCR amplification kit 
(Applied Biosystems GmbH, Darmstadt, Germany) is a STR multiplex assay that 
simultaneously co-amplifies 11 STR loci and the amelogenin locus. Kits were used according 
to the protocol recommended by the manufacturer, but concerning the QIAGEN Multiplex 
PCR kit reaction volumes were adapted to low-volume PCR applications, while AmpF/STR 
SEfiler reaction volumes were just scaled down to 16.5 µl for conventional PCR 
performances. 
Using the QIAGEN Multiplex PCR kit, 1 µl of total PCR reaction mix contained 0.5 µl of 
2x QIAGEN Multiplex PCR Master Mix (final 1x), 0.2 µl of 5x QIAGEN Q-Solution (final 
0.33x), 0.12 µl of AdvaGold (Advalytix AG/Beckman Coulter Biomedical GmbH, Munich, 
Germany), 0.2 µl of sterile water (Ampuwa, Fresenius, Bad Homburg, Germany) and 0.04 
µl of 50 pmol STR primer-pair solutions D7S1824-F/R and D9S302-F/R and D10S2325-F/R 
(final 2 pmol = 2 µM per primer-pair solution). Primer sequences were listed in the appendix, 
chapter 9.2. 1 µl of extracted DNA sample solution from mummy and scientific staff was 
dried up on reaction sites of a multi LV-PCR microdevice at 30°C for 10 min. Dried input 
DNA sample material, comprising 60 pg of microdissected mummy DNA or several ng of 
scientific staff DNA, was covered with 1 µl of PCR reaction mix. 1 µl of positioned master 
mix was immediately covered with 5 µl of Sealing Solution to prevent evaporation and 
external cross-contamination. For PCR cycling a „touch-down“ protocol was used comprising 
the following conditions: 15 min initial denaturation at 95°C, 14 cycles of 94°C for 30 sec, 
64°C to 50°C for 60 sec (temperature increment -1°C per cycle), 72°C for 30 sec, continued 
by 25 cycles of 94°C for 30 sec, 50°C for 30 sec, 72°C for 30 sec, and a final product 
extension at 72°C for 7 min. Blank and negative controls (containing no DNA) were included 
in every reaction batch and all experiments were performed in multiplicates. Data acquisition 
was performed via STR fragment length analysis (chapter 2.2.4). 
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Using the AmpF/STR SEfiler PCR amplification kit, DNA typing reactions were 
performed according to the manufacturer’s recommendations, but reaction volumes were 
scaled down to 16.5 µl for conventional PCR performances. 16.5 µl of total PCR reaction 
volume, prepared in sterile 0.2 ml PCR-tubes (Eppendorf AG, Hamburg, Germany), 
contained 10 µl AmpF/STR PCR Reaction Mix, 5 µl of AmpF/STR SEfiler Primer Set, 
0.5 µl of AmpliTaq Gold DNA Polymerase 5U/µl (final 2.5 U) and 1 µl of DNA sample 
solution from mummy and scientific staff. 3-step PCR cycling was performed as 
recommended by the manufacturer’s protocol of the AmpF/STR SEfiler PCR 
amplification kit: 11 min initial denaturation at 95°C, 28 cycles of 94°C for 60 sec, 59°C for 
60 sec, 72°C for 60 sec, followed by a final product extension at 60°C for 45 min. Data 
acquisition was performed using STR fragment length analysis (chapter 2.2.4). 
Multiplex STR PCR on anticoagulant treated whole blood and degrading dried blood spots. 
For LV-PCR analysis of whole blood a combined setup of the AmpF/STR SEfiler PCR 
amplification kit (Applied Biosystems GmbH, Darmstadt, Germany) and the KOD Xtreme 
Hot Start DNA Polymerase PCR system (Novagen, Merck, Darmstadt, Germany) was used 
for 3-step PCR and reaction volumes were adapted to low-volume PCR applications. The 
AmpF/STR SEfiler PCR amplification kit is a STR multiplex assay that simultaneously 
co-amplifies 11 STR loci and the amelogenin locus. 1.12 µl of total PCR reaction mix 
contained 0.5 µl of 2x Xtreme Buffer (final 1x), 0.2 µl of Xtreme dNTPs (2 mM each), 
0.02 µl of KOD Xtreme Hot Start DNA Polymerase 1U/µl (final 0.02U), 0.3 µl of 
AmpF/STR SEfiler Primer Set and 0.1 µl of 10x concentrated blood sample (either EDTA 
K treated blood or resolved blood spots). For input blood samples concentrations of 100% 
whole blood or 10% whole blood were used, resulting in final concentrations of 10% or 1% 
whole blood present in 1 µl total reaction mix. According to Ganong WF (2003), 1 µl of 
whole blood target material contains 4000 to 11000 leukocytes. That means 400 to 1100 
leukocytes present in 10% blood typing reactions and equivalently 40 to 110 leukocytes 
present in 1% blood typing reactions, representing a target DNA amount of 2.8 to 7.0 ng or 
280 to 700 pg respectively. 1 µl of prepared master mix was placed on reaction center B of 
LOC chips or on reaction sites of a multi LV-PCR microdevice and was immediately covered 
with 5 µl of Sealing Solution to prevent evaporation and external cross-contamination. 3-step 
PCR cycling was performed as recommended by the manufacturer’s protocol of the 
AmpF/STR SEfiler Plus PCR amplification kit: 11 min initial denaturation and cell lysis 
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at 95°C, 28 cycles of 94°C for 60 sec, 59°C for 60 sec and 72°C for 60 sec, followed by a 
final product extension at 60°C for 45 min.  
Blank, negative (containing no DNA) and positive controls (AmpF/STR SEfiler Plus 
Control DNA 9947A, Applied Biosystems GmbH, Darmstadt, Germany) were included in 
every reaction batch and all experiments were performed in multiplicates. 100 pg of the 
AmpF/STR SEfiler Control DNA 9947A was amplified simultaneously via LV-PCR as 
positive control (named “PK-1”). Additionally, Control DNA 9947A was amplified in a 
conventional in-tube PCR reaction using a standard thermocycler (Cyclone25, PeqLab 
Biotechnologie GmbH, Erlangen, Germany) and the recommended PCR protocol of the 
AmpF/STR SEfiler kit as a pure positive control (named “SE-PK-2”). Reaction volumes, 
prepared in sterile 0.2 ml PCR-tubes (Eppendorf AG, Hamburg, Germany), were scaled down 
to about 5.5 µl of total PCR reaction volume, containing 2.7 µl of AmpF/STR PCR Reaction 
Mix (final 1x), 1.35 µl of AmpF/STR SEfiler Primer Set, 0.45 µl of AmpliTaq Gold 
DNA Polymerase 5U/µl (final 2.25U) and 1 µl of AmpF/STR SEfiler Control DNA 
9947A 100 pg/µl (final 100 pg). Blank and negative controls (containing no DNA) were 
included in every reaction batch and experiments were performed in multiplicates. Total data 
acquisition was performed via STR fragment length analysis (chapter 2.2.4). 
2.3.2  Real-time PCR 
Real-time PCR (RT-PCR) is a special form of PCR, quantifying the amount of amplified 
DNA present after each round of PCR cycling via measuring fluorescence signals (Wilhelm J 
and Pingoud A, 2003). As the fluorescence increases proportional with the amount of DNA, 
after each cycle the amount of DNA can be detected in the exponential phase. Signals are 
either indicated by fluorescently tagged PCR primers or a DNA-intercalating fluorescent dye 
is added to the PCR mixture, of which the most popular is SYBR Green I binding to double-
stranded DNA. A big drawback of the SYBR Green I method is the low specificity as no 
differentiation between PCR products can be achieved. Only when performing an additional 
melting point analysis after PCR, the fragment lengths and thus the specificity of the PCR 
products can be detected and authentic PCR products can be distinguished from occurring 
unspecific primer dimers. During a melting point analysis DNA is melted via raising the 
temperature continuously from 50°C to 95°C. At fragment-specific melting temperatures the 
double-stranded DNA molecules denature, whereas the fluorescence dye is released and a 
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decrease in fluorescence intensity is detected. As specific PCR products have a higher melting 
point as unspecific primer dimers, a differentiation is possible. 
Real-time PCR using the Stratagene Mx 3000P thermocycler. Real-time PCR was applied 
on microdissected ancient bone samples of Egyptian mummy material. RT-PCR was 
performed to quantify the amount of extracted DNA originating from microdissected ancient 
bone samples of Egyptian mummy material. Real-time PCR was applied to sample mummy4, 
exemplary for all of four mummy samples, in a Stratagene RT-PCR cycler (Stratagene Mx 
3000P, Stratagene, La Jolla, CA, USA) using the QuantiFast SYBR Green I PCR kit 
(QIAGEN GmbH, Hilden, Germany) for 2-step PCR according to the protocol recommended 
by the manufacturer. RT-PCR DNA amplification rates of sample mummy4, were compared 
to RT-PCR amplification rates of 1 ng/µl, 500 pg/µl, 100 pg/µl, 50 pg/µl and 20 pg/µl male 
and female starting DNA target material concentrations serving as reference probes and 
internal target amount standards. 1 µl of these standard concentrations was used for analysis, 
while just 0.5 µl of extracted mummy DNA was used due to the scarcity of mummy material. 
The mummy sample was filled up to 1 µl with sterile water (Ampuwa, Fresenius, Bad 
Homburg, Germany). In a 96-well plate (ABgene PCR Plates, Thermo Scientific, Epsom, 
Surrey, UK) 1 µl of DNA sample solution was mixed with 24 µl of RT-PCR master mix, 
containing 12.5 µl of 2x QuantiFast SYBR Green I PCR Master Mix (final 1x), 2.5 µl of 
10 µM primer solutions Amel1 and Amel2 (final 1 µM per primer) and 6.5 µl of RNase-Free 
water. Primer sequences were listed in the appendix, chapter 9.2. 2-step PCR conditions were 
used according to the manufacturer’s protocol recommending 5 min initial denaturation at 
95°C, followed by 40 cycles of 95°C for 10 sec and 60°C for 30 sec and subsequent melting 
curve analysis. Conditions for generating these dissociation curves were 95°C for 1 min, 55°C 
for 30 sec, slowly ramping the temperature from 55°C to 95°C, and final denaturation time of 
95°C for 30 sec. Data was obtained during ramping, while continuously fluorescence data was 
collected. Data analysis was performed via appropriate software for the Stratagene Mx 3000P 
“MxPro – Mx3000P v3.00” (Stratagene, La Jolla, CA, USA). 
Real-time PCR using the lab-on-a-chip integrated Fluorescence Reader. The Fluorescence 
Reader module of the lab-on-a-chip system comprised a blue LED (λmax = 470±2 nm) for 
excitation light (LUXEON Rebel LXML-PB01-0023, 3.4 V forward bias, 0.7 A operating 
current), filter sets, a self-made LED power control box, a trigger signal break-out box (NI 
SCB-68 with the PCI ADC/DAC, Quick Reference Label, S-Series Devices, National 
Instruments Germany GmbH, Munich, Germany) and a CCD camera as detection device for 
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capturing emitted light (Rolera-XR, QImaging, Surrey BC, Canada). Filter sets included an 
excitation filter with λmax = 482 nm (spread 36 nm = 464-500 nm excitation spectrum) and an 
emission filter with λmax = 536 nm (spread 40 nm = 516-556 nm emission spectrum) 
(Interferenzfilter of BrightLine series, AHF Analysentechnik AG, Tübingen, Germany). For 
automatic picture taking, a self-programmed LabVIEW-based software was used 
“Grand_NIVision_Intensity_Consec_Subtract_Loopback_NewCamera.VI” (LabVIEW 8.6, 
National Instruments Germany GmbH, Munich, Germany). The software was adapted for 
taking pictures manually (named “Norbert.VI”). For real-time PCR operations, excitation and 
emission devices of the Fluorescence Reader were directed to reaction center B on the LOC 
chip surface. 
Calibration of fluorescence intensities. The fluorescence signal was calibrated using the 
QuantiFast SYBR Green I PCR kit (QIAGEN GmbH, Hilden, Germany). Decreasing 
amounts of DNA were used to synthesize dilution series, whereas 0.1 µl of 10x concentrated 
DNA was mixed with 0.9 µl of 2x QuantiFast SYBR Green I PCR Master Mix. DNA 
concentrations of 100 ng/µl, 50 ng/µl, 10 ng/µl, 5 ng/µl and 1 ng/µl of male and female 
reference DNA were used, resulting in final concentrations of 10 ng, 5 ng, 1 ng, 500 pg and 
100 pg present in prepared dilutions. 1 µl of each dilution was placed on reaction center B of 
a LOC chip, covered with 5 µl of Sealing Solution (Advalytix AG/Beckman Coulter 
Biomedical GmbH, Munich, Germany) and centered to the detection path of the CCD camera. 
This whole setup was darkened by capping it totally with a black cloth in order to exclude 
interfering ambient light. Pictures were taken manually via LabVIEW-based software 
“Norbert.VI”. Increasing exposure times were chosen starting with 200 ms, to 400 ms,  
600 ms, 1000 ms, 2000 ms and 4000 ms. Measurements were performed at room temperature 
as well as at 55°C and 72°C. Measurements were repeated several times and pictures 
concerning fluorescence intensity were analyzed visually. 
Experimental setups of performing real-time PCR. Real-time PCR was performed using the 
QuantiFast SYBR Green I PCR kit for 2-step PCR (QIAGEN GmbH, Hilden, Germany) 
according to the protocol recommended by the manufacturer, but reaction volumes were 
adapted to low-volume PCR applications. 1 µl total LV-PCR reaction mix contained 0.5 µl of 
2x QuantiFast SYBR Green I PCR Master Mix (final 1x), 0.1 µl of 10 µM primer 
solutions β-Actin up and β-Actin down or Amel1 and Amel2 respectively (final 1 µM per 
primer), 0.2 µl of sterile water (Ampuwa, Fresenius, Bad Homburg, Germany) and 0.1 µl of 
10x concentrated input DNA (final 1x). Primer sequences were listed in the appendix, 
chapter 9.2. For input male and female reference target DNA concentrations of 10 ng/µl,  
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5 ng/µl and 1 ng/µl were used, resulting in final concentrations of 1 ng, 500 pg and 100 pg 
present in 1 µl total reaction mix. 1 µl of prepared master mix was placed on reaction center B 
of a LOC chip, covered with 5 µl of Sealing Solution (Advalytix AG/Beckman Coulter 
Biomedical GmbH, Munich, Germany) and centered to the detection path of the CCD camera. 
This whole setup was darkened by capping it totally with a black cloth in order to exclude 
interfering ambient light. 2-step PCR cycling conditions recommended by the manufacturer’s 
protocol were slightly changed concerning temperature hold times: 5 min initial denaturation 
at 95°C, 40 cycles of 95°C for 30 sec and 60°C or 55°C respectively for 60 sec. Increasing 
fluorescence intensities were recorded by taking pictures at the end of each annealing and 
extension step at 55°C or 60°C during 35-45 cycles in total. Pictures were either taken 
manually via LabVIEW-based software “Norbert.VI” or automatically via LabVIEW-based 
software “Grand_NIVision_Intensity_Consec_Subtract_Loopback_NewCamera.VI”. Chosen 
exposure times chosen ranged from 200 ms, to 400 ms and 600 ms. PCR reactions were 
repeated several times and pictures concerning fluorescence intensity were analyzed visually. 
Real-time PCR was also performed using the QuantiTect SYBR Green I PCR kit for 3-
step PCR (QIAGEN GmbH, Hilden, Germany) according to the protocol recommended by 
the manufacturer, but reaction volumes were adapted to low-volume PCR applications. 1 µl 
total LV-PCR reaction mix contained 0.5 µl of 2x QuantiTect SYBR Green I PCR Master 
Mix (final 1x), 0.1 µl of 10 µM primer solutions β-Actin up and β-Actin down or Amel1 and 
Amel2 respectively (final 1 µM per primer), 0.2 µl of sterile water (Ampuwa, Fresenius, 
Bad Homburg, Germany) and 0.1 µl of 10x concentrated input DNA (final 1x). 3-step PCR 
cycling conditions recommended by the manufacturer’s protocol were slightly changed 
concerning temperature hold times: 15 min initial denaturation at 95°C, 35-45 cycles of 95°C 
for 30 sec, 55°C for 60 sec, 72°C for 30 sec, and final product extension at 72°C for 7 min. 
Conditions for picture taking and real-time PCR performances were according to the 2-step 
PCR performance just described. 
2.3.3  Microarray hybridization 
In microarray applications biological probes are arrayed onto planar surfaces and slides 
through the use of a robotic array spotter, while biological probes comprise short single 
stranded DNA oligonucleotides. PCR-amplified DNA fragments in solution are subjected to 
hybridization with these surface coupled complementary strands, providing information on 
the corresponding nucleotide sequence (Schena M, 1999). Hybridization happens specifically 
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via the building of hydrogen bonds between complementary sequences of probes and 
amplified DNA fragments. Due to the small size, a huge amount of probes detecting for 
thousands of gene fragments can be arrayed, just dependent on the size of the supporting 
surface. As fluorescently tagged primers were utilized, e.g. tagged with chromogenic dyes 
“Cy3” or “Cy5”, PCR products are fluorescently labeled as well. Detection of hybridization 
events between surface-bound probes and primer-labeled fluorescent PCR products is 
performed via on-line detection methods. 
Spot array design. A 2x2 spot array was designed for the determination of PCR-amplified 
male and female sample material, according to gender determining approaches used in 
forensic research. Probes of the microarray were designed in a way, to detect a 6 bp insertion 
sequence AAAGTG between male and female PCR-amplified amelogenin fragments. So 
either probes matched the 106 bp X-chromosomal sequence or were complementary to the 
112 bp Y-chromosomal sequence. Three different probes were designed for hybridization 
providing distinct sites for specific PCR product hybridization. Probes Amelo1(Y) and 
Amelo3(Y) were designed for binding male amelogenin PCR products having the 6 bp insert, 
while probe Amelo2(X) was destined for hybridizing to female PCR products lacking the  
6 bp insert (probe sequences were listed in the appendix, chapter 9.2). Successful 
hybridization events of fluorescently labeled PCR products were detected via the intensity of 
fluorescence signals. 
For microarray applications, probes were spotted on reaction sites (∅ 1.6 mm) of a multi LV-
PCR microdevice (AmpliGrid AG480F, Advalytix AG/Beckman Coulter Biomedical 
GmbH, Munich, Germany; chapter 2.3.1) and on reaction center B (∅ 500 µm) of LOC chips 
(chapter 2.3.1). Probes were spotted in a 2x2 array structure using a Nadelspotter (spotting 
operations were performed by Advalytix AG/Beckman Coulter Biomedical GmbH, Munich, 
Germany). There were 6 different array designs spotted. Each array consisted of 4 spots, 
while full arrays were spotted with 4 spots having the same probe content (array designs 1-3), 
and split arrays where only 2 spots had the same probe content (array designs 4-6). Array 
designs were as follows: (1) 4 spots of Amelo1(Y), (2) 4 spots of Amelo2(X), (3) 4 spots of 
Amelo3(Y), (4) 2 spots of Amelo1(Y) + 2 spots of Amelo2(X), (5) 2 spots of Amelo2(X) + 2 
spots of Amelo3(Y), (6) 2 spots of Amelo1(Y) + 2 spots of Amelo3(Y). Spot size was about 
120 µm (100-160 µm) with a spot distance of about 160 µm, comprising an array diameter of 
about 400 µm. Spotting solution contained 50 µM oligonucleotide probe solution dissolved in 
1x Advalytix spotting buffer AT100. Spotting, washing and passivation steps after spotting 
were done by Advalytix AG/Beckman Coulter Biomedical GmbH, Munich, Germany as well. 
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PCR and hybridization of male and female human genomic reference DNA. For PCR 
amplification prior to hybridization and for detection of hybridized PCR products, a Cy3 
fluorescently labeled primer Amel1-f-Cy3 was used in combination with an unlabeled primer 
Amel2. Primer sequences were listed in the appendix, chapter 9.2. For amplification and 
hybridization, the QIAGEN Fast Cycling PCR kit (QIAGEN GmbH, Hilden, Germany) was 
used for 3-step PCR. 1 µl total reaction volume contained 0.5 µl of 2x QIAGEN Fast 
Cycling PCR Master Mix (final 1x), 0.2 µl of 5x QIAGENQ-Solution (final 1x), 0.1 µl of  
10 µM primer solutions Amel1-f-Cy3 and Amel2 (final 1 µM per primer) and 0.1 µl of sterile 
water (Ampuwa, Fresenius, Bad Homburg, Germany) for negative controls or 0.1 µl of 10x 
concentrated input DNA. For input DNA concentrations of 1 ng male or female reference 
DNA was used, resulting in a final concentration of 100 pg present in 1 µl total reaction mix. 
1 µl of prepared master mix was placed on spotted reaction center B of LOC chips or on 
spotted reaction sites of a multi LV-PCR microdevice and was immediately covered with 5 µl 
of Sealing Solution to prevent evaporation and external cross-contamination. 3-step PCR 
cycling was performed according to the manufacturer’s protocol: 5 min initial denaturation at 
95°C, 40 cycles of 94°C for 30 sec, 60°C for 30 sec, 72°C for 30 sec, and final product 
extension at 72°C for 1 min. PCR performance was subsequently followed by a hybridization 
protocol comprising 3 min denaturation at 95°C and 40°C hybridization for 30-60 min. 
Washing protocol. After hybridization, Sealing Solution was washed away from reaction sites 
using sterile water and array chips were subjected to the following washing protocol 
(originally provided by Alopex (Kulmbach, Germany) for using the “Chromo Chip System”) 
comprising washing solutions Wash 1 and Wash 2 (table 1) (washing solutions were taken 
from the Medical Genetic Center, Munich). Washing procedures removed the Sealing 
Solution efficiently as well as unbound PCR products. 
Table 1. Washing protocol and compositions of washing buffers Wash 1 and Wash 2 after PCR and array 
hybridization. Buffers Wash 1A and Wash 2 needed to be autoclaved at 120 °C for 20 min prior to use. Washing 
procedures were performed at room temperature. 
 
Washing solutions Composition Concentrated Buffer Solutions 
1.0 l     Wash 1 
(working solution) 
 100 ml     Wash 1A (10x) 
   20 ml     Wash 1B (5x) 
 880 ml     H2Odest. 
Wash 1A (10x) = 3 M NaCl 
                             0.3 M Na3 Citrate 2H2O 
                             pH 7.0 
Wash 1B (5x) = 10% (w/v) Natriumdodecylsulfate (SDS) 
1.0 l     Wash 2 
(working solution) 
 100 ml     Wash 2 (10x) 
 900 ml     H2odest. 
Wash 2 (10x) = 0.3 M NaCl 
                          30 mM Na3 Citrate 2H2O 
                          pH 7.0 
Washing protocol     
                                   
5x    1 min    Wash 1 
2x    1 min    Wash 2 
1x    3 min    Wash 2 
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For washing the multi LV-PCR microdevice an automated washing station appropriate for 
these slides was utilized (AdvaWash, Advalytix AG/Beckman Coulter Biomedical GmbH, 
Munich, Germany). LOC chips were washed manually by applying a 10 µl overlay of buffers 
onto the hybridization reaction center B of the chips. After washing, array chips were dried 
for 5 min at 37°C until slide surfaces were totally dry and stored in darkness for the scanning 
process (max. 3 h).  
Detection. The multi LV-PCR microdevice was scanned for hybridized PCR products using 
an automated PMT laser-based microarray scanner system (ProScanArray Microarray 
Analysis System, PerkinElmer Life and Analytical Sciences, Shelton, CT, USA) and 
appropriate software (ProScanArray Scanner Software, PerkinElmer Life and Analytical 
Sciences, Shelton, CT, USA). LOC chips were scanned using an inverted optical microscope 
(Axio Obsever.Z1, Carl Zeiss GmbH, Jena, Germany) with integrated fluorescence unit for 
excitation and appropriate filters for excitation, emission and detection. Excitation was done 
using a HBO 100 high-pressure mercury lamp (HBO 100, Leistungselektronik JENA GmbH, 
Jena, Germany). Due to the Stokes-transition between the absorption and emission spectrum, 
it is possible to separate the bright excitation light from the weak fluorescence light in the 
light path of the microscope via using appropriate filter sets. Pictures of fluorescence 
intensities were taken using a CCD camera (Rolera-XR, QImaging, Surrey BC, Canada) and 
QCapture Pro 6.0 imaging software (QImaging, Surrey BC, Canada). 
2.3.4  Solid phase amplification 
Solid phase amplification (SPA) was performed as a special form of arrayed on-chip 
amplification using directly surface-bound primers forming a very dense carpet like probes in 
microarray applications (Bing DH et al., 1996; Adessi C et al., 2000; Nickisch-Rosenegk M 
et al., 2005; Fedurco M et al., 2006).  Amplification can occur via two processes. First 
“interfacial amplification”, where freely diffusing DNA target molecules attach to surface-
bound primers, primers are elongated to complementary DNA copies and these ssDNA 
molecules stay attached to the surface, while the initial DNA molecule returns to the solution 
after the annealing step. Second “surface amplification”, where the free end of the attached 
ssDNA copy hybridizes to a sequence-complementary surface-attached primer in immediate 
proximity. This time primer elongation leads to building bridges between primers, as both 
elongated DNA molecules stay attached to the surface. SPA thus leads to the generation of a 
colony of molecules attached to the surface and located in the same region. Synthesized PCR 
2. Materials and Methods 
 
 
41 
products can be visualized either by confocal microscopy or fluorescence microscopy using 
Cy5-dye fluorescence of modified primers, or the fluorescence of intercalating dyes. 
Spot array design. For solid phase amplification applications, 3 different surface-bound 
primer-pairs were spotted on reaction center B (∅ 500 µm) of LOC chips (chapter 2.3.1). 
Primer-pairs were spotted in a 2x2 spot array structure using a Nadelspotter (spotting 
operations were performed by Advalytix AG/Beckman Coulter Biomedical GmbH, Munich, 
Germany). The following array design was spotted: the array consisted of 4 spots, while each 
spot comprised a different primer-pair content. On one spot primer-pairs DY-fw and DY-rv 
for amplifying male locus DYS392 were spotted, on a second spot primer-pairs DX-fw and 
DX-rv for amplifying female locus DXS10134, on a third spot primer-pairs AM-fw and AM-
rv for amplifying human amelogenin as a positive control and on the forth spot primers DY-
fw and DX-fw as negative control, providing no complementary sequences after 
amplification. Primer sequences were listed in the appendix, chapter 9.2. Spot size was about 
120 µm (100-160 µm) with a spot distance of about 160 µm, comprising an array diameter of 
about 400 µm. Spotting solution contained 50 µM oligonucleotide probe solution dissolved in 
1x Advalytix spotting buffer AT100. Spotting, washing and passivation steps after spotting 
were done by Advalytix AG/Beckman Coulter Biomedical GmbH, Munich, Germany as well. 
Solid phase amplification PCR reactions. For performing solid phase amplification on LOC 
chips the QuantiFast SYBR Green I PCR kit was used for 2-step PCR (QIAGEN GmbH, 
Hilden, Germany). Several PCR protocols were tested as described in the following, first only 
“SPA PCR” using genomic DNA and second a “combined PCR setup” using preamplified 
PCR products. Before PCR, array-spotted LOC chips were preheated for 15 min at 95°C for 
adapting the material to hot temperatures (chapter 2.3.1).  
Using “SPA PCR”, 1 µl of total reaction mix contained 0.5 µl of 2x QuantiFast SYBR 
Green I PCR Master Mix (final 1x), 0.3 µl of sterile water (Ampuwa, Fresenius, Bad 
Homburg, Germany) and 0.2 µl of 10x concentrated input DNA. For input DNA 5 ng/µl of 
male or female reference DNA was used, resulting in a final concentration of 1 ng reference 
DNA present in 1 µl total reaction volume. 1 µl of prepared master mix was placed on primer-
array spotted reaction center B of LOC chips and was immediately covered with 5 µl of 
Sealing Solution to prevent evaporation and external cross-contamination. 2-step SPA PCR 
cycling conditions were 5 min initial denaturation at 95°C, followed by 35 cycles of 95°C for 
30 sec and 60°C for 60 sec. 
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Using the “combined PCR setup”, preamplified PCR products were used as input DNA. For 
preamplification the QuantiTect SYBR Green I PCR kit was used for 3-step PCR 
(QIAGEN GmbH, Hilden, Germany), while 10 µl of total PCR reaction mix contained 5 µl of 
2x QuantiTect SYBR Green I PCR Master Mix (final 1x), 1 µl of 10 µM primer solutions 
(DYS392-fw and DYS392-rv or DXS10134-fw and DXS10134-rv or Amel1 and Amel2; final 
1 µM per primer), 2 µl of sterile water (Ampuwa, Fresenius, Bad Homburg, Germany) and  
1 µl of 10x concentrated input DNA. For input DNA 5 ng/µl of male and female reference 
DNA was used, resulting in a final concentration of 500 pg reference DNA present in 10 µl 
total reaction volume. Primer sequences were listed in the appendix, chapter 9.2. Reactions 
were performed in sterile 0.2 ml PCR-tubes (Eppendorf AG, Hamburg, Germany) using a 
conventional in-tube PCR thermocycler (advanced Primus 96, PeqLab Biotechnologie GmbH, 
Erlangen, Germany). 3-step PCR cycling conditions were 15 min initial denaturation at 95°C, 
followed by 35 cycles of 94°C for 30 sec, 55°C for 60 sec, 72°C for 30 sec, and final product 
extension at 72°C for 7 min. PCR products were analyzed on polyacrylamide gels (CleanGel 
10%, ETC GmbH, Kirchentellinsfurt, Germany) and subsequent DNA silver staining (DNA 
silver staining kit, GE Healthcare, Uppsala, Sweden) (chapter 2.2.3). Blank and negative 
controls were included in every reaction batch. For 0.1 µl input DNA in the following 
“combined PCR setup”, 0.033 µl of each preamplified PCR product tube DYS392, 
DXS10134, Amel for male or female DNA was utilized. The “combined PCR setup” 
comprised three reaction steps performed consecutively on LOC chips, which were 
summarized in table 2, while the QuantiFast SYBR Green I PCR kit was used for 2-step 
PCR (QIAGEN GmbH, Hilden, Germany).  
Table 2. Combined PCR setup. Interfacial amplification, surface amplification and a hybridization step were 
performed consecutively on the LOC chip’s surface for optimizing solid phase amplification output. 
 
Order of performance Composition of reaction mix Thermal cycling conditions 
1. Interfacial 
    amplification 
1 µl total reaction mix contained 0.5 µl of 2x 
QuantiFast SYBR Green I PCR Master Mix 
(final 1x), 0.4 µl of sterile water (Ampuwa, 
Fresenius, Bad Homburg, Germany) and 0.1 µl of 
preamplified PCR products. 
2-step PCR protocol: 5 min 
initial denaturation at 95°C, 
followed by 30 cycles of 
95°C for 30 sec and 55°C for 
60 sec. 
2. Surface 
    amplification 
1 µl total reaction mix contained 0.5 µl of 2x 
QuantiFast SYBR Green I PCR Master Mix 
(final 1x) and 0.5 µl of sterile water (Ampuwa, 
Fresenius, Bad Homburg, Germany). 
2-step PCR protocol: 5 min 
initial denaturation at 95°C, 
followed by 30 cycles of 
95°C for 30 sec and 55°C for 
60 sec. 
3. Hybridization 
1 µl total reaction mix contained 0.5 µl of 2x 
QuantiFast SYBR Green I PCR Master Mix 
(final 1x) and 0.5 µl of preamplified PCR products. 
Hybridization protocol: 3 
min denaturation at 95°C, 
followed by 40°C 
hybridization temperature for 
30-60 min. 
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Washing protocol and detection. After finishing “SPA PCR” or “combined PCR setup”, 
Sealing Solution was washed away from reaction center B using sterile water and array chips 
were subjected to the washing protocol described in table 1. Washing procedures removed the 
Sealing Solution efficiently as well as unbound PCR remainings. LOC chips were washed 
manually by applying a 10 µl overlay of buffers onto the SPA reaction center B of the chips. 
After washing, array chips were dried for 5 min at 37°C until slide surfaces were totally dry 
and stored in darkness for the scanning process (max. 3 h). LOC chips were scanned using an 
inverted optical microscope (Axio Obsever.Z1, Carl Zeiss GmbH, Jena, Germany) with 
integrated fluorescence unit for excitation and appropriate filters for emission and detection. 
Excitation was done using a HBO 100 high-pressure mercury lamp (HBO 100, 
Leistungselektronik JENA GmbH, Jena, Germany). Due to the Stokes-transition between the 
absorption and emission spectrum, it is possible to separate the bright excitation light from the 
weak fluorescence light in the light path of the microscope via using appropriate filter sets. 
Pictures of fluorescence intensities were taken using a CCD camera (Rolera-XR, QImaging, 
Surrey BC, Canada) and QCapture Pro 6.0 imaging software (QImaging, Surrey BC, Canada). 
Additionally, fluorescence signal were detected using the lab-on-a-chip integrated 
Fluorescence Reader and appropriate software “Norbert.VI” for manual picture taking 
(LabVIEW 8.6, National Instruments Germany GmbH, Munich, Germany). Pictures were 
taken with exposure times of 1000 ms, 2000 ms and 4000 ms at room temperature as well as 
at 40°C and 60°C. Furthermore, to check for detached primers and PCR products in the SPA 
reaction solution, reaction mixes were analyzed on polyacrylamide gels (CleanGel 10%, ETC 
GmbH, Kirchentellinsfurt, Germany) and subsequent DNA silver staining (DNA silver 
staining kit, GE Healthcare, Uppsala, Sweden) (chapter 2.2.3). 
2.3.5  Sequencing of amplified ancient sample material 
Sequencing was performed on PCR products of microdissected ancient bone tissue sample 
mummy4, exemplary for all of four microdissected mummy samples. For subsequent 
sequencing, PCR was performed using the QIAGEN Fast Cycling PCR kit (QIAGEN 
GmbH, Hilden, Germany) for 3-step PCR according to manufacturer’s recommendations. 
Reaction volumes were scaled down to 20 µl, prepared in sterile 0.2 ml PCR-tubes 
(Eppendorf AG, Hamburg, Germany). Cycling was performed in a conventional PCR 
thermocycler (Cyclone 25, PeqLab Biotechnologie GmbH, Erlangen, Germany). 20 µl total 
PCR reaction mix contained 10 µl of 2x QIAGEN Fast Cycling PCR Master Mix (final 1x),  
4 µl of 5x QIAGEN Q-Solution (final 1x), 2 µl of 10 µM primer solutions Amel1 and Amel2, 
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or primer solutions β-Actin up and β-Actin down respectively (final 1 µM per primer), 1 µl of 
sterile water (Ampuwa, Fresenius, Bad Homburg, Germany) and 1 µl extracted mummy 
DNA (corresponds to 60 pg). Primer sequences were listed in the appendix, chapter 9.2. 3-
step PCR cycling was performed as recommended by the manufacturer’s protocol: 5 min 
initial denaturation at 95°C, followed by 40 cycles of 94°C for 30 sec, 60°C for 30 sec and 
72°C for 30 sec, and final product extension at 72°C for 1 min.  For product purification and 
sequencing analysis, PCR products were sent to GENEART AG sequencing service 
(Regensburg, Germany). 
2.3.6  Precautions to prevent contamination in ancient sample material analysis 
During experiments, numerous precautions were taken to minimize the risk of contamination, 
which were summarized by Pääbo S et al. (2004). Furthermore, to exclude possible cross-
contaminations between ancient sample material and scientific staff, DNA typing reactions 
were performed using selected STR markers D7S1824, D9S302, D10S2325 and also the 
AmpF/STR SEfiler PCR amplification kit (chapter 2.3.1). DNA profiling of extracted 
mummy material as well as genomic material of involved scientists, archaeologist/excavator, 
technical assistance staff, laboratory personnel and all people who had been knowingly in 
contact with any kind of mummy material (including bone particles, paraffin-embedded tissue 
blocks, tissue slides and mummy DNA extracts) and also with laboratory equipment (e.g. 
laboratory working places and laboratory working tools like laser microdissection 
microscope, DNA extraction accessory and the PCR thermocyclers) was accomplished. 
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3.  Description of the Lab-on-a-chip System 
The existing lab-on-a-chip (LOC) system was designed as a modular composition comprising 
five independent working modules (figure 3). There were two modules for sample 
preparation prior to PCR analysis, in fact a laser-based microdissection unit (chapter 3.1) for 
retrieval of sample material as well as a particle transfer module (SPATS, chapter 3.2) 
providing an interface to the PCR unit after microdissection. The PCR module CytoCycler 
(chapter 3.3) represented the core of the LOC system encompassing a progressive microchip 
design, flexible and open for a huge amount of sample types and analytical applications 
including sample processing, amplification and detection. For informational output, a 
Fluorescence Reader was integrated for post-PCR product detection methods like real-time 
PCR and array applications (chapter 3.5). Following the envisioned automation of all 
sample-processing steps, additionally an automatic fluid-dispensing device was integrated 
compensating manual pipetting operations (BioSpot, chapter 3.4). While each unit was 
handling important sample processing functions individually and totally software controlled, 
altogether these modules combined comprehensively to a universal and programmable micro 
total analysis system. Due to an intelligent slide rail-based integration of all modules sterical 
interferences of modules, while serving the small LOC chip surface, could successfully be 
circumvented. 
 
Figure 3. Overview of the complete lab-on-a-chip system. The modular design includes a laser-based 
microdissection unit for sample retrieval and a transfer unit SPATS for loading the PCR-CytoCycler with sample 
material. While being served by an automatic liquid dispensing unit BioSpot, the CytoCycler PCR 
amplification unit and the fluorescence detection unit provide all necessary equipment for genetic analysis of 
sample material. 
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During the last years, this lab-on-a-chip system was referred in a couple of scientific articles 
(Thalhammer S et al., 2007; Woide D et al., 2008; Thalhammer S et al., 2008; Thalhammer 
S, 2009; Thalhammer S et al., 2009), conference sessions (Woide D et al., 2008, Actuator 
2008, Bremen; Woide D et al., 2008, Science Day 2008, Linz) as well as most notably in a 
professorial dissertation (Thalhammer S, 2009). In the following sections an overview over 
the total LOC system as well as technical features and functional operations of each particular 
modular unit is illustrated. Detailed descriptions of laboratory internal operating procedures of 
each individual LOC module were summarized in the appendix (chapter 9.1) and are 
available on an external media. 
3.1  Laser microdissection module 
During the last decade, laser-based systems have become state-of-the-art technologies for 
precise and non-contact micromanipulation of biological material in biology and medicine. 
However, the initiation of using focused light for micromanipulation goes back to 1912, when 
Tschachotin focused the light of a bulb lamp through the microscope objective onto an object 
plane (“Strahlenstich” method, Tschachotin S, 1912). After the invention of lasers in 1960, 
the first laser was coupled into a microscope to achieve much smaller laser focal spots for 
manipulation purposes (Bessis M et al., 1962). Since then, laser technologies were developed 
further for a broad area of medical applications, while in 1987 optical tweezers as well as 
pulsed UV-lasers integrated in optical instruments began to revolutionize micromanipulation 
of cells and particles without any mechanical contact (Ashkin A et al., 1987; Ashkin A and 
Dziedzic JM, 1987; Srinivasan R, 1986; for a general overview refer to Thalhammer S et al. 
(2003) and Thalhammer S et al. (2004)). Today, modern molecular research and diagnosis 
rely increasingly on the capability to isolate pure single sample particles and their precise 
positioning for further biochemical analysis. Non-contact manipulation techniques based on 
laser microdissection provide not only highly selective isolation and extraction but also the 
precise manipulation of smallest fractions of genetic material due to laser ablation with 
microbeams and with minimum risk of contamination.  
The available laser microdissection unit at hand comprised a modified UVA-laser system 
integrated into an inverted optical microscope. For material isolation the principle of material 
ablation was utilized based on a pulsed nitrogen UVA laser beam (λ = 337 nm) having a 
maximal pulse frequency of 30 Hz and a pulse-duration of 3 ns (pulse energy >270 µJ). For 
laser ablation the laser was coupled via the epifluorescence path into the light path and was 
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focused through the microscope objective to less than one micrometer in diameter. Diameters 
of the laser focus were set via the numerical aperture of the objective. The force of the 
focused, near diffraction limited pulsed UVA laser light was utilized for microdissection of 
biological material with high spatial resolution. As only UVC light (λ = 200-290 nm) was 
identified to cause DNA damage, as the main absorption peaks of DNA and proteins are 
located at 260 nm for DNA and 280 nm for proteins, the 337 nm wavelength was well outside 
of the DNA damaging region. Biological material within the focal spot of the laser was 
ablated due to photofragmentation, a photochemical process without heat transformation into 
the surroundings (“cold-ablation”), also called “ablative photodecomposition” (APD) (details 
in Thalhammer S et al., 2003). Within the focal spot of the laser an extreme photon density 
was achieved (intensity of more than 1 Megawatt/cm2), photofragmenting unwanted cut 
material into small molecules and atoms, which were blown away at supersonic velocities. As 
the ablative force was restricted to the minute laser focal spot only, directly aside of the laser 
focus spot the photon density was not sufficient to cause ablation, leaving the adjacent 
specimen entirely intact (Srinivasan R, 1986). 
The total system for laser-based microdissection included the inverted optical microscope 
with laser interface, motorized and joystick-controlled microscope XY-scanning stage as well 
as particular software “Nanosauger”. The laser interface was a one-box device, which housed 
the laser and all necessary optics to guide the laser into the microscope and to bring the laser 
focus coincide with the optical focus of the microscope at the object plane. The well-directed 
positioning of object slides with nano- and micrometer precision was possible via stepping-
motor-controlled XY-scanning stage while joystick movements were translated into two 
dimensional stage displacements. The stage speed could be adapted software-controlled. Via 
an external control board the laser focus as well as cut energy could be set at the object plane. 
Thus, the laser focus could be changed into z-direction independently from the microscope 
focus. For adjusting the focus plane to the object plane, a telescopic device was applied in the 
light path, while the focus point could also be leveled above/beneath the object via a lens, 
which was especially necessary when working with different objectives or varying sample 
thickness. The beam focus was dependent on the beam quality of the laser, the numerical 
aperture of the focusing objective and the absorption behavior of the specimen (Thalhammer 
S et al., 1997). The nitrogen laser emitted fixed laser energy; for energy settings a grey wedge 
filter was fixed behind the laser coupling out, absorbing the remaining energy. This allowed 
adjusting the laser energy continuously without beam displacement. For documentation there 
were two cameras available, a black & white CCD camera and a color firewire camera. 
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3.2  SPATS particle transfer module 
Based on PEN-membrane supported laser ablation using a pulsed UVA laser, a special 
approach for material extraction was developed for being integrated into the lab-on-a-chip 
system. The device was called “SPATS” meaning single particle adsorbing transfer system 
and facilitated horizontal single particle transfer to any planar devices after UVA laser-based 
microdissection like e.g. on the LOC system, gently controlled via low-pressure technology. 
The device was reported as a novel approach for horizontal transfer of single particles after 
laser microdissection and EU patented (EU patent 08150662.8), published (Woide D et al., 
2009) and tested for various scientific relevant applications (Mayer V et al., 2009; Woide D et 
al., 2010). 
The SPATS was fabricated by the company XYZ High Precision (Darmstadt, Germany) and 
consisted of several components combining mechanical, optical, pneumatical and electronic 
components. Due to its modular character, the SPATS was fixed to the inverted optical 
microscope via a micrometer stepping motor, which provided movements in XY-direction for 
horizontal as well as vertical particle transfer with µm-precision. The SPATS sample take-up 
device comprised a copper collection grid with meshes, attached to a bended transparent glass 
capillary tube, both comprising the adsorbing head, which is connected to the moving part of 
the device, the collection arm (figure 4). For transfer of various samples, adsorbing heads 
could be exchanged by an “easy-to-fit” click system. The glass capillary tube had an external 
diameter of 1.7-2.0 mm, an internal diameter of 500 µm and a length of 60 mm. The 
collection grid was biologically inert, antistatic and UV-C resistant, comprised a diameter of 
500 µm with meshes of 5 µm in diameter. Fixed at the micrometer stepping motor, the 
collection arm was connected to a pneumatic picopump. Low- and high-pressure adaptors 
allowed fine-tuning of both low-pressure and high-pressure for sample take-up and release. 
All functions and parameters of hardware components like scanning microscope XY-scanning 
stage (for positioning sample uptake), camera (for optical control), SPATS device movement 
and pressure-supply box were controlled by particular software “Nanosauger”.  
The new approach was based on the laser pressure catapulting method using a PEN 
supporting membrane for material extraction, but progressive low-pressure technology was 
utilized for sample take-up and release instead of laser shot and formation of a microplasma 
(Thalhammer S et al., 2003). The SPATS device was qualified for extraction and transfer of 
hard material, like e.g. bone tissue particles (Woide D et al., 2010), as well as soft material, 
like tissue sections, single cells (Mayer V et al., 2009) or chromosomes (figure 4 B). 
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Figure 4. SPATS device. A) Closeup of the sample take-up device “single particle adsorbing transfer system” 
SPATS. The adsorbing head comprised a bended glass capillary tube (insert 1, 500 µm internal diameter) and a 
copper collection grid (insert 2 and 3, 500 µm in diameter with meshes of 5 µm in diameter). Insert 2 shows a 
view on the whole adsorption area, while insert 3 provides a view through the microscope onto the sample 
collecting area. B) Workflow of sample transfer. Via applied low-pressure technology the SPATS was capable 
of transferring soft material like e.g. single cells (20 µm in diameter, picture 1-3), or cellular components like 
nuclei and chromosomes (1-10 µm in size, pictures 4-6) as well as hard material like e.g. bone tissue particles 
(about 350x250 µm in size). A typical workflow consisted of material isolation via laser microdissection 
(pictures 1 and 4), adsorption to the collection grid (pictures 2 and 5) and followed by release into a small 
amount of fluid (pictures 3 and 6). 
Microdissected particles in the range from 5-500 µm in diameter could be transferred, 
whereas the adsorption limit of 5 µm however applied only to the size of microdissected 
PEN-membrane carrier fragments. Smaller particles fell below the diameter of the grid 
meshes, and larger ones exceeded the visible adsorption zone. The size of the biological 
sample isolated could be smaller (e.g. a single metaphase chromosome). Particle shape should 
be planar and particle weight depended on the applied pressure and the suction volume 
according to the grid diameter. Due to the chemical composition of the supporting membrane, 
the PEN membrane was stable up to 155°C and did not interfere with subsequent PCR 
analysis. Low-pressure was used to attach isolated material to the collection grid, allowing 
precisely controlled positioning for sample release to any desired predefined target position 
into test tubes as well as onto any planar microchip device. During the transfer process, the 
sample was neither changed morphologically, chemically nor biologically. The SPATS was 
the first device enabling gentle horizontal and highly precise transfer of microdissected 
material, thus emerging a high potential for sample handling in regard to lab-on-a-chip 
technologies. Using virtual reaction chamber microdevices like the lab-on-a-chip system 
described here, small amounts of microdissected material could be directly transmitted and 
immediately used for analysis. 
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3.3  CytoCycler PCR module 
The CytoCycler represented the microfluidic component of the total lab-on-a-chip system, 
driven by surface acoustic wave (SAW) actuation and controlled via interdigital transducers 
(IDT). The CytoCycler PCR device could be considered the core of the whole lab-on-a-chip 
system, providing all necessary equipment for performing virtual reaction chamber PCR 
amplification of genetic sample material. It included LOC chips providing the platform for 
sample analysis, a chip-holder, a temperature control device, a high frequency (HF) generator 
for SAW control via joystick, and particular software “CytoCycler”. The whole CytoCycler 
equipment was fabricated and provided by the company Advalytix AG/Beckman Coulter 
Biomedical GmbH (Munich, Germany). The software “CytoCycler” controlled PCR 
performances via the temperature control device and a temperature sensor at the chip-holder, 
and also transmitted trigger signals to the trigger signal break-out box of the Fluorescence 
Reader (chapter 3.5). The temperature control device was software-controlled, while the HF 
generator and thus droplet actuation via SAW was controlled via joystick operations. 
LOC chip design. LOC chips were designed as virtual reaction chamber (VRC) low-volume 
LV-PCR chips, according to the basic principle of a virtual reaction chamber PCR chip as 
introduced in 2005 (Guttenberg Z et al., 2005). The device was fabricated from piezoelectric 
LiNbO3 as basic material followed by a metal gold layer for the SAW interdigital transducers 
(IDTs), contact wires and gold contacts. Epoxy groups were used to make the surface 
hydrophilic at distinct reaction areas and to form virtual hydrophilic tracks. This surface was 
chemically treated via hydrophobic/oleophobic fluorsilane coating to present an epoxysilane 
hydrophilic tracksystem surrounded by hydrophobic/oleophobic background (figure 5 A). 
The chemically heterogeneous structured fluorsilane/epoxysilane surface of the LiNbO3 chip 
was produced in a structuring process by coating with silanes (Brzoska JB et al., 1994) 
followed by applying photolithography on the resulting organic film (Xia Y and Whitesides 
GM, 1998). The track system included hydrophilic reaction centers, providing high contact 
areas for fluids for fixation and optimal heat transfer. The complete chip was protected with 
sputtered silicon dioxide, which was removed above the gold contact pads. All these 
hydrophilic/hydrophobic structures were patterned by photolithography (figure 5 B). An 
aqueous droplet, e.g. containing sample material and reaction solution, formed a virtual 
reaction chamber when placed on the structured surface. This virtual confinement, forming an 
own wall- and tube-free virtual test tube, was achieved due to surface tension of the liquid and 
surface chemistry of the substrate (figure 7). Depending on the kind of chemical surface 
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modification, droplets with high contact angle could slide on the surface (hydrophilic droplet 
on hydrophobic surface) or the liquid could wet the surface due to low contact angles 
(hydrophilic droplet on hydrophilic surface). Each chip had three reaction centers comprising 
low contact angles and 10 track lanes served by 10 separately addressable SAW transducers 
on crossover directions for aligning the droplets on the heater structures and for fusing 
droplets in reaction centers (figure 5 B). Opposing transducers had different spatial periods to 
avoid crosstalk.  
 
Figure 5. LOC chip design and structuring lithography. A) The chip architecture comprised a layer-by-layer 
design based on LiNbO3 as basic substrate. After a metallization layer including IDTs and gold contacts surface 
chemistry provided the basis for functional compartments. B) Hydrophilic areas (hydrophilic reaction centers 
A+B+C and guiding tracks for the oil droplet movement, orange pattern) were patterned on the chip with 
positive photoresist, while an organic layer of a hydrophobic perfluoroalkylsilane was bound to the whole 
surface (blue pattern). After removing the photoresist, epoxysilane was grafted from an organic solution. Small 
inlets show electron microscopy images of the various functional structures on the chip surface like interdigital 
transducers, reaction points, tracks and gold contacts. Hydrophilic tracks were about 15 µm in width for side 
tracks and 200 µm for the main track from A to C. Reaction centers A and B comprised a diameter of 500 µm, 
while center C was designed as a square with 1x1 mm2 in size. Small anchor spots at sidetracks comprised about 
40 µm in diameter. 
Chip-holder. The chip-holder itself provided a cavity for installing a LOC chip in contact 
with a Peltier element and with a load resistor heating, a temperature sensor, and a contacting 
lid for the high frequency support of the IDTs (figure 6 A). The contacting lid housed gold 
contact pins for contacting the gold contact pads on the chip surface, thus transferring the high 
frequency signal from the HF generator to the designated transducers on the chip surface. At 
the transducers, electrical high frequency signals were converted into mechanical vibrations, 
propagating as surface acoustic waves on the surface (figure 6 B). Heat transfer from the 
Peltier element to the LOC chips was achieved by close contacting of the Peltier element’s 
surface with the chip’s undersurface, thus providing direct heat transfer. 
Heating structures and reaction centers. There were 3 hydrophilic reaction centers (A, B, C) 
chemically generated on the chip surface being heated by two heating devices located within 
the cavity of the chip-holder to contact the chip’s undersurface (figure 6 B). Heating devices 
were a load resistor heating (2x2 mm2 in size) for isothermal cycling and a Peltier element  
(1x1 cm2 in size) with an integrated temperature sensor for thermal PCR cycling. Hydrophilic 
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reaction center A comprised 500 µm in diameter and was thermally served by the load resistor 
heating for isothermal reactions. Hydrophilic reaction center B comprised 500 µm in diameter 
and was thermally served by the Peltier element for PCR and microarray applications (figure 
6 and figure 7 C). Hydrophilic reaction center C comprised a square of 1 x 1 mm2 and was 
designed for array applications, while being thermally served by the Peltier element as well. 
In the area around the heaters, the temperature dropped fast. Heating rates for the load resistor 
heating could be adjusted to 0.01 – 10 K s-1, while heating rates for the Peltier were fixed to  
3 K s-1 and cooling rates to 4 K s-1. To avoid disturbing air streams and dust on the chip 
surface, the reaction area cavity was covered with a glass slide during PCR performances.  
 
Figure 6. Chip-holder and heating elements of the CytoCycler. A) Basis of the chip-holder: the cavity for 
installing a LOC chip is shown (2.5 x 2.0 cm2), as well as the two heating devices, a load resistor heating  
(2x2 mm2, marked with an “A”) and a Peltier element (1x1 cm2, marked with a “B”). B) Assembled chip-holder 
with a transparent LOC chip installed. The contacting lid held gold pins, which were in contact with gold contact 
pads on the chip surface. Via this contacting, HF signals were transmitted to the interdigital transducers and 
transformed into surface acoustic waves propagating on the chip surface. 
SAW droplet actuation. Actuation for moving droplets on the surface of the piezoelectric 
substrate was done by surface acoustic waves (SAW) (Shiokawa S et al., 1989; Uchida T et 
al., 1995) for to bring reagents into contact and to reaction centers. Surface acoustic waves 
were generated by interdigital transducers, which were patterned on the planar LiNbO3 
substrate (figure 5 B and figure 7 C). Electrical signals, sent by the HF generator, were 
conducted via the gold contact pins of the lid to the gold contact pads on the chip surface. 
Gold contacts on the chip served IDTs, where electrical signals were transferred into 
mechanical vibrations propagating on the surface substrate as acoustic sound waves (also 
called acoustic streaming (Moroney RM et al., 1991; Wixforth A, 2003)). When a SAW 
coupled into a droplet, this led to a pressure gradient in the liquid. Depending 1) on the size of 
the gradient, namely the applied HF power, as well as depending on 2) the wetting angle of 
the liquid (namely its contact angle on hydrophilic/-phobic substrate) and on 3) the angle with 
which the wave coupled into the fluid, the droplet either started an internal streaming (small 
gradient) or was pushed to move forward (large gradient) in the same direction as the sound 
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wave (Guttenberg Z et al., 2004; Nyborg WL, 1998). Internal streaming could e.g. be used for 
mixing and a large gradient e.g. for moving droplets as well as for dispensing small droplets 
out of a larger volume (Strobl CJ et al., 2004).  
The LOC chips comprised 10 IDTs located around the chip to serve each lane of the 
tracksystem (figure 5 B and figure 7 C). The high frequency generator was operated via a 
joystick, controlling the actuation of each particular SAW transducer on the chip. Using this 
joystick, droplets could be actuated in a very precise manner in either direction following the 
virtual track system on the chemically structured chip surface. Thus, an exact alignment on 
reaction centers could be achieved. On the chip, SAW provided the connection of subsequent 
sample processing steps, like e.g. moving sample-loaded droplets to various reaction areas on 
the chip surface. SAW were used for providing the oil coverage by simply fusing an aqueous 
sample-containing droplet with a larger-volume mineral oil droplet as well. 
Performing virtual reaction chamber LV-PCR. Reactions were performed on the open 2-
dimensional planar chemically structured surface of the microfluidic chip device. To prevent 
external cross-contamination and evaporation of PCR reagents and sample material at high 
temperatures, the aqueous droplet (including e.g. reaction solution and sample material) was 
encapsulated within a droplet of mineral oil (figure 7).  
 
Figure 7. Principle of virtual reaction chamber PCR. A) Schematic drawing of virtual reaction chamber PCR. 
An aqueous droplet of reaction mix is placed on a chemically modified surface and covered by mineral oil to 
prevent evaporation. A proper arrangement of both droplets was achieved by chemical surface treatment via 
photolithography. A hydrophilic reaction center (500 µm in diameter) is enclosed by a hydrophobic ring, holding 
the reaction mix in place; a surrounding hydrophobic area keeps the cover oil (3 mm in diameter) in place. B) 
Surface chemistry provided virtual confinement on LOC chip surfaces. The different surface tensions of both 
liquids kept the spherical phase separation. For visualizing phase separation, a small droplet of 1 µl of dyed 
aqueous solution was covered with 5 µl of mineral oil. C) Gold contact pads were located around the chip, 
serving the IDTs to generate SAWs in any desired direction on the tracksystem. Via surface acoustic waves VRC 
droplets could be moved between reaction centers and both heater devices, the load resistor heating and the 
Peltier element. The whole chip comprises a size of 2.5 x 1.8 cm2.  
The different surface tensions of the two liquids provided the spatial separation, while still 
retaining the ability to be moved by SAW actuation (figure 7 B). This kind of fluid 
arrangement was transported in single oil covered droplets on a chemically modified surface 
using surface acoustic waves (SAW) on the piezoelectric LiNbO3 substrate (figure 7 C). 
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Benefits of the planar virtual reaction chamber microdevice. The main purpose of a lab-on-
a-chip system is to simplify and automate labor intensive, time consuming and costly 
laboratory procedures. However, conventional 3-dimensionally constructed microfluidic 
systems are using channel networks, in which the liquid is controlled with external or 
integrated miniaturized pumps and valves or via electrocapillary forces bearing some major 
problems (as already described in the introductory part). As the pressure required for moving 
the liquid scales inversely with the channel dimension (Brody JP et al., 1996), the power of 
the pumps therefore has to be increased in the same way the size is reduced, which 
complicates integration into a complete system. According to the channel diameter only 
laminar flow is possible due to low Reynolds numbers. The Reynolds number characterizes 
the tendency of a fluid to develop turbulence. Low Reynolds numbers involve high viscosity 
and laminar flow, while high Reynolds numbers involve low viscosity and turbular streaming. 
But laminar flow is useless for biochemical reactions as this leads to insufficient mixing and 
diffusion takes too much time. For generating turbular flow in channel systems, actuators, 
mixers, sensors and all that stuff are needed. With hydrophilic channels that are filled by 
capillary forces no pumps are needed, but the fluid control is delicate. Furthermore, when a 
biological solution is pumped through a narrow tube, the risk of reagent loss by adhesion to 
the wall is large due to unfavorable surface to volume ratio. Other problems are that small 
channels get easily clogged and that surface modification and functionalization is difficult to 
control. Furthermore, channels are hard to clean so one has to deal with contamination. 
Otherwise these complex structures were too expensive in fabrication to be disposables. 
To overcome all these problems, using a virtual reaction chamber device beared a lot of 
benefits. The fluid actuation was done on a planar surface via SAW generated by IDTs via HF 
signals, so no external pumps and no large pressure were needed. Furthermore, no channels 
were needed, as fluids were confined in virtual test tubes in form of free droplets due to 
surface tension and surface chemistry. Small amounts of liquid did not need to be confined in 
tubes or trenches, they formed their own test tubes held together by surface tension, but 
dependent on the wettability of the surface substrate. There was no large pressure needed, as 
the droplet-in-oil arrangement was easily moved via SAW power. Tracks and reaction 
chambers were defined by a chemically modified surface. As chips could be made cheap and 
served as disposables, even contamination or channel clogging did not play a role.  
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3.4  BioSpot fluid-dispensing module  
The BioSpot device was a nano pipetting system for non-contact liquid handling and was 
fabricated and provided with appropriate software by the company BioFluidix GmbH 
(Freiburg, Germany). It comprised several parts featuring a) a PipeJet dispenser moving in 
Z-directions for liquid uptake and delivery, b) a sample slay fixed on a slide rail moving in X-
directions and c) a power control box also housing a syringe pump supporting aspiration and 
dispension of liquid. Onto the sample slay the chip-holder device of the CytoCycler device 
was installed, carrying a flask-filled reservoir device (figure 10 A). The slide rail was about 
70 cm in length and guided the chip-holder with an accuracy of ±50 µm, thus enabling a 
seamless motion of LOC chips to a sample take-up position close to the microscope, to the 
dispensing PipeJet module and to the Fluorescence Reader (figure 8). 
 
Figure 8. Overview of the particular units of the whole LOC system. The five modules of the lab-on-a-chip 
are shown namely the microscope combining laser microdissection and SPATS transfer, the chip-holder of the 
CytoCycler fixed on a moving slay, the BioSpot dispensing device and components of the Fluorescence 
Reader. The slide rail enabled X-directed motion of the chip-holder, thus providing an elegant connection 
between individual LOC modules. The housing for all the optical components of the Fluorescence Reader as 
well as this graphical overview picture was designed in a computer aided design (CAD) program (SolidWorks 
2006, Solid Works Corp.) and was kindly provided by G. Lieckfeld.  
The BioSpot operating unit consisted of three PipeJets named PipeJet1 (PJ1), PipeJet2 
(PJ) and PipeJet3 (PJ3) executing all aspiration, dispension and shooting operations. The 
PipeJets were equipped with a tube reservoir, which was connected to a syringe pump for 
handling the aspiration and dispension of liquids. PJ1 and PJ2 could handle aqueous liquids 
up to 50 µl, while PJ3 could handle up to 1 ml of mineral oil for droplet coverage when 
performing virtual reaction chamber PCR. Each PipeJet housed an elastic polymer tube, 
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which was actuated by a piezostack driven piston supporting shooting operations. Polymer 
tubes were of low cost and could be used as disposables. “Shooting” meant a sequential 
dispension of liquids at tiniest amounts of a few nl. Squeezing the tube via the piston resulted 
in a fast displacement of the filled liquid to both, the open end of the tube and the end 
connected to the reservoir (figure 9). Thereby a small droplet of about 22.5 nl of liquid was 
dispensed to the designated surface or reservoir, forming droplets of a few µl when repeated 
several times. Dosage volumes could be controlled by the amplitude of the piezo actuator, 
while other parameters involved in the dispensing process could be defined via the freely 
programmable software “BioSpot”. 
 
Figure 9. Dosage principle of the BioSpot’s PipeJet modules. The figure shows the piston driven actuation 
of a polymer tube as housed in PipeJets PJ1, PJ2 and PJ3, resulting in the bidirectional dispension of nanoliter 
droplets. Via a principle of fast displacement and slow release, smallest droplet sizes of 22.5 nl could be loaded 
precisely on the chip surface (BioFluidix GmbH, Freiburg, Germany; Lindemann T et al., 2004). 
The BioSpot provided the easiest way to combine all LOC modules due to the 70 cm long 
slide apparatus, included with the BioSpot, and furthermore it will provide the important 
interface for enabling automation of the total LOC system. As a modular unit of the lab-on-a-
chip system, the BioSpot was used as a dispenser for various liquids needed for the 
molecular biological analysis executed on the LOC chip surface. The BioSpot, as a 
computer-controlled dispensing platform, was capable of unloading reagents at any destined 
domain on the LOC chip surface. The z-axis, where the PipeJets were attached to, allowed 
movements of up to 40 cm, while y-positions of the PipeJets needed to be adjusted 
manually. The distance between the three PipeJets provided enough space that each 
PipeJet could reach the chip surface. 
The software gave access to four single active control windows for operating the whole 
BioSpot device, namely (1) Axis Control and Axis Movement, (2) PipeJet Control, (3) 
Valve Control and Pump Control and (4) Batch Mode. A total operating procedure of the 
BioSpot started with dispensing e.g. 1 µl of master mix to reaction center B on the LOC chip 
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surface for sample uptake. For that, the designated PipeJet was approached to a reservoir 
flask (figure 10 A and B), was driven to aspirate a distinct amount of fluid and was moved to 
the chip surface for unloading (figure 10 C). Subsequently, the chip-holder was moved to the 
microscope, waiting for sample uptake after microdissection and SPATS transfer. Sample 
material, released into predispensed fluid, was immediately covered by mineral oil. For that, 
the chip-holder was moved back to the designated PJ3 for applying Sealing Solution either 
directly by dropping onto the liquid droplet or by dispensing onto the LOC chip surface 
(figure 10 D), while droplet fusion was achieved by surface acoustic wave actuation.  
 
Figure 10. Workflow of the BioSpot applied on the lab-on-a-chip system. A) Via the slide rail the flasks-
holding reservoir device was centered to the PipeJets. B) A distinct amount of fluid was aspirated by one of 
the PipeJets. C) The designated PipeJet was approached to the LOC chip surface and centered to reaction 
center A for liquid dispension. D) Via the piston actuation a small volume of 1 µl of liquid was dispensed onto 
the chip surface (red arrow), which was going to be covered with 5 µl of pre-dispensed mineral oil (green arrow) 
for forming a virtual reaction chamber PCR droplet arrangement. 
Pipetting workflows like this could either be performed manually by operating the various 
active control windows of the software or automatically by executing pre-programmed 
operations using the “Batch mode” setting of the software. 
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3.5  Fluorescence Reader module 
For PCR-based systems, detection of amplified products is surely the most important thing to 
fulfill requirements of an entire modular “sample-in-answer-out” µTAS device, while optical 
detection methods still dominate over others due to sensitivity purposes. However, for 
complexity reasons in most µTAS the optical detection is commonly accomplished using a 
microscope located off-chip. Due to the modular and “open” character of the LOC comprising 
a perfect accessibility to chips installed in the CytoCycler PCR device, a fluorescence 
detection unit “Fluorescence Reader” could be integrated easily as not being part of any 
fabrication process. The Fluorescence Reader consisted of a commercially available CCD 
camera and control equipment. A similar simple, portable and modular fluorescence detection 
system for lab-on-a-chip applications was developed by Novak L et al. (2007). 
The Fluorescence Reader module of the lab-on-a-chip system typically consisted of a) a light 
source for emitting light at a suitable wavelength range (blue LED λmax = 470±2 nm with 
collimating optics (inhibiting power losses over the length of the optical path), b) an 
ET482/35 excitation and ET536/40 emission filter set (λmax ex = 482 nm, λmax em = 536 nm), c) 
a CCD camera as detector for signal processing (capturing emitted light), d) external 
electronics like a LED power supply control box and a trigger signal break-out box and e) 
software for image data analysis. The optical path of excitation light and emission light was 
designed in a 45° arrangement for the optical separation of excitation and emission channels 
(figure 12). A LED was chosen as light source as fluorescence systems based on light 
emitting diodes (LEDs) became popular in the last few years for their low cost, due to their 
long lifetime and that LED’s light output can be modulated (Dasgupta PK et al., 2003). 
Additionally, traditionally used light sources like mercury lamps and lasers, were too bulky 
and expensive for combination with the LOC devices. Due to collimation, the stray light of 
the LED was minimized, in order to reduce the signal-background relation. The optical 
system including LED and filter set was adapted to the fluorescence requirements of SYBR 
Green I providing a typical standard fluorescence detection system. SYBR Green I is a 
fluorescence dye intercalating into double-stranded DNA molecules, absorbing blue light at 
an absorption maximum of 498 nm and emitting green light at an emission maximum of  
521 nm (figure 11). Accordingly, integrated filter sets included an excitation filter with a 
transmission of  λmax = 482 nm (spread 36 nm = 464-500 nm) and an emission filter with a 
transmission of λmax = 536 nm (spread 40 nm = 516-556 nm). 
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Figure 11. SYBR Green I spectra. Excitation and emission curves of the DNA intercalating fluorescence dye 
SYBR Green I are shown (from Fluorescence Dye and Filter Database at www.micro-shop.zeiss.com). The dye 
comprised an emission maximum of 521 nm when enlightened with excitation light at a maximum of 498 nm. 
The Fluorescence Reader was positioned stationary in the middle of the LOC slide, between 
microscope and BioSpot (figure 12). For excitation the LED as light source was placed at an 
angle of 45° shining to the sample positioned on reaction center B on the LOC chip surface. 
LED collimated light was filtered by an exciter ET482/35, exciting the SYBR Green I dye to 
produce fluorescing light. Fluorescent light was detected passing through an emission filter 
ET536/40, followed by the collection of light by a CCD camera (figure 12). 
 
Figure 12. Design of the Fluorescence Reader including CCD camera detector, LED light source and filter 
sets. The Fluorescence Reader was integrated on the LOC slide, located between microscope and BioSpot. A 
fluorescent sample was positioned to reaction center B of a LOC chip installed in the CytoCycler. For detection 
of fluorescent sample signals, an angled arrangement of excitation and emission devices including appropriate 
filters was chosen. Thus the optical part could be split into two paths: excitation light was directed in an angular 
way to a fluorescent sample (blue light path), while emitted fluorescing light was detected and captured direct 
vertically by the CCD camera positioned above (green light path). CAD (SolidWorks 2006, Solid Works Corp.) 
image was kindly provided by G. Lieckfeld.  
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The basic setup of the Fluorescence Reader, including LED light source, filter set, LED 
power control box, trigger signal break-out box and CMOS (Complementary Metal Oxide 
Semiconductor) sensor as fluorescence signal detector was developed in the context of a 
diploma thesis (“Fluoreszenzreader zur Detektion von Biomolekülen auf einem ‘Lab-on-a-
chip’/Fluorescence reader for detecting biomolecules on a lab-on-a-chip device”, submitted 
by Taner Sari, April 2008). This work dealed with the coupling of an optical Fluorescence 
Reader to a “lab-on-a-chip”, whereas DNA molecules (enriched with fluorescent marker) 
were optically excited and quantitatively detected via a detection unit. The setup was 
optimized to the actual state in the context of an internship program (“RT-PCR automation 
for lab-on-a-chip using LabVIEW”, submitted by Muhammad Atyab Imtaar in January 2009), 
where an appropriate LabVIEW-based detection software was written 
(“Grand_NIVision_Intensity_Consec_Subtract_Loopback_NewCamera.VI”) for automatic 
picture taking and the CMOS chip detection unit was exchanged by a CCD camera for 
sensitivity and resolution purposes. Additionally, this software was adapted for manual 
picture taking purposes (“Norbert.VI”).  
For performing fluorescence detection, the chip-holder of the hardware heating-device 
CytoCycler needed to be centered to the Fluorescence Reader (figure 12). The temperature 
control box of the CytoCycler provided the connecting to the software control, but also was 
programmed to give trigger signals to the trigger signal break-out box of the Fluorescence 
Reader. Trigger signals were produced for indicating the end of a PCR cycle. There were 
three trigger signal output-plugs at the backside of the temperature control device named 1, 2 
and 3, representing the three periodically-repeated temperature steps of a PCR protocol. 
Outlet 1 gave a signal after the denaturation step, outlet 2 after the annealing step and outlet 3 
after the extension step. Which of these outlets was connected to the Fluorescence Reader 
depended on the kind of PCR performed. In 2-step PCR, when annealing and extension were 
combined in one step, outlet 2 was the choice, in 3-step PCR outlet 3 needed be connected. 
The trigger signal break-out box captured the trigger signal from the temperature control box 
and activated the image capture and image processing process controlled by the particular 
LabVIEW-based software. The LED was turned on to illuminate the sample for fluorescence 
and a picture of the sample was captured by the CCD camera arrangement (figure 13).  
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Figure 13. Illumination of a fluorescent sample during a PCR cycle. The inserts show the software captured 
images at the specific temperatures of a PCR cycle. The optical units for excitation of a fluorescent sample and 
detection of emitted fluorescence signal were placed above reaction center B of the LOC chip in a 45° design. 
For excitation of the fluorescing dye in the sample through a blue LED, the optical excitation path was focused 
through the oil into the aqueous reaction mix solution.  A) When the sample droplet was enlightened at 94°C 
during the denaturation step, no fluorescence was emitted from the fluorescent dye inside the oil-covered sample 
droplet. This was due to the denatured DNA strands, being single-stranded and thus eliminating binding of the 
fluorescent dye SYBR Green I. Thus, software captured images showed no fluorescence signals. B) When the 
sample droplet was enlightened at 60°C during the annealing and extension step of a 2-step PCR performance, 
green fluorescence signals were emitted from the SYBR Green I dyed sample and captured by the optical 
detection unit. This was due to the double-stranded DNA molecules at the end of this temperature step, enabling 
the incorporation of the fluorescent dye. 
Taken pictures were stored in a separate folder and fluorescence intensities produced at the 
end of each cycle were plotted graphically by the software. At the end, an excel file was 
generated summarizing all the collected and measured intensities. There were two kinds of 
pictures generated, “original” ones as well as “processed” ones. “Original” pictures 
represented the real image, while “processed” pictures represented subtracted fluorescence 
intensities. The previous image was subtracted from current image, so just the fluorescence 
increase was displayed. 
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4.  Technical Evaluation of the Lab-on-a-chip System 
In this section, the performance of the individual LOC elements as well as their interplay was 
characterized concerning operating efficiency. Especially the capability of the PCR 
amplification device CytoCycler was analyzed in several biochemical reactions concerning 
amplification efficiency and detection sensitivity of a small amount of sample material. 
4.1  Reliability of heat transfer  
Temperature measurements were performed by installing an adapted measurement LOC chip 
into the chip-holder of the CytoCycler. Input temperatures, controlled by the software and 
measured by the chip-holder’s temperature sensor, were compared to output temperatures 
measured on reaction center B of the measurement LOC chip by a temperature sensor. Thus, 
the heat transfer from the software to the Peltier element and finally onto the chip surface was 
validated. Various temperatures in a PCR relevant temperature range from 25°C up to 100°C 
were tested. Additionally, the performance of an AmpliSpeed slide cycler was tested as a 
reference PCR system. 
The first temperature profile comprised measurements with increasing temperatures, starting 
from 30°C, and followed by stepwise temperature increments of +5°C up to 100°C, while 
each temperature was held for about 30 sec. There were slight negative deviations detectable 
in the upper temperature range from 70-100°C at an average of -0.243°C, but rather randomly 
distributed than in an increasing linear manner. In the lower temperature range from 30°-
65°C, however, decreasing positive deviations were measured at an average of +0.527°C. 
Results derived for the CytoCycler were summarized in table 3. 
The second temperature profile comprised measurements with temperatures simulating 3-step 
thermal PCR cycling, starting from 95°C held for 10 min, followed by 3-5 cycles of 94°C for 
30 sec, 60°C for 30 sec and 72°C for 30 sec. Two independent runs were performed. 
Temperature measurement results derived for the CytoCycler at each specific temperature 
were summarized in table 3. In both runs there were slight but tolerable positive temperature 
deviations detectable. At 95°C, simulating an initial denaturation step, the averaged positive 
deviation was about +0.90°C. At 94°C, simulating the denaturation steps at each PCR cycle, 
positive deviations were measured at an average of +0.98°C. At 60°C, simulating the 
annealing step at each PCR cycle, the positive deviations were at an average of +0.26°C. And 
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at 72°C, simulating the extension step of each PCR cycle as well as the final product 
extension step, averaged positive deviations were about +0.67°C.  
Table 3. Temperature deviations between input and output temperature measured at the CytoCycler device. The 
particular deviations at each measured temperature are given in brackets and are marked with a delta sign (∆). 
 
Input 
temperature by 
software [°C] 
Averaged output 
temperature on chip 
surface [°C] 
Input 
temperature by 
software [°C] 
Averaged output 
temperature on 
chip surface [°C] 
Averaged output 
temperature on 
chip surface [°C] 
Temperature increment +5°C Simulating PCR cycling 
30 31.05 (∆ +1.05)  Run 1 Run 2 
35 35.92 (∆ +0.92) 95 95.21 (∆ +0.21) 96.60 (∆ +1.60) 
40 40.73 (∆ +0.73) 94 94.47 (∆ +0.47) 95.02 (∆ +1.02) 
45 45.59 (∆ +0.59) 60 60.21 (∆ +0.21) 60.32 (∆ +0.32) 
50 50.43 (∆ +0.43) 72 72.51 (∆ +0.51) 72.86 (∆ +0.86) 
55 55.26 (∆ +0.26) 94 94.28 (∆ +0.28) 95.37 (∆ +1.37) 
60 60.19 (∆ +0.19) 60 60.37 (∆ +0.37) 60.28 (∆ +0.28) 
65 65.05 (∆ +0.05) 72 72.64 (∆ +0.64) 72.68 (∆ +0.68) 
70 69.89 (∆ -0.11) 94  95.23 (∆ +1.23) 
75 74.69 (∆ -0.31) 60  60.22 (∆ +0.22) 
80 79.73 (∆ -0.27) 72  72.67 (∆ +0.67) 
85 84.84 (∆ -0.16) 94  95.26 (∆ +1.26) 
90 89.87 (∆ -0.13) 60  60.22 (∆ +0.22) 
95 94.78 (∆ -0.22) 72  72.70 (∆ +0.70) 
100 99.50 (∆ -0.50) 94  95.23 (∆ +1.23) 
  
60  60.18 (∆ +0.18) 
  
72  72.63 (∆ +0.63) 
Values of input temperatures were plotted against output temperatures and illustrated in a 
graphical image (figure 14 A). The distinct deviation values were related to measured 
temperatures and were shown graphically in an additional plot (figure 14 B). 
 
Figure 14. Temperature measurements of the LOC CytoCycler. A) Graphical display of measured input 
temperature (via software) versus output temperature (via hardware on the chip surface). Slight deviations could 
be detected at each measuring point. The drift of both graphs clearly showed positive deviations at lower 
temperatures and negative deviations at higher temperatures. B) Graphical illustration of the deviations of each 
particular temperature. Input temperatures were plotted against measured temperature deviations. 
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The PCR-simulated temperature profile of 94°C, 60°C and 72°C was applied to the 
AmpliSpeed slide cycler as well. Slight deviations of constantly about ±0.5°C were recorded 
for the slide cycler, featuring this cycler as an ideal reference system for the LOC system, 
especially for performing negative and positive control reactions during PCR performances.  
According to an optimal setup based on contacting surfaces of the Peltier element and the 
chip underside, the CytoCycler provided a stable heat transfer onto the chip surface. Besides 
an efficient and optimal temperature transfer, a stable temperature support could be provided 
by this setup. Repeated temperature measurements were performed in two independent runs. 
Temperature output was quite constant at simulated PCR cycling any time tested, accounting 
for reproducible temperature measurements. In several independent measuring approaches, 
constantly slightly positive temperature deviations close to the desired input temperature were 
detected. These positive temperature deviations represented an optimal temperature transfer 
effectivity from the Peltier element to the LOC chip surface. This optimal temperature output 
on the chip surface validated the CytoCycler for reliable PCR performances on the LOC 
system. This setup of direct contact between the heating element and the microchip was 
comparable to the used multi LV-PCR microdevices, which were applied on conventional 
thermocycler devices using an appropriate in situ adapter, like e.g. reported in Schmidt U et 
al. (2006), Proff C et al. (2006), Lutz-Bonengel S et al. (2007) and Schmidt U et al. (2008). 
This contacting setup was also applied in the special thermocycler designed for slide-based 
PCR (AmpliSpeed slide cycler, Advalytix AG/Beckman Coulter Biomedical GmbH, Munich, 
Germany). This commercially available AmpliSpeed slide cycler device provided a 
comparable contact heating method for performing low-volume PCR amplification reactions 
using a multi LV-PCR microdevice. Thus, it was taken as reference system for all conducted 
measurements. As temperature measurement results were quite comparable between both 
devices, the AmpliSpeed slide cycler was taken as a permanent reference PCR system for 
validating the results obtained from the LOC CytoCycler PCR performances. 
4.2  Evaluating the minimum amount of target material 
The CytoCycler was characterized for product detection limits of amplification using 
decreasing amounts of input DNA for low-volume PCR (LV-PCR) analysis. The effectivity 
of the PCR was tested by reducing template concentrations until no successful amplification 
product could be detected after a large number of cycles. The minimum amount of target 
material was detected, thus validating the detection limit of PCR analysis performed on the 
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CytoCycler. Thermal cycling performances of LOC chips on the CytoCycler were validated 
against reference performances of a multi LV-PCR microdevice (AmpliGrid AG480F) on 
an AmpliSpeed slide cycler during parallel cycling including positive and negative controls. 
Concentrations for input DNA were 1 ng, 500 pg, 100 pg, 50 pg, 25 pg and 12.5 pg of 
purified human female genomic reference DNA material. Amplifications were performed on a 
297 bp fragment of the human high copy gene β-actin as well as on 106/112 bp fragments of 
the human gender determining gene amelogenin. As a 106 bp fragment is amplified from the 
X-chromosome and a 112 bp fragment from the Y-chromosome, a determination of male and 
female samples was possible. 
Concerning the upper range of input DNA, performances of LOC chips and the multi LV-
PCR microdevice were quite comparable in β-actin amplification (figure 15). Both devices 
revealed positive and reliable product detection data starting from 1 ng down to 25 pg of 
human genomic female input DNA, whereas product bands produced by the multi LV-PCR 
microdevice were always slightly stronger. Amplification results of 1 ng and 500 pg were not 
shown due to most stable performances and thus lack of comparability. While the multi LV-
PCR microdevice could successfully amplify even 12.5 pg of genomic input DNA (figure 15 
D), the minimal amount of genomic starting material which gave still a reproducible result for 
LOC chip amplification was 25 pg (figure 15 C). Amplification of 10 pg of genomic input 
DNA failed in both devices (figure 15 A). For a better overview, results of sensitivity tests 
were summarized in a schedule (table 4). 
 
Figure 15. PAAGE data of detection limits for PCR amplification of a 297 bp β-actin fragment. Validation 
of the amplification efficiency of LOC chips compared to a multi LV-PCR microdevice is shown. Decreasing 
concentrations of genomic female reference DNA were used as input DNA. M = molecular length standard  
(100 bp DNA ladder, New England BioLabs, Beverly, MA, USA). NC = negative control. A) Amplification of 
100 pg and 10 pg target DNA material. Lane 1: 100 pg on LOC chip; lane 2: 100 pg on multi LV-PCR 
microdevice; lane 3: NC on multi LV-PCR microdevice; lane 4: 10 pg on LOC chip; lane 5: 10 pg on multi LV-
PCR microdevice; lane 6: NC on multi LV-PCR microdevice. B) Amplification of 50 pg target DNA material. 
Lane 1: 50 pg on LOC chip; lane 2: 50 pg on multi LV-PCR microdevice; lane 3: NC on multi LV-PCR 
microdevice. C) Amplification of 25 pg target DNA material. Lane 1: NC on multi LV-PCR microdevice; 
lane 2: 25 pg on multi LV-PCR microdevice; lane 3: 25 pg on LOC chip. D) Amplification of 12.5 pg target 
DNA material. Lanes 1+2: 12.5 pg on multi LV-PCR microdevice; lane 3: 12.5 pg on LOC chip; lane 4: NC on 
multi LV-PCR microdevice. 
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In amelogenin amplification, performances of LOC chips and the multi LV-PCR microdevice 
were comparable as well (figure 16). Both devices revealed positive and reliable product 
detection data starting from 1 ng down to 50 pg of genomic female input DNA, whereas again 
product bands produced by the multi LV-PCR microdevice were always slightly stronger. 
Amplification results of 1 ng and 500 pg were not shown due to most stable performances and 
thus lack of comparability. At lower DNA concentrations, the multi LV-PCR microdevice 
could successfully amplify 25 pg of genomic input DNA, but failed in amplifying 12.5 pg. 
For amelogenin, a reliable LOC chip performance was detected down to 50 pg. As LOC chips 
failed in amplifying 25 pg and 12.5 pg of genomic input DNA, the minimal amount of 
genomic starting material which gave still a reproducible result indicating a reliable LOC chip 
amplification performance was 50 pg. According to the previous results, the amplification of 
10 pg was not even tried. For a better overview, results of sensitivity tests were summarized 
in a schedule (table 4). 
 
Figure 16. PAAGE data of detection limits for PCR amplification of 106 bp amelogenin fragments. 
Validation of the amplification efficiency of LOC chips in comparison to a multi LV-PCR microdevice is 
shown. Decreasing concentrations of genomic female reference DNA were used as input DNA. M = molecular 
length standard (Superladder-low 100 bp ladder with ReddyRun, Thermo Scientific, ABgene, Epsom, Surrey, 
UK). NC = negative control. A) Amplification of 100 pg and 50 pg target DNA material. Lane 1: 100 pg on 
LOC chip; lane 2: 100 pg on multi LV-PCR microdevice; lanes 3+4: NC on multi LV-PCR microdevice; lane 5: 
50 pg on LOC chip; lane 6: 50 pg on multi LV-PCR microdevice. B) Amplification of 25 pg target DNA 
material. Lane 1: 25 pg on LOC chip; lane 2: NC on multi LV-PCR microdevice; lanes 3+4: 25 pg on multi LV-
PCR microdevice. C) Amplification of 25 pg and 12.5 pg target DNA material. Lane 1: 25 pg on multi LV-
PCR microdevice; lanes 2+4: NC on multi LV-PCR microdevice; lane 3: 25 pg on LOC chip; lane 5: 12.5 pg on 
LOC chip; lanes 6+7: 25 pg on multi LV-PCR microdevice. D) Amplification of 12.5 pg target DNA material. 
Lane 1: 12.5 pg on LOC chip; lanes 2+3: 12.5 pg on multi LV-PCR microdevice; lane 4: NC on multi LV-PCR 
microdevice. 
At higher concentrations from 1 ng to 50 pg, results of PCR performances were always 
constantly positive and quite comparable between both cyclers and both amplification 
performances, β-actin as well as amelogenin. There were just slight differences in the 
thickness of bands in the PAAGE gel data.  
As summarized in table 4, for LOC chips 25 pg genomic input DNA was the detection limit 
for amplifying β-actin gene fragments and 50 pg for the amplification of amelogenin 
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fragments. Below these thresholds, no bands could be detected reliably any more. In 
comparison, the multi LV-PCR microdevice managed to amplify 12.5 pg of genomic DNA 
reliably in β-actin application and 25 pg in amelogenin PCR, thus having a slightly better 
detection limit than LOC chips.  
Table 4. Summary of detection limits of LOC chips compared to a multi LV-PCR microdevice. Positive PCR 
products were marked with a “+”, while failed amplifications were marked with a “-“. 
 
 1 ng 500 pg 100 pg 50 pg 25 pg 12.5 pg 10 pg 
 β-actin PCR amplification detection limit 
LOC chip + + + + + - - 
Multi LV-PCR microdevice + + + + + + - 
 
Amelogenin PCR amplification detection limit 
LOC chip + + + + - - / 
Multi LV-PCR microdevice + + + + + - / 
Differences in the various detection limits of LOC chips and the multi LV-PCR device when 
amplifying β-actin and amelogenin gene fragments could be attributed to the nature of these 
genes amplified. The β-actin gene is known as a gene having a high copy number distributed 
throughout the whole genome in pseudogenes (Ng SY et al., 1985), thus presenting a much 
higher amount of target material, which is going to be amplified. Amelogenin, in contrast, is 
only located on gender chromosomes (Lau EC et al., 1989) and thus presents a less amount of 
target sequences that potentially can be amplified during PCR.  
General differences in detection limits between LOC chips and the multi LV-PCR 
microdevice could be related to the diverse architectures of reaction centers and the associated 
capability of heat transfer. The multi LV-PCR device comprised hydrophilic reaction centers 
of 1.6 mm in diameter, where attached liquids had a low contact angle and could wet the 
substrate in a way that they are forced to form a semicircular shape. Reaction center B of 
LOC chips offered just a hydrophilic area of 500 µm in diameter, where attached liquids had a 
higher contact angle and could wet the substrate less efficiently forming an almost circular 
shaped droplet. This design might seem kind of suboptimal, but it was definitely needed for 
sustaining the capability of actuating and moving droplets by the power of surface acoustic 
waves. The multi LV-PCR microdevice could provide a better heat transfer into the oil-
covered master mix droplet, as having a larger contact area to the heated surface of the 
microdevice. As LOC chips provided a smaller contact area of the almost roundly shaped 
master mix droplet to the heated chip surface, the heat transfer was less efficient and resulted 
in a less sensitive amplification threshold. Additionally, the design of the outer hydrophilic 
ring, which keeps the mineral oil centered to the aqueous droplet, was different and could also 
had an effect on cycling efficiency. While this ring completely surrounded the reaction 
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centers on the multi LV-PCR microdevice, on LOC chips these border was intermitted by the 
virtual tracks to all four sides providing access to the reaction center for SAW actuated 
droplets. However, these four gaps favored a movement of the oil in some cases, interfering 
with the shape of the covered PCR droplet and enabling evaporation effects. These possible 
evaporation events could also have shrinked the sensitivity limit of LOC chip PCR 
performances. However, despite these little handicaps, the PCR performance on LOC chips 
was quite promising, as a DNA amount of about 7 human genome copies (about 50 pg) was 
enough for a reliable amplification of amelogenin fragments. In β-actin PCR only a DNA 
amount of 3-4 human genome copies (about 25 pg) was sufficient due to the high-copy 
character of this gene. 
Furthermore, amplification was done on human genomic DNA, which can be considered a 
“difficult” template as it has a high sequential and spatial complexity. In genomic DNA 
analysis a well-known problem of PCR is the lack of specificity for the desired product 
resulting in a number of longer or smaller fragments that can also be detected after the 
process. As can be seen in figure 15 and figure 16, there were some unspecific products, 
some smear bands, detected besides the authentic product, especially when higher input DNA 
concentrations were used. Side products were reduced when less DNA was used, accounting 
again for a more specific analysis when using just a small amount of genomic target DNA, as 
favored in LV-PCR analysis. However, these stained smears were also detected in lanes of 
negative controls, where demonstrably no specific product was detected. As these smears 
were not stronger in these blank lanes, this accounts still for staining artifacts as well as a 
highly specific amplification, when real input DNA was available, as otherwise blank band 
strengths were expected to be stronger due to less competition for target DNA. Generally, 
these side products can be suppressed when analysis conditions get optimized concerning 
temperatures and cycling times. However, also reducing the amount of target material could 
reduce these side products, as was shown especially for the β-actin cycling results (figure 15). 
An enhanced sensitivity and efficiency of analysis when using low-volume PCR was reported 
several times in literature when departing from big voluminous standard reaction volumes 
(Guttenberg Z et al., 2005; Schmidt U et al., 2006; Proff C et al., 2006; Lutz-Bonengel S et 
al., 2007; Schmidt U et al., 2008). In such a small reaction volume of just 1 µl in total, 
sensitivity is believed to increase especially due to a higher impact probability between 
reactants present in the biochemical reaction mixture. As reactants are in closer contact and 
valuable target material gets less diluted in microfluidic devices (Gaines ML et al., 2002; 
Kloosterman AD and Kersbergen P, 2003; Kricka LJ and Wilding P, 2003; Leclair B et al., 
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2003; Proff C et al., 2006; Schmidt U et al., 2006) also the highest sensitivity within a PCR 
device could be reached. The successful amplification of a single DNA template was shown 
for a glass microchamber (Lagally ET et al., 2000; Lagally ET et al., 2001), however, just 
pre-purified DNA material was used. As the ultimate achievement of a micro total analysis 
system is to analyze crude unpurified samples of low-copy number down to a single cell, low-
volume PCR applied on microdevices provides a good basis for that.  
4.3  Ultimate speed of cycling 
The effectivity of the CytoCycler PCR device was characterized for product detection limits 
of amplification using decreasing cycling times as well as decreasing DNA amounts of input 
DNA for low-volume PCR (LV-PCR) analysis. Thus, the ultimate speed of cycling 
performances was determined. Cycling times were reduced starting from 30 sec to 10 sec and 
down to a minimum of 5 sec temperature hold-time per PCR temperature step, while the 
number of cycle repetitions was constantly set to 30 cycles in total. Amplifications were 
performed on a 297 bp fragment of the human high copy gene β-actin as well as on  
106/112 bp fragments of the human gender determining gene amelogenin. A 2-step PCR 
protocol as well as a 3-step protocol was tested, using DNA amounts of 500 pg, 100 pg, 50 pg 
and 25 pg of human genomic male reference input DNA. Thermal cycling performances of 
LOC chips on the CytoCycler were validated against reference performances of a multi LV-
PCR microdevice (AmpliGrid AG480F) on an AmpliSpeed slide cycler during parallel 
cycling including positive and negative controls. 
Concerning the 2-step PCR procedure, temperature hold-times could successfully be adapted 
to a fast PCR performance, speeding up total cycling times for the amplification of β-actin as 
well as amelogenin fragments. Denaturation time in each cycle was performed at 95°C for  
10 sec instead of 30 sec, while combined annealing and extension times were shortened to  
30 sec in total instead of 60 sec standard PCR protocol (figure 17 A). Despite a lot of side 
products, fragments could successfully be amplified from 500 pg human genomic male 
reference input DNA and the total PCR amplification time for LOC chips was reduced from 1 
h 30 min to about 1h, and for the multi LV-PCR microdevice from 1 h 45 min to about  
1h 15 min. Results of speeding up reactions were summarized in table 5. 
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Figure 17. PAAGE data of cycling efficiency concerning temperature hold-times. Validation of the 
amplification efficiency of LOC chips in comparison to a multi LV-PCR microdevice is shown. Decreasing 
cycling times for LV-PCR amplification of 297 bp β-actin and 106/112 bp amelogenin gene fragments were 
tested, while male and female reference DNA was used, in concentrations ranging from 500 pg to 100 pg, 50 pg 
and 25 pg. M = molecular length standard (ReddyRun Superladder-low 100 bp ladder, Thermo Scientific, 
ABgene, Epsom, Surrey, UK). NC = negative control. A) Lanes 1-6 = 2-step PCR, 500 pg input DNA. Lane 1: 
500 pg β-actin on LOC chip; lane 2: 500 pg β-actin on multi LV-PCR microdevice; lane 3: NC on multi LV-
PCR microdevice; lane 4: 500 pg amelogenin on LOC chip; lane 5: 500 pg amelogenin on multi LV-PCR 
microdevice; lane 6: NC on multi LV-PCR microdevice. Lanes 7-11 = 3-step PCR, 500 pg input DNA. Lane 7: 
500 pg β-actin on LOC chip (10 sec); lane 8: 500 pg β-actin on multi LV-PCR microdevice (10 sec); lane 9:  
500 pg amelogenin on LOC chip (10 sec); lane 10: 500 pg amelogenin on multi LV-PCR microdevice (10 sec); 
lane 11: NC on multi LV-PCR microdevice. B) Lanes 1-16 = 3-step PCR on amelogenin. Lanes 1-3 = 500 pg 
input DNA. Lane 1: 500 pg on LOC chip (5 sec); lane 2: 500 pg on multi LV-PCR microdevice (5 sec); lane 3: 
NC on multi LV-PCR microdevice (5 sec). Lanes 4-7 = 100 pg input DNA. Lane 4: 100 pg on LOC chip  
(10 sec); lane 5: 100 pg on multi LV-PCR microdevice (10 sec); lane 6: 100 pg on LOC chip (5 sec); lane 7:  
100 pg on multi LV-PCR microdevice (5 sec). Lanes 8-11 = 50 pg input DNA. Lane 8: 50 pg on LOC chip  
(10 sec); lane 9: 50 pg on multi LV-PCR microdevice (10 sec); lane 10: 50 pg on LOC chip (5 sec); lane 11:  
50 pg on multi LV-PCR microdevice (5 sec); lane 12: NC on multi LV-PCR microdevice (5 sec). Lanes 13-16 = 
25 pg input DNA. Lane 13: 25 pg on LOC chip (10 sec); lane 14: 25 pg on multi LV-PCR microdevice (10 sec); 
lane 15: 25 pg on LOC chip (5 sec); lane 16: 25 pg on multi LV-PCR microdevice (5 sec). 
Concerning the 3-step PCR procedure, temperature hold-times could successfully be adapted 
to a fast PCR performance, speeding up total cycling times for the amplification of β-actin as 
well as amelogenin fragments. In each cycle, temperature hold-times for the denaturation, 
annealing and extension steps were reduced to a duration of 10 sec as well as 5 sec in total for 
each temperature instead of 30 sec standard PCR protocol (figure 17 A and B). Additionally, 
the final product extension time was shortened from 60 sec to 30 sec. In the 10 sec protocol, 
fragments could successfully be amplified for 500 pg down to 25 pg on both devices, while 
only amplification of 100 pg on the multi LV-PCR microdevice failed. In the 5 sec protocol, 
input DNA amounts from 500 pg down to 25 pg succeeded in amplification on both devices, 
LOC chips as well as the multi LV-PCR microdevice (figure 17 B). The “10 sec”-based total 
3-step PCR amplification time for LOC chips could be reduced from 1 h 30 min to about  
33 min, and for the multi LV-PCR microdevice from 1 h 45 min to about 54 min. The  
“5 sec”-based total PCR amplification time for LOC chips was successfully reduced from 1 h 
30 min to about 26 min, and for the multi LV-PCR microdevice from 1 h 45 min to about  
47 min. Results of speeding up reactions were summarized in table 5. 
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Table 5. Overview of PCR amplifications performed while shrinking down cycling times. Positive PCR 
products were marked with a “+”, while failed amplifications were marked with a “-“. Amelogenin 
amplifications were marked as “am”, and β-actin ones as “act”. 
 
PCR kit Original PCR protocol 
Adapted PCR 
protocol LOC chips 
Multi LV-PCR 
microdevice 
QuantiFast 
SYBR Green 
I PCR kit 
(2-step PCR) 
95°C   5 min 
40 x 
95°C   30 sec 
60°C   60 sec 
95°C   5 min 
40 x 
95°C   10 sec 
60°C   30 sec 
500 pg - act 
500 pg - am 
+ 
+ 
500 pg - act 
500 pg - am 
+ 
+ 
500 pg - act 
500 pg - am 
+ 
+ 
500 pg - act 
500 pg - am 
+ 
+ 
100 pg - am + 100 pg - am - 
50 pg - am + 50 pg - am + 
QIAGEN Fast 
Cycling PCR 
kit 
(3-step PCR) 
95°C   5 min 
30 x 
94°C   30 sec 
60°C   30 sec 
72°C   30 sec 
72°C   60 sec 
95°C   5 min 
30 x 
94°C   10 sec 
60°C   10 sec 
72°C   10 sec 
72°C   30 sec 25 pg - am + 25 pg - am + 
500 pg - am + 500 pg - am + 
100 pg - am + 100 pg - am + 
50 pg - am + 50 pg - am + 
QIAGEN Fast 
Cycling PCR 
kit 
(3-step PCR) 
95°C   5 min 
30 x 
94°C   30 sec 
60°C   30 sec 
72°C   30 sec 
72°C   60 sec 
95°C   5 min 
30 x 
94°C   5 sec 
60°C   5 sec 
72°C   5 sec 
72°C   30 sec 25 pg - am + 25 pg - am + 
An optimal heat transfer to the sample as well as fast heating and cooling rates of the 
microdevice are main characteristics for rapid cycling times and fast reaction performances, 
as focused in microdevice application. Heating and cooling rates are mainly featured through 
the thermal mass of the device destined for thermal control. Compared to LOC chips, the heat 
transfer to the sample was ensured in a more optimal way in the multi LV-PCR device due to 
the architecture of reaction centers, as discussed in chapter 4.2. Thus, band strength was 
again stronger in multi LV-PCR microdevice applications for 2-step PCR cycling times up to 
30 sec combining annealing and extension steps. However, for shorter cycling times in  
“10 sec”- and “5 sec”-based 3-step PCR performances, band intensity of LOC chip 
amplification products was slightly stronger. These benefits in effectivity could be attributed 
to faster heating and cooling rates of the LOC CytoCycler. As the AmpliSpeed slide cycler 
device applied on the multi LV-PCR microdevice comprised heating and cooling rates of  
3 K s-1, the LOC CytoCycler comprised a heating rate of 3 K s-1 as well but also a faster 
cooling rate of 4 K s-1. The faster cooling rate is due to the lower thermal mass of the 1x1 cm2 
sized heating area of the Peltier element of the LOC CytoCycler in comparison to the larger 
7.6 x 2.5 cm2 sized heating area of the AmpliSpeed slide cycler. This lower thermal mass 
resulted in more efficient and specific amplification reactions when cycling times of PCR 
were speeded up and of course in a more rapid amplification performance as well. As both 
heating devices, the CytoCycler as well as the AmpliSpeed slide cycler had notedly a lower 
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thermal mass and higher heating and cooling rates as conventional thermal cyclers, which are 
around 1-2 K s-1, times needed for amplification reactions could successfully be reduced to  
5 sec per temperature step. Surely, the LOC CytoCycler system is inferior to other PCR 
microdevices using flow-through applications or IR-heating, designed for setting kind of 
world records in PCR cycling within 1.7 min (Hashimoto M et al., 2004), 5 min (Oda RP et 
al., 1998; Hühmer AFR and Landers JP, 2000; Giordano BC et al., 2001 (a) + (b)) or 6 min 
total time (Obeid PJ et al., 2003). However, mostly high concentrations of input DNA were 
used there and the LOC CytoCycler was not designed for ultra-fast reaction performances. 
Here, higher values were rather set on a) providing a modular solution capable of accepting 
various kinds of tiny sample materials, b) on a universal applicability for pre- and post-PCR 
sample processing based on a planar surface device and c) on disposability purposes, which 
are the reasons for having chosen the Peltier element-based design. 
Additionally, there were other virtues favoring rapid operations in LV-PCR applications. 
Faster cycling times further provide a minimized risk of possible evaporation effects 
influencing the PCR results, which were reported to occur to 10% (v/v) in virtual reaction 
chamber LV-PCR amplifications (Guttenberg Z et al., 2005). Short process times also have a 
positive effect on the effectivity of the polymerase in the PCR solution, as the lifetime of the 
enzyme is reduced during the high temperature states. And finally, fast cycling times hold the 
potential to prevent temperature gradients and thus to reduce the generation of unwanted and 
unspecific side products and smear bands during PCR amplification. Compared to 
amplification results shown in chapter 4.2, where a lot of smear could be detected, shorter 
cycling times as shown in this chapter were capable of eliminating these kinds of genomic 
side products almost totally due to less genomic target material used on the one side, and 
optimized analysis conditions on the other side.  
4.4  Sensitivity of the Fluorescence Reader 
Besides the evaluation of sensitivity and efficiency of reactions that can be performed on the 
LOC CytoCycler, the capacity (namely the operating efficiency) or respectively the sensitivity 
of the LOC integrated Fluorescence Reader was analyzed. SYBR Green I treated sample 
droplets of 1 µl total volume were positioned on reaction center B on LOC chips installed in 
the CytoCycler, were covered with mineral oil and illuminated via the Fluorescence Reader 
setup after eliminating ambient light. When enlightened with blue exciting light, green 
fluorescence signals were emitted from the sample by the dsDNA intercalating dye SYBR 
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Green I, present in sample droplets. The intensity of the emission depended on the amount of 
double-stranded DNA present in the solution, because its quantum yield increased by orders 
of magnitude when it intercalated. Interpretation of pictures, concerning fluorescence quantity 
and quality, was performed visually by image data analysis.  
Calibration of fluorescence intensities was performed according to the DNA amount present 
in 1 µl reaction volume. Decreasing standard concentrations of 10 ng, 5 ng, 1 ng, 500 pg and 
100 pg of reference DNA were mixed with fluorescent SYBR Green I dye. Fluorescence 
intensities were recorded as image data using LabVIEW-based software at exposure times of 
200 ms, 400 ms, 600 ms, 1000 ms, 2000 ms and 4000 ms at room temperature as well as at 
55°C and 72°C. Latter temperatures were chosen as simulating relevant temperatures of 
picture taking during PCR performances. Image data of calibration tests performed at room 
temperature was summarized in figure 18. Strong fluorescence signals at nearly each 
exposure time were provided by samples containing concentrations of 10 ng, 5 ng and 1 ng 
DNA, and also the sample containing 500 pg DNA showed clear intensities down to an 
exposure time of 200 ms. The 100 pg loaded sample, however, gave just hardly detectable 
signals at exposure times of 200 ms and 400 ms, but stronger signals from 600 ms on. Thus, 
600 ms was considered the best-suited exposure time used for validation of subsequent real-
time PCR performances due to two reasons. First, at 600 ms a clear signal was achieved even 
when using a small amount of target DNA material like e.g. 100 pg input DNA. And second, 
exposure times were aimed to be kept as short as possible to avoid dye bleaching, thus longer 
exposure times could be neglected. Image data of calibration tests performed at simulated 
PCR cycling times 55°C and 72°C was summarized in figure 19. Only image data of using an 
exposure time of 600 ms is shown, as this setting was considered most relevant for real-time 
PCR performances. At 55°C and 72°C strong fluorescence signals could be detected using 
input DNA concentrations of 10 ng and 5 ng present in the sample droplet. Lower 
concentrations of 1 ng, 500 pg and 100 pg produced weaker but still reliably detectable 
signals at 55°C. However, at 72°C these lower concentrations were even harder to detect. As 
signal intensities dropped dramatically, 500 pg and 100 pg DNA concentrations could no 
more be detected reliably as a clear fluorescence signal.  
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Figure 18. Calibration of fluorescence intensities measured at room temperature. Pictures of evaluated 
fluorescence intensities of various decreasing standard DNA concentrations from 10 ng down to 100 pg are 
shown at exposure times from 200 ms to 1000 ms. Longer exposure times like 2000 ms and 4000 ms just 
provided even stronger signals, but this data was not shown due to unrealistic applicability when regarding 
bleaching effects of fluorescing dyes over time. 
 
Figure 19. Calibration of fluorescence intensities measured at 55°C and 72°C. Pictures of evaluated 
fluorescence intensities of various decreasing standard DNA concentrations from 10 ng down to 100 pg are 
shown at an exposure time of 600 ms, as most relevant for PCR performances. Measurements were performed at 
PCR relevant temperatures of 55°C simulating an annealing/extension step at 2-step PCR performances and 
72°C simulating the extension step when using 3-step PCR performances. 
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Experimentally, real-time PCR was carried out on the LOC CytoCycler using a SYBR Green 
I-based fluorescence detection system. In real-time PCR, the direct observation of the amount 
of DNA present in the reaction mix after each cycle is facilitated. Increasing fluorescence 
signals in dependence of increasing amounts of amplified DNA products are detected, 
indicating a successful amplification. As the amount of dsDNA is highest at the end of each 
extension phase during PCR, at this point the intensity was captured, pictures were taken and 
the ratio of cycle number to intensity signal was plotted to a graph in the software screen. The 
actual state of the PCR during the temperature cycles was continuously displayed by 
LabVIEW-based software. Different amounts of male and female human genomic reference 
input DNA comprising 1 ng, 500 pg and 100 pg were amplified via LV-PCR on the chip 
surface. Amplified products were detected both via conventional PAAGE and as image data 
using LabVIEW-based software. Both, 2-step and 3-step PCR performances were analyzed 
for validation, while exposure times were 200 ms, 400 ms and 600 ms. In 2-step PCR 
performances, pictures were taken at 55°C or 60°C, while in 3-step PCR pictures were taken 
at 55°C and 72°C for comparability reasons.  
Exemplarily for a broad range of real-time PCR amplification reactions performed, 2-step 
ones as well as 3-step ones, which all showed quite comparable results, the image data of 
three amplification reactions were shown. In figure 20 the amplification of β-actin fragments 
using 500 pg input DNA and a 2-step PCR procedure was illustrated. Pictures were taken at 
60°C after the combined annealing/extension step. By trend, an increase in fluorescence 
intensity against increasing cycle numbers could be detected via software and a graph was 
plotted. About the same proportional rise in fluorescence intensities were detected when 
starting amounts of 1 ng or 100 pg were used. Additionally, amplified β-actin products could 
successfully be detected via PAAGE afterwards. 
In figure 21 the amplification of amelogenin fragments using 500 pg input DNA in a 2-step 
PCR procedure is demonstrated. Pictures were taken at 55°C after the combined 
annealing/extension step. Again, a considerable increase in fluorescence intensity could be 
detected continuously by software and a graph was plotted. Comparable results were obtained 
when 1 ng or 100 pg input DNA was used. Additionally, PAAGE was applied on amplified 
amelogenin products. In different approaches, some positive bands could be detected 
successfully, while in other approaches no positive amplification bands could be detected at 
all despite a software-recorded increasing fluorescence (figure 21 J).  
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Figure 20. Image data of 2-step β-actin real-time PCR. The amplification of 500 pg input DNA starting 
material was used in a 2-step PCR protocol amplifying a 297 bp fragment of the human β-actin gene. Pictures 
were taken at the end of the combined annealing/extension steps at 60°C at an exposure time of 600 ms. A-J) 
The summarized picture alignment shows the increase in fluorescence intensity over cycling times, taken at the 
end of each PCR cycle. Pictures of every fifth cycle out of 40 cycles in total are shown. K) The graph of the RT-
PCR reaction is shown, which was plotted by the LabVIEW-based software according to the measured values at 
each cycle. The graph displayed very fluctuating values up to 0.4 of mean light intensity, while only hardly an 
increase in fluorescence intensity values could be detected.  
 
Figure 21. Image data of 2-step amelogenin real-time PCR. The amplification of 500 pg input DNA target 
material was used in a 2-step protocol amplifying 106/112 bp fragments of the human amelogenin gene. Pictures 
were taken at the end of the combined annealing/extension steps at 55°C at an exposure time of 600 ms. A-H) 
Aligned pictures show the increase in fluorescence intensity over cycling times, taken at the end of each PCR 
cycle. Pictures of every fifth cycle out of 35 cycles in total are shown. J) PAAGE image data of amplified 
amelogenin PCR products. Either there were positive bands detectable after real-time PCR performed on LOC 
chips (lanes 5-8), or there were no bands detectable on the gel for real-time PCR performed on LOC chips (lanes 
1-4). M = Molecular length standard (ReddyRun Superladder-low 100 bp ladder, Thermo Scientific, ABgene, 
Epsom, Surrey, UK). Lane 1: 500 pg on LOC chip; lanes 2+3: 500 pg on multi LV-PCR microdevice (positive 
controls); lane 4: negative control on multi LV-PCR microdevice. Lane 5: 500 pg on LOC chip; lanes 6+7:  
500 pg on multi LV-PCR microdevice (positive controls); lane 8: negative control on multi LV-PCR 
microdevice. K) The graph of the RT-PCR reaction is shown, which was plotted by the LabVIEW-based 
software according to the measured values at each cycle. The graph displayed a plane run, with relatively stable 
values around zero mean light intensity, while no increase in fluorescence intensity values could be detected. 
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In figure 22 the amplification of amelogenin fragments using 1 ng input DNA in a 3-step 
PCR procedure is presented. Pictures were taken at 55°C after the annealing step as well as at 
72°C after the extension step for validation of fluorescence intensities compared to 2-step 
procedures. Thereby, the duration of the annealing step was chosen that long as performed in 
2-step PCR, where annealing and extension times were combined in one step. At 55°C, the 
rising of fluorescence intensity could be detected continuously by the software. At 72°C, there 
could no increase in fluorescence intensity be detected. A graph counting measured values for 
55°C and 72°C directly afterwards was plotted by the software (figure 22 V). Comparable 
results were obtained when 500 pg or 100 pg input DNA was used. In subsequent PAAGE 
application, no amplified products could be detected on gel data at all.  
 
Figure 22. Image data of 3-step amelogenin real-time PCR. The amplification of 1 ng input DNA target 
material was used in a 3-step protocol amplifying 106/112 bp fragments of the human amelogenin gene. Pictures 
were taken at the end of annealing steps at 55°C as well as at the end of extension steps at 72°C, using an 
exposure time of 1000 ms. A-K) Aligned pictures show the increase in fluorescence intensity over cycling times, 
taken at the end of each annealing step at 55°C. Pictures of every fifth cycle out of 45 cycles in total are shown. 
L-U) The picture alignment shows the increase in fluorescence intensity over cycling times, taken at the end of 
each extension step at 72°C. Pictures of every fifth cycle out of 45 cycles in total are shown. V) Graphical 
illustration of measured fluorescence intensities during 3-step amelogenin real-time PCR. The graph of the RT-
PCR reaction is shown, which was plotted by the LabVIEW-based software according to the measured values at 
55°C and subsequently 72°C during each cycle of 45 cycles in total. The graph displayed a plane run, with 
relatively stable values around zero mean light intensity, while no increase in fluorescence intensity values could 
be detected. Even fluctuations between values measured at 55°C and those measured at 72°C were illustrated as 
tiniest differences in fluorescence intensity, absolutely not matching the pictured fluorescence intensities 
recorded at these temperatures. 
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Graphical images plotted by the LabVIEW-based software always showed unordinary 
characteristics. Graphs were never increasing, never reached a plateau phase. Graphs were 
very inconsistent as either some kind of “mountain range”-like run was displayed with values 
fluctuating up and down (figure 20) or a quite plane distribution of fluorescence intensity 
values (figure 21 and figure 22). Thus, measured values plotted by the software were not 
reliable at all, and just showed some measurement inaccuracies instead of a real graph 
following the principle of real-time PCR. Definitely, there were some cumulative 
fluorescence signals pictured from the beginning to the end of real-time PCR cycling, but the 
values of those signals did not conform to the characteristics of a real-time PCR curve. 
Generally, during a successful experiment, the signal curves away from the plateau of the 
background at a certain cycle number and increases until saturation is reached. The start point 
of the signal change depends on the template concentration. Such a value distribution could 
never be reached for the real-time PCR experiments performed with the Fluorescence Reader. 
The recorded fluorescence intensities in the graph did definitely not fit to the amount of 
amplified products. As shown in figure 21, there was a strong band for amelogenin fragments 
detectable via PAAGE, and there must have been a strong increase detectable via the 
software-plotted graphical illustration. However, there was no increase detectable as the graph 
just showed a plane run without rising signals. Moreover, the expected really big increase in 
fluorescence especially at the end of the PCR for reaching saturation was totally missing even 
when a huge amount of 45 cycles of PCR was performed (figure 20 and figure 22). 
Additionally, pictures of increasing fluorescence intensities did not always match the results 
when detecting amplified PCR products via PAAGE application. Gel images showed quite 
inconsistent amplification products. For instance, in one approach there were clear positive 
amplification bands detectable on a polyacrylamide gel after real-time PCR, indicating a 
successful PCR performance, while in another approach no bands could be detected after real-
time PCR. However, in fluorescence pictures of foregoing real-time PCR, both approaches 
showed quite the same increasing fluorescence intensities, which in the end accounted for an 
unreliable performance of the total Fluorescence Reader device (figure 20 and figure 21). 
The same phenomenon was observed when 3-step PCR was performed and fluorescence 
signals were recorded by the software, but no amplification bands could be detected via 
PAAGE afterwards to verify the authenticity of fluorescence signals via detection of 
amplified products (figure 22). As the recorded fluorescence intensity was always quite the 
same in pictures taken at 55°C and almost invisible at pictures taken at 72°C, no matter if 
there was a band detectable on the PAAGE gel or not, was a clear evidence, that the whole 
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Fluorescence Reader setup needed really to be optimized. There were some discrepancies 
supposed to be in the total setup, which are described in the following.  
First, the utilized filter set was supposed to be somehow suboptimal for SYBR Green I 
applications and needed to be optimized. The chosen filter set indeed covered the excitation 
and emission spectrum of SYBR Green I. For the excitation a range from 464 – 500 nm was 
provided by the filter ET482/36, while the excitation maximum of the filter lied at 482 nm. 
The excitation maximum of SYBR Green I, however, is around 498 nm, thus just within the 
range of the filter, but clearly too far away from its maximum. This could have led to losses in 
excitation power and thus could have shrinked the excitation signal from the beginning on. 
Comparably, the emission filter ET536/40 provided a range between 515 – 556 nm, having its 
maximum at 536 nm, while the emission maximum of SYBR Green I is around 521 nm, thus 
as well within the range but far aside the maximum. Thus, both filters were not optimally 
suited for the SYBR Green I dye. However, according to the manufacturer, these filters were 
capable of not loosing fluorescence intensity within their range, so that at the marginal filter 
range still a signal with sufficient intensity is guaranteed to be generated. Ordered filters were 
considered having a wide bandwidth, serving almost their whole range. However, as tested 
several times, there might definitively had been a loss in fluorescence intensity, which was 
more important than expected and made the detection of fluorescence signals during PCR 
quite hard. 
Second, the interaction of trigger signals, software and LED control was supposed to be 
somehow deranged and not perfectly coordinated in interacting timings. Maybe the cross-talk 
between the software, the trigger and the camera was affected. 
Third, the values for fluorescence intensities recorded by the software during RT-PCR were 
subjected to a deficient calculation as those values did not really match the pictures. Similar 
values were e.g. given for fluorescence intensities when 10 ng standard DNA was measured 
and was compared to maybe 500 pg afterwards. Independent of utilized amounts of DNA, the 
values for fluorescence intensity were always quite the same and were fluctuating around 
zero. Thus, values were believed to count anything else, but no usable fluorescence 
intensities. Graphical illustrations plotted by the software according to those values were 
always far away from an authentic real-time PCR curve showing the characteristic curvature. 
The software also included a function of generating processed images that the actual picture is 
going to be subtracted from the previous one. Maybe the software did some strange 
calculation in behind and gave values counted from irreproducible calculations. This value 
data definitely needed to be optimized. 
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Forth, the area on the chip surface, where the picture was taken, was maybe chosen too large 
and too wide. Actual, just almost the whole chip surface was focused and recorded when 
pictures were taken, showing a large dark area having just a small fluorescent droplet in the 
middle. Maybe this large black background was the reason, that measured values arranged 
always around zero as small changes in fluorescence intensity could only hardly be detected. 
An additional refinement of the picture taking area would definitely improve measurements, 
even if this could not explain the strange values and the missing increase in fluorescence 
intensity. 
Fifth, special software was utilized to validate the fluorescence intensities of taken pictures, 
integrating the fluorescence intensity over each pixel of the fluorescing droplet sphere. 
Integrated pixel intensities were combined to a total fluorescing droplet, and this was done for 
the fluorescence intensity picture of each PCR cycle. However, even this software did not 
generate an authentic real-time PCR curve according the calculations. The graph looked 
similar to the one generated by the LabVIEW-based software. Thus, something must be 
wrong in the total setup of picture taking. The problems could not be attributed to the PCR 
mix, as there were products detectable on the polyacrylamide gel. It was not a problem of the 
fluorescence dye, as reactions performed in a conventional real-time PCR cycler (Stratagene 
Mx 3000P) worked perfectly well. Problems were not due to the utilized CCD camera, as it 
worked always brilliant when used at the optical inverted microscope. Additionally, it was not 
a problem of the LED, as light was emitted at the correct time points at the end of a PCR 
cycle. Additionally, the camera, the software, the LED and the trigger were somehow 
working well when used individually, but together the whole setup did not match and was not 
sensitive enough to be used for valuable and most importantly reliable real-time PCR 
performances on the LOC. 
Finally, as the software was just written for taking pictures of fluorescence, the analysis of 
fluorescence results was not reliable at all. Originally, the software was written for a 
prototype application of real-time PCR using the dsDNA intercalating dye SYBR Green I. 
Generally, when SYBR Green I is used for the online detection of the DNA amplification, no 
specific information about the kind of dsDNA in the solution is given. As this dye binds to 
specific PCR products as well as to unspecific ones, there was no possibility included in the 
software to differentiate between real positive product and false positive products or 
unspecific side products, as any amplified product’s fluorescence was detected. Thus, the 
software needed an additional update implementing a subsequent melting curve analysis after 
real-time PCR performance to determine the specificity of PCR products using SYBR Green I 
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(Fixman M and Freire JJ, 1977; Rutledge RG, 2004), which is performed by conventional 
real-time PCR cyclers as well. It is the standard procedure and the method of choice to 
identify the desired product, capturing the transition temperature from ssDNA to dsDNA, 
which is dependent on the length and sequence of the product. As this step is completely 
missing in our system of RT-PCR performance the system could not really be validated. 
However, with a few improvements the system could be made competitive to fluorescence 
readers like reported and shown by Guttenberg Z et al. (2005) and Novak L et al. (2007) for 
microdevice applications. Guttenberg Z et al. (2005) provided an elegant solution, indeed, but 
this device was fixed to just one part of the chip. It was a fluorescence detection device, 
which was integrated into the fabrication of the chip and thus was fixed in application, not 
separable from the PCR device and just one specific area of the chip surface could be 
analyzed. Our Fluorescence Reader, in comparison, is free of focusing a sample anywhere on 
the chip surface due to a very flexible modular design. Additionally, our device can easily be 
extended to an approach using several kinds of filter sets, analyzing various kinds of 
fluorescence signals and thus various kinds of differently labeled PCR products. 
4.5  Viability of microarray hybridization 
Besides the detection of PCR products directly on the chip surface via real-time PCR, on-chip 
LV-PCR was also combined with a kind of microarray for on-chip hybridization. Thus, the 
feasibility of microarray applications on the lab-on-a-chip was evaluated. Arrayed on-chip 
hybridization was performed by hybridization of fluorescently labeled primer specific PCR 
products to complementary probes predefined on the LOC chip surface. On-chip 
hybridization arrays were designed for gender determination of sample material via amplified 
gene amelogenin, as used in forensics research. Amelogenin is generally used as gender 
determining gene, as its genetic sequence is located on the X- as well as on the Y-
chromosome, while having particular sequence dissimilarities, which can be detected due to 
varying length of PCR products. The most commonly used PCR primer set for amplifying 
amelogenin fragments spans a region encompassing a 6 bp difference AAAGTG between 
male and females, thus generating 106/112 bp fragments in male and 106 bp fragments in 
female individuals (figure 23). 
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Figure 23. Sequence data and sequence BLAST (Basic Local Alignment Search Tool) of amelogenin 
fragments. Sequence alignment of amplified X- (106 bp) and Y-chromosome (112 bp) specific amelogenin 
fragments, showing a 6 bp difference at a particular genomic location within the amelogenin gene sequence. 
Sequences were taken from the UCSC Genome Browser (http://genome.ucsc.edu). Sequence alignment was 
performed at the webpage of the European Bioinformatics Institute (www.ebi.ac.uk). 
Based on the well-established amelogenin system (Lau EC et al., 1989; Shadrach B et al., 
2004), amplification of X- and Y-chromosomal fragments of the amelogenin gene was 
performed, which were hybridized to surface-bound probes Amelo1(Y) and Amelo3(Y) 
matching Y-chromosomal fragments and Amelo2(X) complementary to X-chromosomal 
products (figure 24). For amplification, purified male and female human genomic reference 
DNA was used.  
 
Figure 24. Design of microarray probes Amelo1(Y), Amelo2(X) and Amelo3(Y). The area of interest, 
namely the 6 differing base pairs AAAGTG between X- and Y-chromosomal sequences, is marked explicitly in 
each scheme. Hybridization probe Amelo1(Y) was spanning a domain of 20 bp named “Hybridization sequence 
1”, whereas the sequence of the 6 relevant bases CACTTT for hybridizing to AAAGTG was located directly in 
the middle, thus marking a male binding probe. Hybridization probe Amelo2(X) was spanning an area of 20 bp 
named “Hybridization sequence 2”, where the 6 relevant bases for hybridization were missing, marking a female 
binding probe. Hybridization probe Amelo3(Y) was spanning an area of 20 bp named “Hybridization sequence 
3”, where the sequence of the 6 relevant bases CACTTT for hybridizing to AAAGTG was located at the 3’-end, 
marking a male binding probe. 
On a multi LV-PCR microdevice 6 different array designs were spotted comprising not only 
single probes Amelo1(Y), Amelo2(X), or Amelo3(Y), but also combined setups of these 
probes in configurations like Amelo1(Y)/Amelo2(X), Amelo3(Y)/Amelo2(X) or 
Amelo1(Y)/Amelo3(Y) (figure 25).  
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Figure 25. Amelogenin-based microarray data of the multi LV-PCR microdevice. Rows 1-12 were divided 
into 6 array fields, each comprising various combinations of hybridization probes. Probe names were shortened 
in the scheme for better overview, while “Am” was always short for “Amelo”, displaying Am1(Y) for probe 
Amelo1(Y), Am2(X) for probe Amelo2(X) and Am3(Y) for probe Amelo3(Y). Constantly, line A contained 
male input DNA in amplification reactions, while line B contained female input DNA and line C and D no DNA, 
serving as negative controls. 
As can be seen in figure 25, on-chip hybridization after PCR worked quite well for the 
established amelogenin system. The various array designs showed quite interpretable results 
of the different array designs. Negative controls were negative at all times, thus contaminating 
effects could be excluded. Array Amelo1(Y) showed positive signals for male DNA in line A, 
as well as for female DNA in line B, but signals in line B were slightly weaker than those in 
line A. Normally, there was no direct binding expected for female PCR products to male 
probe Amelo1(Y). This indefinite and ambiguous signal for probe Amelo1(Y) was 
inapplicable for an analysis differentiating between male and female PCR products. Array 
Amelo2(X) showed positive signals for male DNA in line A as well as for female DNA in 
line B, with both signals having about the same intensity. As X-specific fragments were 
expected in male as well as in female PCR products, theses positive hybridization signals 
were taken as an internal positive control, showing a successful working performance. Array 
Amelo3(Y) showed a stronger positive signal for male DNA in line A, and just a very weak 
signal for female DNA in line B. This could be taken as a more reliable probe for gender 
differentiation compared to probe Amelo1(Y), as here sequence differences between male and 
female PCR products revealed clear varying fluorescence signals.  
The combined array with the Amelo1(Y)/Amelo2(X) design showed no real differences 
between male and female hybridization signals. All 4 spots of an array showed the same 
fluorescence intensity, while probe Amelo1(Y) should have given a stronger signal when 
male DNA was amplified and hybridized. Hybridization results were quite ambiguous, thus 
array design and hybridization conditions needed be optimized for a reliable gender 
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determining analysis. The combined array with the Amelo3(Y)/Amelo2(X) design showed a 
quite good differentiation between male DNA in line A and female DNA in line B. Male 
DNA in rows 7 and 8 showed strong signals for male probe Amelo3(Y), and weak signals for 
female probe Amelo2(X), while female DNA in these two rows showed just weak signals for 
both probes, Amelo3(Y) and Amelo2(X). These results were considered as a promising basis 
for a differentiating analysis between male and female DNA. However, these two rows 
showed just 60% positive results, as row 9 showed just completely different results. Here, 
male as well as female DNA showed strong signals for female probe Amelo2(X) and weak 
signals for male probe Amelo3(Y). Thus, 30% of the experiment showed completely different 
results. This might be due to the annealing temperature, and means, that temperature of 
hybridization needs to be optimized. However, these results were quite promising, despite 
those varying results, as at least 60% of the experiment gave good results with expected 
signals for male and female hybridization. The combined array with the 
Amelo3(Y)/Amelo1(Y) design showed a quite good differentiation between male DNA in 
line A and female DNA in line B. Male DNA in rows 11 and 12 showed strong signals for 
both male probes Amelo3(Y) as well as Amelo1(Y), while female DNA in these rows showed 
just very weak signals. These results could be considered as a real evidence for a 
differentiating analysis between male and female DNA. However, again, the results of these 
two rows showed just 60% positive results, as row 10 showed just completely different 
results. Here, male as well as female DNA showed strong signals for male probe Amelo1(Y) 
and weak signals for male probe Amelo3(Y). Thus, 30% of the experiment showed 
completely different results. This might again be due to the annealing temperature, and 
means, that temperature of hybridization needs to be optimized. However, these results were 
quite promising, despite those varying results, as at least 60% of the experiment gave good 
results with expected signals for male and female hybridization products. Finally, considering 
probe combinations, combined designs Amelo1(Y)/Amelo2(X) and Amelo3(Y)/Amelo2(X) 
were detected as the most reliable ones for application on the multi-LV-PCR microdevice.  
According to results of the multi LV-PCR microdevice, on LOC chips 2 different array 
designs were spotted on reaction center B comprising combined configurations of probes 
Amelo1(Y)/Amelo2(X) and Amelo3(Y)/Amelo2(X) (figure 26). Results of hybridization 
events of amplified male and female PCR products are summarized in figure 27.  
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Figure 26. Array designs for microarray application on LOC chips. Array designs were spotted on reaction 
center B. Combined array designs are shown, comprising both probes for X-chromosomal as well as Y-
chromosomal amelogenin PCR product hybridization. Probe names were shortened in the scheme for better 
overview, while “1, 2 and 3” were short for probes Amelo1(Y), Amelo2(X) and Amelo3(Y). Letters “X” and 
“Y” in the right scheme just simplify the particular hybridization pattern provided by the three probes. 
 
Figure 27. Amelogenin-based microarray data of LOC chips. A) Original, unhybridized microscopy image 
of a probe array spotted on reaction center B on a LOC chip. B) Hybridization signals of 100 pg amplified male 
sample on array design Amelo2(X)/Amelo1(Y). C) Hybridization signals of 100 pg amplified female sample on 
array design Amelo2(X)/Amelo1(Y). D) Hybridization signals of 100 pg amplified male sample on array design 
Amelo3(Y)/Amelo2(X). E) Hybridization signals of 100 pg amplified female sample on array design 
Amelo3(Y)/Amelo2(X). 
On-chip hybridization on LOC chips could successfully be performed and different 
hybridization pattern could clearly be detected according to the gender of amplified male or 
female sample material. Male samples showed strong fluorescence signals when amplified Y-
chromosomal amelogenin products were hybridized to probes Amelo1(Y) and Amelo3(Y). 
Female samples never showed a strong fluorescence for male determining probes Amelo1(Y) 
and Amelo3(Y). Amplified X-chromosomal fragments of male and female samples showed 
consistently homogenous fluorescence signals with intensities below those of Y-chromosomal 
fragments. On LOC chips, for both array designs a clear differentiation between male and 
female sample products could successfully be detected.  
On-chip hybridization was performed on a multi LV-PCR microdevice as well as on LOC 
chips, while applications on LOC chips generated more reliable results. On the multi LV-PCR 
microdevice, hybridization signals within a single probe were quite inconsistent despite an 
analogous performance. And in combined array designs, fluorescence signal intensities could 
not reliably been attributed to successful hybridization events, as e.g. female samples showed 
fluorescence signals for male probes Amelo1(Y) or Amelo3(Y). In contrast, on-chip 
hybridization performed on LOC chips revealed absolutely reliable signals, contributing to a 
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well-defined gender determination between male and female samples. Hybridization on the 
chip worked reproducible with low background fluorescence and high specificity to clearly 
detect bp differences via varied fluorescence intensities between a male and a female sample. 
Solely, the Fluorescence Reader setup needed to be optimized, to get usable for microarray 
applications. However, successful on-chip hybridization validated the lab-on-a-chip for 
further array-based applications, like e.g. those performed by Guttenberg Z et al. (2005), 
where a single bp deletion was detected between wildtype and mutant DNA via a simple on-
chip microarray application. Furthermore, a successful microarray performance further 
featured the lab-on-a-chip for combining PCR analysis with a highly sensitive downstream 
product detection application, representing a big step toward the envisioned automation of all 
steps from sample extraction to final product detection performed on just one single chip. 
4.6  Operability of solid phase amplification 
Besides conventional on-chip amplification in combination with on-chip hybridization, as just 
described in the previous microarray-related chapter, an extended and more sophisticated 
array application was performed on the surface of LOC chips. Solid phase amplification 
(SPA), also known as “bridge amplification” is based on the principle of performing a local 
PCR via surface-bound primers. Four amplification spots were spotted on the chip surface, 
locally defined and arranged in a 2x2 array-like structure, while each spot was loaded with a 
different kind of primer-pair (figure 28). Thus, the feasibility of locally performed PCR 
applications on the lab-on-a-chip was evaluated. 
 
Figure 28. Design of the primer array for performing solid phase amplification. The scheme shows the four 
array spots, comprising each a different primer-pair for providing simultaneous local PCR amplification of four 
different PCR products. Primer-pairs were immobilized on a plane chip surface and covered by the same master 
mix in a 1 µl total reaction volume droplet. Spot 1 was loaded with primers amplifying the Y-chromosomal STR 
marker DYS392, while spot 2 and 3 served as positive controls, amplifying the X-chromosomal STR marker 
DXS10134 as well as fragments of the amelogenin gene. The forth spot served as negative control containing a 
pair of forward primers, thus eliminating a bridge-based amplification due to non-matching of amplified 
sequences. 
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Four primer pairs were spotted on distinct, separate array spots, while forward and reverse 
primers were spotted simultaneously and equally concentrated into single spots. Just 1 µl of 
PCR reaction mix was used to serve all 4 primer spots with reagents necessary for performing 
SYBR Green I-based real-time PCR, thus enabling 4 different amplification reactions at a 
time to take place in just 1 droplet. Again, the arrayed layout of on-chip SPA amplification 
was designed for forensic relevant determination and differentiation of male and female PCR 
products, when binding to and amplified by the appropriate XY-specific primer-pair. LOC 
chips with spotted SPA array were applied on male and female human genomic reference 
DNA. Results of solid phase amplification reactions were summarized in figure 29. Solid 
phase amplification as well as various amplification, annealing and hybridization procedures, 
including combined and separated “interfacial amplification” and “surface amplification” was 
tested on several LOC chips A12, A03, A21 and A01.  
Using spotted LOC chip A12 (figure 29 A-C), a 2-step SPA PCR with 1 ng of female 
reference input DNA was carried out. Due to the female nature of the DNA, two fluorescent 
signal spots were expected. As can be seen in figure 29 C, there were 4 fluorescent spots 
detectable, indicating a totally wrong array result. However, due to the geometry of the array 
(figure 29 A), at least 2 fluorescent signal spots out of these four fluorescent spots did not 
match the pattern. Spot arrangement was somehow out of alignment. The most possible 
authentic spots seemed to be the upper one and the outer right one. These were supposed to 
represent spots for the locus DXS10134 and Amelogenin, and thus the right and expected loci 
for a female sample. But there were a lot of non-specific fluorescent spots detectable outside 
the array area as well (figure 29 B), so the result of the array area still remained quite 
unreliable. 
Using spotted LOC chip A03 (figure 29 D-F), the same SPA PCR procedure as applied on 
chip A12 was performed, using 1 ng of female reference input DNA, intended to repeat the 
previous experiment and to confirm the detected result. Again, due to the female input DNA, 
just two fluorescent spots were expected. As can be seen in figure 29 F, there were just two 
fluorescent spots detectable, one in the upper left area and one in the lower right area. Again, 
both spots seemed to present the expected result, but those spots did definitely not match to 
the quadratic geometry of the array and seemed somehow displaced (figure 29 D). 
Additionally, after washing steps there were a lot of precipitates detected present on the chip 
surface (figure 29 E), which could have influenced the amplification reaction and led to non-
working reactions on the right array positions.  
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Using spotted LOC chip A21 (figure 29 G-J), a 2-step SPA PCR with 1 ng of male reference 
input DNA was carried out. Due to the male nature of the DNA, three fluorescent signal spots 
were expected. As can be seen in figure 29 J, there were just 2 fluorescent spots detectable. 
However, due to the geometry of the array (figure 29 G), these 2 fluorescent signal spots did 
not match the pattern at all. Spots were detected close to the borders of the reaction center and 
were arranged in a non-square manner. The most possible authentic spot seemed to be either 
the upper one or the outer right one. These were supposed to represent spots for the locus 
DXS10134 or Amelogenin, and thus the right and expected loci for a male sample. But still, 
the third male spot for the DYS392 locus was missing which should be located in the lower 
left area, thus all three spots forming an “L”-like shape. However, no such pattern could be 
detected at all, and it was very questionable, if any of these two spots represented an authentic 
signal. There were a lot of precipitates present after the PCR (figure 29 H) and a lot of non-
specific fluorescent spots detectable outside the array area as well (figure 29 J), so the result 
of the array area still remained quite unreliable and questionable. 
As those normal solid phase amplification reactions did not turn out the expected results, or 
reliable results at all, another approach was tested. Instead of human genomic input DNA, 
preamplified PCR products were used to enhance the starting amount of input DNA, thus 
facilitating more interfacial amplification reactions to take place on the chip surface. For 
amplification, a combined 3-step PCR procedure was applied encompassing a) a SPA PCR 
with preamplified PCR products, followed by b) a reaction where just PCR master mix was 
applied, to enhance surface amplification, and finally c) a hybridization of preamplified PCR 
products, to cover single amplified strands bound to the surface but having failed to form 
bridges. The combined setup was tested on used chips A03 and A21, but did not bring an 
optimized result compared to conventional SPA PCR performed previously. No male or 
female specific fluorescence pattern could be detected on these chips. Combined PCR 
reactions with preamplified PCR products were repeated with chip A01 (figure 29 K-O). As 
the master mix contained male and female specific PCR products, a male result was expected, 
showing an “L”-like pattern. After reactions, there were a lot of precipitates visible on the 
chip surface (figure 29 L), while fluorescence detection revealed four fluorescent signals 
(figure 29 M). The signals, however, showed no quadratical arrangement and did not match 
the square-like pattern of the spotted array at all (figure 29 K). Even after an additional 
washing procedure, there was still some precipitation visible on the surface (figure 29 N), 
which, however, did not improve fluorescence signal output (figure 29 O). Thus, even these 
combined PCR procedures did not reveal a successful performance.  
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Figure 29. Image data of solid phase amplification. Amelogenin, X-chromosomal and Y-chromosomal 
fragments were amplified from male and female human genomic reference DNA in SYBR Green I-based SPA 
reactions. Array spots comprised each a diameter of about 100-150 µm and were spotted within the hydrophilic 
area of 500 µm of reaction spot B (marked by red arrows). Spotted 2x2 primer arrays were pictured before use 
via stereo microscope (A, D, G, K, P). A-C) SPA array chip A12. Images of fluorescence signals taken after 
SPA PCR using the Fluorescence Reader (B) or the fluorescence microscope (C). D-F) SPA array chip A03. 
Image of precipitates visible on the chip surface after SPA PCR (E). Image of fluorescence signals (F). G-J) 
SPA array chip A21. Image of precipitates visible on the chip surface after SPA PCR (H). Image of fluorescence 
signals (J). K-O) SPA array chip A01. Images of precipitates visible on the chip surface after SPA PCR (L) and 
hybridization (N). Images of fluorescence signals taken after SPA PCR (M) or hybridization (O). P) SPA array 
chip A11. The array structure of this chip was analyzed via atomic force microscopy prior to use (figure 30). 
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After SPA, reaction mixes were also applied to PAAGE, to check for the presence of PCR 
products. Those could have been generated via detached primers in the reaction solution that 
could also have destroyed a working SPA performance. However, no PCR products were 
detected on polyacrylamide gels, accounting for a stable coupling of primers to surfaces.  
To check for a proper structure of array spots, besides using a stereomicroscope for optical 
detection, atomic force microscopy was applied to a new and unused LOC chip A11. Atomic 
force microscopy (AFM) is a technique for mapping the atomic-scale topography of a sample 
surface by means of the repulsive electronic forces between the surface and the tip of a 
microscopic probe moving above the surface. AFM imaging was done and supported by D. 
Adigüzel (research participate), and images were kindly provided. An AFM image of a 
possible spot of the 2x2 spot array, located in the supposed area of reaction center B, was 
generated (figure 30). It comprised a spot size of about 100 µm in diameter with a height of 
about 6.5 µm, but revealed a strange shape of the array spot. The spot height was not 
distributed equally throughout the spot size, but could only be measured in an area within the 
diameter, where the spotting solution was concentrated while the rest of the spot area was 
plane.  
 
Figure 30. Image data of atomic force microscopy applied to a single array spot. A) The AFM image 
represented the shape, size and structure of a possible spot of the 2x2 spotted primer array, located in the 
supposed area of reaction center B on LOC chips. B) Cross section of the pictured spot revealed an elevation of 
about 6.5 µm, which is about 70 µm in length, while the whole spot was supposed to be 100 µm in diameter. 
Despite the strange shape of the array spot detected via AFM, the measured spot diameter of 
about 100 µm fitted perfectly well with the supposed total size of this array. According to the 
spotting protocol of the company, which performed the spotting (Advalytix AG/Beckman 
Coulter Biomedical GmbH, Munich, Germany), spot size was supposed to be between 100-
150 µm, while spot-spot distance was fixed to 160 µm in both dimensions. Thus, a total array 
diameter of about 400-500 µm was spotted, fitting perfectly well within the hydrophilic 
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reaction center on reaction spot B, comprising a diameter of about 500 µm. However, due to 
the strange shape of the spot, it seemed like as the spotting solution has somehow contracted 
after the spotting process, as it comprised just an area of 70 µm in length while a wide area of 
originally about 100 µm in diameter was indicated on the surface through the remainings of 
spotting solution. This shrinking could be an explanation why hybridization and solid phase 
amplification did not work well, as probably the reactive site, the primers on the surface, 
could not be contacted properly by the target DNA material, as they were somehow 
condensed. For further application, the spotting process as well as the interplay of spotting 
solution with LOC chip surface must be checked for optimization. Additionally, concerning 
the precipitations after PCR performance, the interaction between spotting solution as well as 
PCR reaction mix must be improved in a way that mostly saltless aqueous solutions were 
utilized to eliminate precipitations. 
Besides the accumulated structure of the surface of the array spot, a general problem of 
performing SPA on LOC chip surface could have been the design of the array. Due to spotted 
primer-pairs, the amplification products for the male STR locus DYS392 were supposed to be 
290-323 bp, for the STR locus DXS10134 240-291 bp and for amelogenin 106 bp and 112 bp. 
Product lengths of STR loci were amongst the longest used for DNA profiling applications on 
sex chromosomes (www.chrx-str.org; www.yhrd.org) and used as standard STR loci in 
forensic DNA profiling kits worldwide. However, possibly the PCR products generated by 
STR loci as well as amelogenin were chosen too short and thus no “bridge-building” via 
surface amplification was possible in solid phase amplification reactions, but only interfacial 
amplification to surface bound primers. Compared to the literature, in successful SPA only 
quite long PCR products of about 427 bp (Fedurco M et al., 2006), 545 bp (Bing DH et al., 
1996), or 666 bp and 800 bp (Adessi C et al., 2000) were reported to having been applied. 
Additionally, SPA reactions were performed in reaction volumes of 25-100 µl in total, while 
either plasmid DNA (Nickisch-Rosenegk M et al., 2005) or preamplified DNA fragments 
were used (Bing DH et al., 1996; Adessi C et al., 2000). The products used for LOC chip 
SPA comprised just about 300 bp in maximum, and reactions were performed in just 1 µl total 
reaction volume using human genomic DNA, which has never been reported for SPA 
application before. Maybe a possible solution could also be the use of labeled primers, like 
used for microarrays, which are going to be spotted on the surface. To attribute difficulties to 
input DNA, primers, chip surface, reaction volume, master mix, failing interfacial or surface 
amplification, and to definitely judge on a successful working performance of SPA on LOC 
chips, applications according to cited articles remain to be tested on LOC chips. 
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5.  Applications of the Lab-on-a-chip System in Forensic Sciences 
The developed lab-on-a-chip system (LOC) incorporated several working units that were 
combined to one total system in a modular way. Due to the unique flexible character of the 
open, planar lab-on-a-chip system, it provided all qualifications being used as a stand-alone 
enabling technique for applications in various fields of molecular biological diagnostics. 
Based on the characterization and validation of the working performance and the efficiency in 
low-volume PCR amplification of purified human genomic DNA material, the capability of 
the lab-on-a-chip system for applicability on various forensically relevant sample materials 
was tested. 
5.1  Gender determination of human intestine, mamma and bladder tissue 
In forensic pathology, pieces of internal soft tissues are generally used to yield information 
about sex, age, and medical conditions of the inspected sample material. Thereby, the 
separation of various cell types and extraction of distinct cell clusters is most important in 
forensic analysis to guarantee for a detailed, sensitive and reliable analysis. The introduction 
of laser-based microdissection techniques in this field of research has greatly improved the 
capability to select distinct areas of interest out of surrounding tissue material, while reducing 
the risk of any cross-contamination. The use of microscopic instrumentation supported by a 
focused laser beam provides an elegant solution for direct visualization and dissection of 
defined cells and tissue sections out of microscope object slides (Schütze K and Lahr G, 
1998). In the field of forensic medicine, laser microdissection has been reported e.g. for 
isolation of sperm cells and dissection of tissue sections (Elliott K et al., 2003; Sanders CT et 
al., 2006; Bauer M et al., 2002; Di Martino D et al., 2004 (a)) as well as on cells isolated 
from single hair follicles (Di Martino D et al., 2004 (b)) which have successfully been typed 
by STR profiling. Thus, sensitive material amplification methods are necessary as well to 
generate reliable PCR products from that very few amount of individual cell material.  
An enhancement of short tandem repeat (STR) analysis sensitivity could be achieved by 
downscaling reaction volumes, as was shown several times on chemically structured slides to 
have improved genotyping success (Proff C et al., 2006; Schmidt U et al., 2006; Lutz-
Bonengel S et al., 2007; Schmidt U et al., 2008). For instance, complete STR profiles from as 
little as 32 pg of genomic DNA have been reported when performing virtual reaction 
chamber-based low-volume PCR on chemically structured chips (Schmidt U et al., 2006). 
5. Applications of the Lab-on-a-chip System in Forensic Sciences 
 
 
93 
Thus, linking laser microdissection and low-volume on-chip PCR together, as realized on the 
lab-on-a-chip, was supposed to be a valuable tool for most sensitive analysis. Fixed and 
paraffin-embedded tissue sample material was applied to LV-PCR after microdissection to 
validate the applicability of the LOC system to unpurified sample material, as often used in 
medical genetic analysis, like e.g. cytogenetics, cancer research and forensic pathology. As 
most lab-on-a-chip systems were designed for accepting just minor sample amounts of a 
specific type, preferably purified DNA material, here genetic analysis was performed directly 
on tiny tissue particles after laser microdissection without DNA extraction. 
Laser microdissection was applied to paraffin-embedded tissue pieces, originating from three 
different human tissue types, that were intestine, bladder and mamma tissues (figure 31).  
 
Figure 31. Paraffin-embedded tissue slides comprising various tissue types. Tissues were named tissue 1-8, 
while tissue 1 (A), 2 (B), 4 (E), 5 (F), 7 (H) and 8 (D) originated from intestine tissue, tissue 3 (C) from bladder 
tissue and tissue 6 (G) from mamma tissue. 
After deparaffinization, small pieces of eight masked human soft tissue samples were 
successfully isolated via laser microdissection. Single tissue particles of about 500 µm in 
diameter were microdissected and were gently separated from histological tissue sections. 
Using the SPATS device, dissected tissue islets were extracted out of the surrounding tissue 
material via low-pressure supported adsorption to the SPATS-related collection grid (figure 
32 A-C). Tissue particles were transferred horizontally and released exactly into a 0.5 µl 
droplet of H2O, while controlled with µm-precision. Droplets for sample material take-up 
were placed directly on chemically defined reaction sites of a multi LV-PCR microdevice or 
on reaction center B of LOC chips (figure 32 D). A total of eight different tissue samples, 
released in a highly precise manner exactly onto reaction sites, was successfully tested for 
gender determination using directly LV-PCR analysis on primer-specific amelogenin 
fragments. 
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Figure 32. Workflow of the tissue transfer process via low-pressure single particle adsorbing transfer 
system. Scale bar in every illustration is about 100 µm. A) Laser microdissection of tissue material and isolation 
of a tissue fragment in the range of about 500 µm in diameter out of surrounding histological material. B) Low-
pressure uptake and subsequent transfer of single microdissected tissue fragments were visually controlled via 
adsorption to the collection grid of the SPATS-related adsorbing head. C) The area of tissue fragment extraction 
out of surrounding tissue material is shown. D) Precisely controlled release of adsorbed sample material was 
performed into a small droplet of 0.5 µl of H2O via operated high-pressure impulse. The fluid was placed 
directly onto a reaction site of a LV-PCR microdevice, defined via a chemically modified surface. 
As access to DNA enclosed in the cellular material was achieved by incorporating an 
extended initial heat step in the PCR protocol for cell lysis, no additional precedent DNA 
purification was necessary. After PAAGE four out of eight masked tissue samples turned out 
to originate from a male, and the other 50% of the tissue samples turned out to originate from 
a female individual (figure 33 A-C). Intestine tissues 1, 2 and 5 as well as bladder tissue 3 
showed 106/112 bp male-specific amelogenin amplification products, while intestine tissues 
4, 7 and 8 as well as mamma tissue 6 showed 106 bp female-specific amelogenin products. 
Clear and sharp amplification bands could be detected on polyacrylamide gels, without any 
unspecific or contaminating bands and side products of larger or smaller size being present.  
 
Figure 33. PAAGE data of LV-PCR amplification applied on eight microdissected human tissue samples. 
LV-PCR of amelogenin fragments for sex determination purposes were performed on a multi LV-PCR 
microdevice. M: molecular length standard (O’GeneRuler DNA Ladder, ultra low range, Fermentas, St. Leon-
Rot, Germany). A) Intestine tissue 1 and intestine tissue 2. Lane 1: tissue 1, showing 106/112 bp male 
amelogenin fragments; lane 2: tissue 2, showing 106/112 bp male amelogenin fragments; lanes 3+4: negative 
controls (PCR master mix, H2O control); lanes 5+6: positive controls (standard 106/112 bp male and 106 bp 
female human genomic reference DNA). B) Bladder tissue 3, intestine tissue 4 and intestine tissue 5. Lanes 
1+2: positive controls (standard 106 bp female and 106/112 bp male human genomic reference DNA); lane 3: 
negative control (PCR master mix); lane 4: tissue 4, showing 106 bp female amelogenin fragments; lane 5: tissue 
3, showing 106/112 bp male amelogenin fragments; lane 6: tissue 5, showing 106/112 bp male amelogenin 
fragments. C) Mamma tissue 6, intestine tissue 7 and intestine tissue 8. Lane 1: tissue 6, showing 106 bp 
female amelogenin fragments; lane 2: tissue 7, showing 106 bp female amelogenin fragments; lane 3: negative 
control (PCR master mix); lane 4: tissue 8, showing 106 bp female amelogenin fragments; lanes 5+6: positive 
controls (standard 106 bp female and 106/112 bp male human genomic reference DNA). 
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Tissue experiments for amplifying crude, unpurified fixed sample material were also 
performed on LOC chips. Sample extraction, transfer of dissected tissue particles as well as 
LV-PCR amplification was performed in a comparable performance. However, due to the 
integrated BioSpot device, manual pipetting operations could successfully be neglected. 1 µl 
of master mix for sample material uptake and performing LV-PCR on the chip surface as well 
as 5 µl of mineral oil cover solution were provided by means of the automatic dispensing 
device BioSpot. A whole workflow procedure of the lab-on-a-chip system could 
successfully be run, including microdissection-based sample isolation, SPATS transfer onto 
the LOC chip surface and finally LV-PCR (figure 34), while handling of fluids was 
completely done using the automatic pipetting functions of the BioSpot device. Small 
particles of about 600 µm in diameter were successfully microdissected out of male intestine 
tissue 5 and transferred directly into 1 µl of master mix, which had afore been dispensed on 
reaction center B of the LOC chip by using PipeJet1 of the BioSpot (figure 34 A-D). 
After sample take-up, the master mix droplet could immediately successfully be covered by 
about 5 µl of Sealing Solution (figure 34 E and F). A proper amount of Sealing Solution was 
dispensed by operating PipeJet3 of the BioSpot, as this PipeJet was designated for 
handling viscous fluids like the mineral oil. Successful amplification of male specific 106/112 
bp fragments of the amelogenin gene could be detected for tissue 5 via PAAGE (figure 34 
K).  
 
Figure 34. Workflow of laser microdissection, SPATS transfer and LV-PCR amplification performed on 
the lab-on-a-chip. Results were shown for male sample tissue 5, exemplarily for all of eight tissues. A) Isolation 
of a tissue particle with about 600 µm in diameter via laser microdissection. B) Transfer of dissected particle via 
low-pressure operated SPATS. The particle was adsorbed to a sample collection grid. C) Control of successful 
particle extraction out of surrounding tissue. D) Release of tissue particle directly into 1 µl of master mix, 
prepared on the chip surface via BioSpot-operated fluid dispension. E+F) 1 µl of master mix containing tissue 
was covered with 5 µl of mineral oil and was thus prepared for subsequent PCR analysis. The oil cover was 
provided via dispensing functions of the BioSpot. G) Low-volume PCR performance: image was taken during 
the first cycles of PCR via the CCD camera associated with the Fluorescence Reader. H+J) Images taken 
directly after PCR, to control the proper arrangement of particle, master mix and covering oil. K) PAAGE image 
data of amplified PCR products. M = molecular length standard (Superladder-low 100 bp ladder with 
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ReddyRun, Thermo Scientific, ABgene, Epsom, Surrey, UK). Lane 1: tissue 5, showing 106/112 bp male 
amelogenin fragments; lane 2: negative control on multi LV-PCR microdevice. 
Performing genetic analysis directly from fixed, paraffin-embedded tissue material without 
preceding DNA purification could successfully be achieved by LV-PCR application. Genders 
of eight different masked human tissue samples were reliably determined via amplification of 
human amelogenin fragments. No matter if LV-PCR was applied on a multi LV-PCR 
microdevice or on LOC chips, clear bands of amplified PCR products could be detected on 
polyacrylamide gels. Amplification results of gender determination were validated with 
existing data sets about these samples, provided by the Institute of Pathology (Klinikum 
Bogenhausen, Munich, Germany). These data sets confirmed the results obtained in our 
laboratory. These successful amplification results accounted not only for the successful 
application of the LOC modules, but also for successful lysis of cellular material via an 
additional performed heat step, thus making any external DNA purification and extraction 
procedures invalid. However, concerning the results of the LOC-based procedure, the band 
representing the larger 112 bp fragment originating from the Y-chromosome showed just a 
very weak signal compared to the 106 bp band of the smaller X-chromosomal fragment. This 
might more probably be due to inhomogeneous staining rather than to an imbalanced 
amplification performance, thus presented results for the LOC chip performance could 
nevertheless be attributed to a reliable, sensitive and unambiguous analysis.  
However, there was a lot of bubbling observed in master mixes during the initial denaturation 
and cell lysis step of the LOC-based PCR performance. Generally, when performing VRC 
LV-PCR, causing air bubbles was avoided during the preparation of the master mix solution, 
as smallest air bubbles in the aqueous master mix were known to expand when treated with 
heat. In the master mix prepared on the chip surface, there were seemingly a lot of air bubbles 
present. The air bubbles leaking from the master mix ruined the proper arrangement of virtual 
reaction chamber PCR, causing the master mix to evaporate while the oil was bubbling. The 
dimension of destroyed reactions was about three ruined reactions out of five. This 
phenomenon of bubbling reaction mixes on the LOC chip surface might be due to the 
automatic dispensing process performed by the BioSpot, where 5 nl droplets of master mix 
were shot onto the chip surface building a droplet of 1 µl after a certain amount of repeats. 
When a liquid droplet present on the chip surface was shot by several tiniest droplets at high 
speed, this meant an enormous mixture, stirring and agitation inside this droplet. This 
extensive actuation was supposed to have generated smallest invisible bubbles in dispensed 
master mix droplets, which might have spread during PCR performance, when the master mix 
was heated to hot temperatures. The same phenomenon was reported and happened, when 
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stirring the master mix extensively with a pipet, by pipetting up and down for mixing 
reagents. Thus, the automatic dispension performance definitely needed further improvement 
to circumvent extensive agitation especially of aqueous master mix solutions.  
Anyway, several LOC units like e.g. laser microdissection, SPATS transfer, CytoCycler-
based material lysis and amplification as well as using the BioSpot for loading reaction 
volumes onto the chip surface, could for a first time successfully be joined in a whole 
interplay. This performance showed a promising first application to perform a combined run 
of independently operating modules of the lab-on-a-chip system. Especially the coupling of a 
pipetting robot like the BioSpot upgraded the whole performance, as manual sample 
handling between single analysis steps could be eliminated totally, thus reducing the risk of 
introducing external contaminations, which is quite important in every field of genetic 
analysis. And additionally, the successful material isolation via laser microdissection, particle 
extraction and transfer via SPATS, as well as successful LV-PCR DNA amplification, 
represented the applicability of the various LOC modules on forensic or forensic pathological 
relevant sample material, either working apart from each other as well as in a combined 
performance. No comparable system has been reported up to now, which can fulfill all of 
these processing steps on one microfluidic device, and definitely not with such kind of crude 
solid sample material. No comparable system exists, which combines laser microdissection 
with low-volume PCR, both highly predestined approaches, serving the needs of handling 
smallest amounts of sample material. Thus, this lab-on-a-chip system provides highest 
potential for becoming integrated and utilized in research areas, where genetic analyses are 
dependent on other sample materials than liquid ones. 
5.2  DNA profiling of whole blood 
Microdissected fixed tissue sample material was shown to perform well when directly applied 
to LV-PCR genetic analysis. No additional DNA purification or preprocessing steps were 
needed as cell lysis was achieved by a simple extended initial heat step, to get access to 
genetic material. However, there, relevant sample material had to be prepared for laser 
microdissection purposes and needed to be fixed and applied onto PEN carrier-membrane 
mounted object slides. Though, for a real fast, sensitive and reliable analysis, a lab-on-a-chip 
must be capable of accepting crude, untreated, authentic sample material, solid specimen as 
well as liquid ones, like e.g. whole blood. 
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Blood samples or traces are excellent evidences used for genetic analysis. PCR is a well 
described powerful tool for molecular genetic analysis of blood samples, currently applied for 
diagnostic purposes in medical analysis as well as ancestry surveys and human identification 
in forensics. However, one of the major limitations with PCR-based analysis is the sensitivity 
of Taq DNA polymerases to inhibitory substances present in crude specimens such as blood 
(Panaccio M and Lew A, 1991; Al-Soud WA et al., 1998; Al-Soud WA and Radström P, 
2000; Kermekchiev MB et al., 2009). Generally, whole blood cannot be used for direct 
genetic testing, due to several characterized PCR inhibitors influencing the Taq DNA 
polymerase activity. Inhibitory effects were either attributed to natural components of blood 
like mainly the heme from hemoglobin, lactoferrin, immunoglobulin G (IgG), or to added 
anticoagulants such as EDTA and heparin. Therefore complex and extensive DNA 
purification procedures are mandatory prior to PCR to generate PCR-usable material. 
However, generally these additional pretreatment steps are time-consuming, labor-intensive, 
and may further lead to loss of target nucleic acids during processing and unlike may remove 
inhibitors subtotal. Indeed, there are several reports about thermal or chemical treatments of 
blood sample or PCR mixture prior to PCR to overcome purification procedures and the 
inhibitory effects of blood on Taq DNA polymerase (Schwartz EI et al., 1990; Mercier B et 
al., 1990; McCusker J et al., 1992; Burckhardt J, 1994; Park SJ et al., 2008). However, 
despite these remedies, the application of this enzyme in whole blood amplifications remains 
still quite controversial. AmpliTaq Gold DNA polymerase, currently the standard enzyme in 
several multiplex short tandem repeat (STR) kits worldwide, was found to be among the most 
sensitive to inhibition (Al-Soud WA and Radström P, 1998). This underlines the importance 
of meticulous sample handling and DNA purification when using this polymerase in STR 
analysis. To overcome all these limitations associated with Taq DNA polymerases, the choice 
of using a non-Taq DNA polymerase was reported to have a huge impact on resistance to 
inhibition. These DNA polymerases were shown to have less sensitivity to inhibitors, could 
tolerate higher concentrations of whole blood (Panaccio M and Lew A, 1991; Katcher HL and 
Schwartz I, 1994; Wiedbrauk DL et al., 1995; Al-Soud WA and Radström P, 1998) and 
outperformed AmpliTaq Gold as recently reported (Hedman J et al., 2009). 
Besides a good interaction between DNA quality and used DNA polymerase, a high 
sensitivity of analysis is desirable. Enhancement of sensitivity can to some extend be 
achieved by simply reducing the reaction volume (Gaines ML et al., 2002; Kloosterman AD 
and Kersbergen P, 2003; Leclair B et al., 2003), as adding less crude target material to the 
amplification is proven to improve performances greatly. Low-volume PCR (LV-PCR), 
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performed in 1 µl total reaction volume, provided enhanced sensitivity when applied to 
commercial multiplex STR assays (Proff C et al., 2006; Schmidt U et al., 2006; Lutz-
Bonengel S et al., 2007; Schmidt U et al., 2008). For instance, low copy number samples 
produced 27% complete allelic profiles in LV-PCR, while in-tube PCR just revealed 
incomplete allelic profiles (Schmidt U et al., 2008). Unfortunately, there, purification 
procedures were used prior to typing analysis.  
To overcome these Taq-related problems of inhibition and purification, a more appropriate, 
less-sensitive thermostable non-Taq DNA polymerase was used for LV-PCR based DNA 
profiling directly from whole unpurified blood. By using a KOD DNA polymerase-based 
PCR system, predestined for amplification of crude sample material, tube-less low-volume 
PCR was performed in extremely small reaction volumes of maximum 1 µl on chemically 
structured microdevices. EDTA K treated fresh and aged whole blood samples as well as 
time-dependently aged dried blood spots were taken as sample material and used for DNA 
typing via STR fragment length analysis. No previous pretreatment or preparation steps were 
applied besides dilution. Anticoagulant treated blood was directly used for LV-PCR in 10% 
or 1% dilutions and dried blood spots were directly resolved and used in 1% dilutions. 
Whole blood DNA typing was performed on blood samples with added anticoagulant EDTA 
K. Direct DNA STR profiling could be performed repeatedly successful and reliably in 1 µl 
low-volume PCR reactions using as little as 0.1 µl of unpurified blood samples as target 
material. A small detail of typing profiles can be seen in figure 35. Typing of four individual 
blood samples gave reproducible results for 10% as well as 1% reaction batches, showing a 
clear effect of decreasing peak intensities with decreasing blood concentrations (figure 35, 
vertical black arrows). For instance, here peak intensities of 3000 rfu could be reached for 
10% blood samples, while 1% blood samples showed just peak heights of 300 rfu. Peak 
heights reached from 2000 to 8000 rfu maximum and 300 to 1000 rfu minimum in 10% blood 
samples and from 80 to 400 rfu maximum and 50 to 400 rfu minimum for 1% blood samples. 
Fragment peaks were unsoiled, showing no contamination profiles and no stutter peaks and 
had sufficient heights, indicating values clearly above the general accepted detection 
threshold of 50 rfu. An overview of typing results is given in table 6, displaying averaged 
percentages of loci drop out, allelic drop out as well as complete allelic profiles obtained. 
Concerning the 10% blood samples, the rate of complete allelic profiles observed ranged from 
83.4% to 89% on average. Regarding the 1% blood samples, this rate ranged at an average 
from 61.2% to 87.6%. Allelic drop out simulating homozygosity as well as drop out of 
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individual STR systems was found randomly distributed. Although the sensitivity was 
enhanced in those 1 µl low-volume PCR reactions, drop out of loci and single alleles were 
observed more often in 1% reactions, which probably occurred as a consequence of a higher 
dilution factor and thus could be interpreted as stochastic effects due to pipetting of very 
small volumes as already reported by Kloosterman AD and Kersbergen P (2003).  
Table 6. Typing results of 4 individual EDTA K treated blood samples using LV-PCR. Data analysis of every 
single sample was performed in triplicates in two independent approaches leading to 6 peak profiles per sample. 
Only peak signals above 50 rfu were counted. The percentages represented the averaged rate of loci drop out, 
allelic drop out and of complete allelic profiles obtained in samples 1-4 as well as positive controls PK-1 and 
SE-PK-2. 
 
 Age of blood 
sample 
AmpF/STR SEfiler kit  
(11 STR loci + amelogenin) 
Material EDTA K treated blood samples;  
2 male (1, 2) and 2 female  
(3, 4) samples 
1 = 3 months 
 
2, 3, 4 =  
1-3 weeks 
Loci 
drop 
out 
Allelic  
drop 
out 
Complete 
allelic 
profiles 
PCR-Kits - KOD Xtreme Hot Start DNA 
  Polymerase kit  
- AmpF/STR SEfiler PCR 
  amplification kit 
1-10% 
2-10% 
3-10% 
4-10% 
16.6 % 
13.8 % 
16.6 % 
  8.3 % 
     - 
     - 
     - 
2.7 % 
83.4 % 
86.2 % 
83.4 % 
   89 % 
Preparation Blood samples of 100% and 10% 
(diluted with sterile water) 
1-1% 
2-1% 
3-1% 
4-1% 
11.1 % 
  8.3 % 
36.1 % 
11.1 % 
1.3 % 
8.3 % 
2.7 % 
5.5 % 
87.6 % 
83.4 % 
61.2 % 
83.4 % 
Starting 
amount of 
blood for 
PCR 
10% or 1% blood in 1 µl reaction mix  
(= 0.1µl of 100% or 10% blood sample) 
PK-1 
SE-PK-2 
  3.1 % 
     - 
     - 
     - 
96.9 % 
 100 % 
Negative controls were included in every reaction batch and were consistently negative 
(figure 35). Two kinds of positive controls were performed using control DNA. On the one 
hand, control DNA was amplified using LV-PCR, the KOD Xtreme PCR reaction mix and 
the AmpF/STR SEfiler Primer Set, the same setup as used for whole blood sample 
analysis (named PK-1). On the other hand, control DNA was amplified using a standard 
thermocycler and the original AmpF/STR SEfiler PCR Reaction Mix, as recommended by 
the manufacturer’s kit manual (named SE-PK-2). This pure positive control validated results 
obtained in the mixed kits’ setup, as using just the AmpF/STR SEfiler Primer Set, without 
the recommended PCR system provided with the AmpF/STR SEfiler kit, might have 
changed the optimized PCR setup of the kit. As can be seen in figure 35, the KOD Xtreme 
master mix matched well with the AmpF/STR SEfiler Primer Set. Clear peaks were 
detectable and allelic profiles could be obtained from the LV-PCR-based positive controls 
PK-1 showing a rate of 96.9% compared to a rate of 100% of complete allelic profiles, 
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obtained with SE-PK-2 (table 6). Slight drop out of loci in PK-1 compared to SE-PK-2 could 
again be attributed to stochastic effects due to pipetting of very small volumes (Kloosterman 
AD and Kersbergen P, 2003).  
 
Figure 35. Blood typing allelic profiles of 10% and 1% (v/v) EDTA K-treated whole blood samples using 
LV-PCR. The figure represents just an except, exemplarily for all four individual typing profiles and loci of 
samples 1-4. Allelic profiles for the amelogenin locus (A…), as well as for 2 STR loci (D8S1179, SE33) were 
shown, derived from two blood samples, a female (sample 4) and a male (sample 2) one, as well as negative 
control and two positive controls (PK-1, SE-PK-2). Samples yielded clear allelic profiles, comprising pure peaks 
without contamination or stutter peaks and displaying concentration dependant peak heights (vertical black 
arrows). PK-1, showing complete allelic profiles, validated that the KOD Xtreme PCR master mix in 
combination with the AmpF/STR SEfiler Primer Set harmonized well. Fragment sizes of PK-1 compared to 
SE-PK-2 clearly showed the 1 bp-shifting caused by using the KOD DNA polymerase (horizontal red arrows). 
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The conventionally cycled positive control SE-PK-2, using the complete SEfiler PCR setup, produced peaks 
matching perfectly with the provided SEfiler Allelic ladder, as AmpliTaq Gold DNA polymerase was used. 
Besides the described positive profiling results, it has to be noted that the AmpF/STR 
SEfiler Allelic ladder peaks were displaced exactly 1 bp to sample peaks of LV-PCR-based 
analysis (figure 35, horizontal red arrows). Allelic ladder peaks just matched perfectly well 
with the positive control SE-PK-2, cycled according to manufacturer’s recommendations 
using AmpliTaq Gold DNA polymerase (figure 35, horizontal red arrows). This fragment 
size shifting was due to the used polymerases. AmpliTaq Gold DNA Polymerase, provided 
by the kit, catalyzed the addition of a single nucleotide (predominately adenosine) to the 3’ 
ends of double-stranded PCR products (Clark JM, 1988; Magnuson VL et al., 1996). This 
non-template adenylation was not performed by the KOD DNA polymerase therefore all 
fragment lengths of LV-PCR products, including PK-1, were 1 bp shorter. Generating an 
appropriate allelic ladder using the KOD DNA polymerase would solve this discrepancy. 
Whole blood DNA typing was performed on dried blood specimens over time without added 
anticoagulants. Dried blood spots were resolved in sterile water after several time intervals 
and 1% blood (v/v) was used for DNA typing analysis in a total reaction volume of 1 µl, to 
check for successful allelic profiling in dependence of sample age (figure 36). Allelic profiles 
were obtained for up to 3 months old blood spots.  
 
Figure 36. Sample preparation and low-volume amplification of dried blood spots (DBS). A) Preparation of 
dried blood spots. Fresh blood was spotted in 1 µl drops on a pre-cleaned object slide (76 x 26 mm) and dried at 
room temperature. After distinct periods of time samples were taken: a 1 µl dried blood spot was resolved in 
sterile water and 10% blood solutions were then used for LV-PCR typing analysis, comprising a final 
concentration of 1% blood (v/v) present in 1 µl total reaction mix. B) Low-volume virtual reaction chamber 
PCR: 1 µl total blood containing reaction mix (red enclosed solution, 500 µm in width) was covered by 5 µl of 
Sealing Solution (transparent covering oil, 3 mm in width) to prevent evaporation and external contamination as 
well as cross-contamination. 
The obtained data of sample analysis are summarized in table 7, showing typing results in 
averaged percentages grouped into loci drop out, allelic drop out and complete allelic profiles 
obtained. In the “0 min” samples one single locus dropped out completely, resulting in 98% 
successful typing of untreated fresh blood samples. Sample analysis after a drying time from 
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30 to 360 min showed quite inconsistent allelic peaks. At these time intervals allelic profiles 
ranged between no allelic profiles at all as well as a huge amount of loci drop out and allelic 
drop out, either producing no signals or peaks going below the threshold. Here, rates of 
successful typing reached from 56.8% to 20.9% on average. In samples dried for 1 day, 2 
days, 4 days and 1 week minor fluctuations concerning typing efficiency were detected, 
ranging at an average from 90% to 70%, which might be due to a terminated drying process, 
while blood components still have unchanged properties. Here, a few loci drop out were 
observed that were very randomly distributed over all of the loci. 2 weeks, 3 weeks and 4 
weeks old samples showed consistent marker peaks, most stable in appearance and height. 
They ranged from 89% to 91.7%, whereas locus drop out occurred preferably in one 
particular locus. Concerning the 3 months old samples, the obtained complete allelic profile 
rate was about 85.9% on average. Drop out of single loci or alleles may be due to pipetting 
artifacts, as a volume of 0.1 µl blood sample is a random mixture of solid particles like e.g. 
lymphocytes out of the sample, so stochastic effects could be expected (Kloosterman AD and 
Kersbergen P, 2003). To obtain statistically reliable results, LV-PCR was performed in three- 
to sixfold series. In most instances 2-4 complete profiles could be obtained, while 1 or 2 
samples showed enhanced drop out due to pipetting artifacts. Allelic drop out, as a 
consequence of a higher dilution factor, was randomly distributed and not correlated to size of 
missing alleles. Thereby, getting usable DNA typing profiles with clear marker peaks was 
successful even after 3 months of storage of dried blood spots and DNA remained very stable 
in dried blood. 
Table 7. Typing results of dried blood spots using low-volume PCR. Data analysis of every single time interval 
was performed in multiplicates (double to threefold runs) in two independent approaches leading to 3 to 6 peak 
profiles per time point. Only peak signals above 50 rfu were counted. The percentages represented the averaged 
rate of loci drop out, allelic drop out and of complete allelic profiles obtained. 
 
 Age of blood 
sample 
AmpF/STR SEfiler kit  
(11 STR loci + amelogenin) 
Material Untreated blood  
(w/o anticoagulants) 
Fresh blood,  
dried at room 
temperature 
Loci 
drop 
out 
Allelic  
drop 
out 
Complete 
allelic 
profiles 
PCR-Kits - KOD Xtreme Hot Start DNA 
  Polymerase kit  
- AmpF/STR SEfiler PCR 
  amplification kit 
    0 min 
  30 min 
  60 min 
120 min 
360 min 
     2 % 
41.6 % 
   60 % 
61.6 % 
79.1 % 
- 
1.6 % 
- 
1.6 % 
- 
    98 % 
 56.8 % 
    40 % 
 36.8 % 
 20.9 % 
Preparation Blood spots of 1 µl dried at RT on glass 
slide; samples taken after time intervals 
of 0, 30, 60, 120 min, 6 h, 24 h,  
2 d, 4 d, 7 d, 2 we, 3 we, 4 we, 3 months 
    1 day 
    2 days 
    4 days 
    7 days 
   10 % 
15.2 % 
   20 %  
   30 % 
- 
1.3 % 
- 
- 
    90 % 
 83.5 % 
    80 % 
    70 % 
5. Applications of the Lab-on-a-chip System in Forensic Sciences 
 
 
104 
Starting 
amount of 
blood for 
PCR 
- 1µl blood spot dissolved in  
  10µl H2O (10% blood solution) 
- final 1% blood in 1 µl reaction mix  
  (0.1µl of 10% blood spot solution) 
    2 weeks 
    3 weeks 
    4 weeks 
    3 months 
  8.3 % 
  8.3 % 
  8.3 % 
13.3 % 
- 
- 
2.7 % 
0.8 % 
 91.7 % 
 91.7 % 
    89 % 
 85.9 % 
Blood DNA profiling analysis of dried blood spots could successfully be applied to a multi 
LV-PCR microdevice as well as on LOC chips. Results of loci drop out, allelic drop out and 
full allelic profiles obtained were quite comparable at each distinct time point during 3 
months of aging. However, signal intensities of allelic profiles obtained were always stronger 
when using a multi LV-PCR device. Peak heights reached from 120 rfu up to 600 rfu, as 
illustrated in allelic profiles of dried blood spots obtained after 4 weeks of aging (figure 37). 
 
Figure 37. Fragment length analysis of dried blood spots after 4 weeks of drying using a multi LV-PCR 
microdevice. Peak heights reached values clearly above the generally accepted threshold of 50 rfu, signaling 
authentic marker peaks. Clear marker peaks without contaminating effects could be detected. Values of 120 rfu 
at minimum and 600 rfu at maximum were obtained for 4 weeks old dried blood spots, analyzed on a multi LV-
PCR microdevice. 
Concerning blood samples analyzed on LOC chips, peak heights were well below the ones 
obtained when a multi LV-PCR microdevice was used. Exemplarily, in figure 38 profiling 
peaks from dried blood spots aged for 3 months were shown, reaching signal intensities from 
20 rfu up to 350 rfu. Despite partly marker peaks below the accepted threshold of 50 rfu were 
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detected, these peaks could clearly be identified as authentic and reliable profiling peaks, as 
background signals were perfectly low. No interfering allelic peaks, no competing stutter 
peaks and no fluctuating background signal could influence a clear data analysis in distorting 
authentic signals. Thus, profiling peaks, even when detected below threshold level, could 
successfully be applied for an unambiguous validation. 
 
Figure 38. Fragment length analysis of dried blood spots after 3 months of drying analyzed on LOC chips. 
Peak heights reached not constantly values clearly above the generally accepted threshold of 50 rfu, signaling 
authentic marker peaks. Values of 20 rfu at minimum and 350 rfu at maximum were obtained for 3 months old 
dried blood spots, analyzed on LOC chips. However, clear marker peaks without contaminating effects could be 
detected.  
A non-inhibitory PCR performance on whole EDTA K-treated blood as well as age-
dependent typing of dried blood spots could successfully be demonstrated. As a KOD DNA 
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polymerase operated PCR system was used, predestined for amplification of crude sample 
material, allelic profiles could be obtained in dependence of age and alteration of blood spots 
during the drying and coagulation process. Blood DNA typing was performed in 1 µl total 
reaction volume containing only 1% whole blood (v/v) on a chemically structured surface, 
using a multi LV-PCR microdevice as well as LOC chips. Due to this one step procedure no 
additional purification steps were necessary while increasing analysis sensitivity by reduced 
target material. 
As validated in chapter 4.2, again the LV-PCR performance concerning PCR product output 
was more efficient in multi LV-PCR microdevice-based amplifications. STR profiling peaks 
reached clearly higher signal intensities compared to LOC chip-based operations. This 
phenomenon could again be due to a less optimal LV-PCR setup concerning the contacting of 
master mix droplet to surface area, resulting in a less efficient heat transfer. Despite LOC-
chip-based amplification peaks were partially below an accepted 50 rfu-threshold of authentic 
peak signals, clear STR profiles could be obtained due to a highly unsoiled background 
signal. Authentic peaks could unambiguously be separated from background fluctuations. As 
contamination effects could successfully be eliminated, peak signals could clearly be detected 
and typing results were interpretable at all, the applicability of a lab-on-a-chip based approach 
for a sensitive forensic relevant analysis like this could definitely be demonstrated. Successful 
LV-PCR DNA amplification on whole unpurified blood represented the applicability of the 
lab-on-a-chip for forensic relevant applications like e.g. blood DNA profiling. Allelic profiles 
were obtained reproducibly and concentration dependencies could be detected. A reliable 
experimental performance could be noted and savings in time and cost could be highlighted 
due to eliminated purification steps prior to PCR. Preparative steps could be neglected, as 
only a very small amount of sample material was needed for LV-PCR and a special DNA 
polymerase was used, which could tolerate inhibitory effects better than Taq polymerases. 
In conclusion, the use of DNA polymerases resistant to PCR-inhibitory components in 
combination with the use of appropriate facilitators of analysis efficiency (like LV-PCR), 
could, to some extent, eliminate the need for extensive processing of blood samples prior to 
PCR. Furthermore, the relative concentration of PCR inhibitors in this low reaction volume, if 
present, is probably less critical. As could be reported in the next application (chapter 5.3), 
LV-PCR is a valuable tool for highly sensitive analysis of ancient DNA material (Woide D et 
al., 2010) as well as single cell analysis (Mayer V et al., 2009), as reported earlier, while 
providing reliable contamination free performances. Reagent-saving LV-PCR also provides 
considerable economies. As genetic analysis trends to get smaller-volume, faster, more cost-
5. Applications of the Lab-on-a-chip System in Forensic Sciences 
 
 
107 
efficient and most sensitive, a contamination-free lab-on-a-chip procedure like this might 
signify a big benefit. It can be used with commercially available PCR amplification kits, 
allows validation and comparison with existing data sets and is capable of being integrated 
easily into laboratory routine. Cost-effectiveness is especially important when using these 
costly commercially available PCR amplification kits and most economic when applying the 
highly priced and costly multiplex STR DNA profiling kits. 
Generally, the applicability of blood on a chip seems to be easier when using a planar open 
processing surface, like the virtual reaction chamber concept. For most cavity- and channel-
based lab-on-a-chip systems it is hard to accept whole blood as crude sample material for 
analysis, and thus a lot of pre-purification steps were necessary to make blood samples chip-
compatible. Another promising approach for blood analysis on a planar chip including 
purification, cell separation and PCR amplification, was introduced by Pipper J et al. (2007). 
Superparamagnetic particles were utilized for sample tracking and DNA amplification was 
performed using virtual reaction chamber low-volume PCR in a clockwork lab-on-a-chip 
principle. However, here blood purification was included prior to PCR analysis. As shown in 
the previous experiments described here, PCR amplification on a planar chip can be 
performed much easier. When just a small amount of blood is applied to reactions (like e.g. 
1% blood (v/v)) and an appropriate DNA polymerase is used, more resistant to inhibiting 
effects related with whole blood, labor-intensive purification procedures can be circumvented 
and eliminated, speeding up reaction performances. 
5.3  Nanotechnological analysis of ancient bone tissue material 
The best opportunity to validate the capability of a PCR system is to test for a highly sensitive 
analysis on low-copy number sample material (LCN). LCN samples are generally defined as 
samples having a very low amount of amplifiable DNA material, generally less than 100 pg 
like e.g. single cells comprising about 7 pg of DNA target material, as well as samples 
containing degraded DNA. DNA degradation means fragmentation of DNA strands due to 
environmental influences, preparative sample treatment steps or simply age dependent effects 
on the DNA material. LV-PCR analysis was performed on ancient bone tissue material 
originating from Egyptian mummy material. This kind of sample material was definitively 
expected to be affected by several DNA degradation events, qualifying it perfectly as 
„difficult-to-analyze“ sample material to determine the potential of LV-PCR for sensitive 
analysis on pathological relevant material. However, LV-PCR analysis was applied on 
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purified mummy DNA material after DNA extraction, which was performed off-chip, due to 
complexity of DNA extraction from hard sample materials like bone tissue. 
The study of ancient DNA plays an important role in archaeological and palaeontological 
research as well as in pathology and forensics. Molecular archaeology, which was first 
described in the early eighties, is a particularly promising emerging archaeometric discipline 
for dealing with molecular biological analyses of human remains (Pääbo S, 1985). For 
instance, sex determination of human findings can easily be defined using small amounts of 
remains such as bones and teeth via i.e. polymerase chain reaction (PCR) (Hummel S and 
Herrmann B, 1991; Faerman M et al., 1995; Faerman M et al., 1997). For a significant 
genetic analysis usually 1 to 2 grams of bone or tooth material are adequate. This material is 
purified and pulverized, and ancient DNA (aDNA) is then chemically extracted. Here, the co-
extraction of humic acids, these are organic compounds originating from the soil, being 
present in soil buried bones and teeth, and having the same chemical characteristics as DNA 
can cause a problem inhibiting enzymatic reactions like PCR (Goodyear PD et al., 1994). 
Various ancient DNA extraction methods are currently in use, which rely on different 
principles like spin column, alcohol precipitation or silica binding. All of these methods aim 
to maximize DNA yields, while minimizing the co-extraction of PCR inhibitors. No single 
method has been shown to outbalance the others therefore no standardized procedure exists so 
far. 
Microdissection techniques, performed on tissue structures from histological preparations, 
enable the precise manipulation and isolation of genetic material in the range of several 
micrometers (Greulich KO and Leitz G, 1994; Thalhammer S et al., 2004). These techniques 
can be combined with subsequent analysis of DNA in these microdissectants. Several 
dissection techniques such as extraction via glass needle (Weimer J et al., 2001), laser capture 
(Simone NL et al., 1998), laser pressure catapulting (Thalhammer S et al., 2003), laser 
impulse (Kirschner J and Plaschke-Schluetter A, 2007) or via gravity effects (Di Martino D et 
al., 2004 (a+b)) are commonly in use. Recently, we could introduce the novel LOC-related 
technique based on the combination of laser microdissection and low-pressure technology 
(Woide D et al., 2009). This technique enabled gently controlled extraction and horizontal 
transfer of a smallest amount of isolated material.  
The reduction in target material requires an additional enhancement of analysis sensitivity, 
which can be achieved by reducing the reaction volume of PCR reactions (Gaines ML et al., 
2002; Kricka LJ and Wilding P, 2003; Leclair B et al., 2003). It is believed that this enhanced 
sensitivity may result from the better contact between primer or polymerase molecules and 
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the DNA because the overall amount of DNA is less diluted than in a higher volume (Proff C 
et al., 2006; Schmidt U et al., 2006). Thus, using low-volume PCR (LV-PCR) technology in 
combination with the laser-based DNA extraction method, offers the opportunity to further 
reduce the amount of DNA starting material needed while retaining sensitive genetic analysis. 
DNA of four mummy samples was extracted in two independent approaches, where a novel 
laser microdissection-based method was highlighted compared to a conventionally used 
extraction technique. Main results concerning target DNA amount as well as PCR 
amplification were summarized in table 8. Laser microdissection, SPATS transfer and LV-
PCR were applied on mummy material, presenting a pathological applicability of the modular 
lab-on-a-chip system. The contamination-free performance comprised extraction of smallest, 
best preserved amounts of paraffin-embedded bone particles via laser microdissection and 
subsequent gentle low-pressure mediated transfer of particles into PCR-tubes containing 
DNA extraction buffer. The amount of microdissected DNA was checked via real-time PCR. 
This laser-based DNA extraction method was compared to a conventional DNA extraction 
technique used in pathology, operating with pulverization of whole bone tissue pieces. 
Extracted DNA amounts of pulverized samples were detected by UV spectrophotometry. 
After DNA extraction, amelogenin and β-actin fragments were amplified using LV-PCR to 
check DNA quality and preparation-dependant PCR efficiency of both DNA extraction 
methods. For validation of results, sequencing was performed on microdissected PCR 
products as well as DNA typing via STR fragment length analysis. Thus, possible DNA 
contamination of mummy sample material with recent DNA originating from scientists or 
else could clearly be excluded. 
DNA extraction. In our laboratories, strict precautions were taken during all molecular 
genetic analysis minimizing the hazard of amplifying contaminating modern DNA in ancient 
specimens, and controls performed at all steps were consistently negative. Based on the 
results of DNA typing analysis, we were able to widely exclude contamination and cross-
contamination of the ancient bone samples. Ancient DNA could successfully be extracted out 
of pulverized mummy bone material via DNA precipitation (Zink A et al., 2003). DNA 
extraction using 1 g of pulverized bone tissue material of each mummy sample revealed DNA 
amounts of 2.1-10.0 ng/µl, as measured via UV spectrophotometry. For the laser 
microdissection-based approach, nested isolation of bone tissue pieces was performed (figure 
40 A) to reduce the risks of external contaminating effects. After paraffinization, microtome-
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cuts of paraffin-embedded bone tissue slices were prepared on PEN-membrane coated object 
slides (figure 39).  
Several single osteon islets comprising 150 to 350 µm in diameter could successfully be 
isolated out of mummy bone tissue via laser microdissection (figure 40 B). 
 
Figure 39. Preparation of mummy sample material for laser microdissection. Nested bone tissue pieces 
were paraffin-embedded and paraffin blocks were cut to 3-5 µm thin slices. Microtome-cut slices were mounted 
onto PEN-carrier membrane coated object slides and were applicable for laser microdissection after 
deparaffinization. The images show paraffin-embedded tissue blocks and microtome-cut tissue slices of A) 
mummy1, B) mummy2, C) mummy3 and D) mummy4. 
Tissue material was taken exclusively from the inner parts of the bone tissue slices for 
subsequent conventional DNA extraction. Thus, tissue pieces were pooled from several 
sections in order to enrich the material. Osteons, about 50 to 500 µm in diameter, are 
composed of concentric layers of mineralized matrix surrounding a Haversian canal, which is 
20 to 150 µm in diameter. Particle transfer was mediated via the low-pressure operated 
SPATS device, and sample material was released directly into a small amount of DNA 
extraction buffer (figure 40 C-F). Numerous blank extraction controls, containing PEN 
carrier-membrane but no tissue sample material, were processed in parallel and were 
consistently negative. 
 
Figure 40. Preparation and collection of smallest amounts of target material from ancient bone tissue. A) 
For sample extraction, the outer surface was removed from bone material and tiny tissue blocks were prepared 
out of the inner bone tissue parts (arrow). B-F) Workflow of bone particle isolation as performed in the laser-
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based extraction method. The isolated particle could be tracked along the entire isolation and transfer process. B) 
Laser microdissection-based isolation of an osteon bone particle comprising 300 µm in diameter. The laser cut, 
isolating the osteon particle from its surrounding, was marked by an arrow. C) SPATS mediated sample take-up 
is shown, where isolated bone material was adsorbed to a collection grid via applied low-pressure technology. 
D) The sample extraction area after successful particle isolation is displayed. E) Release of the low-pressure 
transferred particle into a 0.2 µl droplet of lysis solution. F) Magnification of the isolated and released bone 
particle. 
Due to the fact that osteons consist to the greatest extent of concentric layers of mineralized 
matrix and that the Haversian canal enclosed forms just a minor part, the DNA amount 
extracted from microdissected mummy osteon material was approximately 60 pg of DNA 
present in 1 µl of extracted mummy sample material, as revealed via real-time PCR (figure 
41). Real-time PCR was performed on sample mummy4, exemplarily for all of four mummy 
samples. Simultaneously, standard concentrations of 5 ng, 1 ng, 500 pg, 100 pg, 50 pg and  
20 pg were co-amplified as reference DNA concentrations. For validation of amplification 
results of mummy4, its amplification plot was related to the plots of standard DNA 
concentrations (figure 42).  
 
Figure 41. Amplification plots of real-time PCR performed on microdissected mummy DNA. 
Amplification plots of RT-PCR analysis of sample mummy4 compared to cycled standard concentrations of  
5 ng, 1 ng, 500 pg, 100 pg, 50 pg and 20 pg of human genomic reference DNA. The graphs show the cycle 
number from cycle 1 to 40 plotted against fluorescence intensity from 0 dRn to 0.8 dRn. The plot of mummy4 
clearly revealed a DNA starting amount between 50 pg and 20 pg DNA, as located between these two standard 
curves. Negative control represents a reaction where no input DNA was present during RT-PCR cycling. 
The exact DNA concentration of sample mummy4 was detected via standard curve, plotting 
the initial DNA quantity to the particular Ct-value of each amplification curve (figure 42). 
The Ct-value is described as the value, at which the DNA concentration in the RT-PCR 
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reaction mix reached an amplification threshold. Higher starting concentrations reach this 
threshold earlier than lower ones. Thus the Ct-value can be taken as measure for initial DNA 
concentrations, when reference specimens are present. Data analysis revealed the following 
Ct-values of 1 µl of reference DNA concentrations, as plotted in the standard curve:  
30.83 dRn for 1 ng, 32.20 dRn for 500 pg, 34.81 dRn for 100 pg, 35.22 dRn for 50 pg and 
35.89 dRn for 20 pg. For sample mummy4 a Ct-value of 35.82 dRn was obtained, 
representing a DNA amount of 29.41 pg. As only 0.5 µl of mummy4 DNA were applied to 
the real-time PCR, data analysis revealed a DNA amount of 29.41 pg present in 0.5 µl of 
extracted mummy material. When translating these results to 1 µl of extracted microdissected 
mummy material, this meant a final DNA concentration of about 60 pg present in 1 µl of 
extracted microdissected DNA material of mummy4. 
 
Figure 42. Standard curve of real-time PCR analysis. Initial DNA concentrations of human genomic 
reference DNA samples were plotted against measured Ct-values [dRn]. The standard curve of RT-PCR analysis 
revealed an extraction amount of approximately 60 pg DNA present in 1 µl of extracted microdissected mummy 
material. 
Amplification of β-actin and amelogenin gene fragments using low-volume PCR. DNA 
amplification experiments were performed using low-volume PCR in 1 µl total reaction 
volume covered with 5 µl of mineral oil. The reliability of this method was 90-95%, apart 
from 1-2 reaction batches out of about 20. These reactions were accidentally destroyed by 
bubbling reaction mixes, which might be due to evaporating gas bubbles present in the 
aqueous master mix. This was either caused by too extensive mixing of reagents or by inferior 
surface chemistry of the slides. Amplification was performed on 106/112 bp fragments of the 
amelogenin gene for gender determination, as well as on a larger fragment of the human β-
actin gene comprising 297 bp. DNA was extracted from each of the four mummy samples at 
least twice in separate preparations. Each mummy DNA extract was tested at minimum of 
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five to eight times via PCR for amplifiable β-actin and amelogenin gene fragments. Amplified 
gene fragments were rated as reproducible and authentic only after a) five PCR reactions 
showed consistent fragment determination, b) this result could be reproduced in another 
extract from the same mummy sample and c) all controls were negative. 
a) LV-PCR amplification of pulverized samples. When amplifying small gene fragments of 
106/112 bp of the amelogenin gene, two out of the four mummy samples revealed a 
successful amplification of sex specific fragments (table 8). While samples mummy3 and 
mummy1 showed no positive PCR products (figure 43 C and D), sample mummy2 revealed 
female specific 106 bp fragments (figure 43 A) and sample mummy4 revealed male specific 
fragments of 106 bp respectively 112 bp in size (figure 43 B). Amplification of a 297 bp 
fragment of the β-actin gene was less successful. Despite repeated efforts, samples mummy1 
and mummy4 revealed inconstant positive amplification products, while mummy2 and 
mummy3 revealed no positive amplification product at all (table 8). Sample mummy1 
showed an amplification rate of about 2:4, revealing a positive β-actin PCR product in two 
out of six reactions. The amplification rate of sample mummy4 was about 1:5, having just one 
positive PCR product in six reaction batches. All extraction and PCR negative controls 
including lysis mix, PEN supporting membrane, H2O control and the PCR master mix 
containing no DNA, were consistently negative (figure 43). 
b) LV-PCR amplification of microdissected samples. Microdissected samples mummy1-4 
were tested for the existence of amplifiable nuclear DNA, in respect to isolated osteon islets, 
comprising a very minute tissue amount of just a few micrometers (corresponding to 1 to  
5 µg) compared to standard amounts of 1 to 2 g of bone tissue material. All of four mummy 
samples revealed successful amplification products of 106/112 bp male and female 
amelogenin fragments (table 8). While samples mummy2 and mummy1 showed female  
106 bp segments (figure 43 A and D), samples mummy4 and mummy3 produced male 
segments of 106 bp and 112 bp (figure 43 B and C). Concerning the larger 297 bp segment 
of the human β-actin gene, in each approach human β-actin fragments could successfully and 
constantly be amplified and detected in each of the microdissected samples mummy1-4 
(figure 43; table 8). All extraction and PCR negative controls like lysis mix, PEN supporting 
membrane, H2O control and PCR master mix, containing no DNA, were consistently negative 
in all cases (figure 43). 
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Figure 43. Polyacrylamide gel electrophoresis data of isolated and via LV-PCR amplified mummy DNA. 
Four different mummy samples were examined. PCR was performed on fragments of the human gene β-actin 
(297 bp) and the sex specific amelogenin gene (female specific 106 bp fragment, male specific 106/112 bp 
fragments). M: 100 bp molecular length standard (PeqLab Biotechnologie GmbH, Erlangen, Germany). A) LV-
PCR results of sample mummy2. Lane 1: ∼60 pg female mummy2 DNA (amelogenin PCR, laser 
microdissection-based DNA extraction method); lane 3: 50 pg female mummy2 DNA (amelogenin PCR, 
conventional DNA extraction method); lane 5+6: 100 pg female and male human reference DNA (amelogenin 
PCR, positive control); lanes 2, 7, 4, 8: PEN carrier membrane, lysis buffer, PCR master mix and H2O control 
(amelogenin PCR, negative controls); lane 9: ∼60 pg mummy DNA (β-actin PCR, laser microdissection-based 
DNA extraction method); lane 10: PCR master mix (β-actin PCR, negative control). B) LV-PCR results of 
sample mummy4. Lane 8: ∼60 pg male mummy4 DNA (amelogenin PCR, laser microdissection-based DNA 
extraction method); lane 7: 100 pg male mummy4 DNA (amelogenin PCR, conventional DNA extraction 
method); lane 2+3: 100 pg male and female human reference DNA (amelogenin PCR, positive control); lanes 6, 
5, 4, 1: PEN carrier membrane, lysis buffer, PCR master mix and H2O control (amelogenin PCR, negative 
controls); lane 9: ∼60 pg mummy DNA (β-actin PCR, laser microdissection-based DNA extraction method); 
lane 10: PCR master mix (β-actin PCR, negative control). C) LV-PCR results of sample mummy3. Lane 2: 
∼60 pg male mummy3 DNA (amelogenin PCR, laser microdissection-based DNA extraction method); lane 1: 
100 pg male mummy3 DNA (amelogenin PCR, conventional DNA extraction method); lane 7+8: 100 pg male 
and female human reference DNA (amelogenin PCR, positive control); lanes 3, 4, 5, 6: PEN carrier membrane, 
lysis buffer, PCR master mix and H2O control (amelogenin PCR, negative controls); lane 9: ∼60 pg mummy 
DNA (β-actin PCR, laser microdissection-based DNA extraction method); lane 10: PCR master mix (β-actin 
PCR, negative control). D) LV-PCR results of sample mummy1. Lane 5: ∼60 pg female mummy1 DNA 
(amelogenin PCR, laser microdissection-based DNA extraction method); lane 4: 100 pg female mummy1 DNA 
(amelogenin PCR, conventional DNA extraction method); lane 1+2: 100 pg male and female human reference 
DNA (amelogenin PCR, positive control); lanes 6, 8, 7, 3: PEN carrier membrane, lysis buffer, PCR master mix 
and H2O control (amelogenin PCR, negative controls); lane 9: ∼60 pg mummy DNA (β-actin PCR, laser 
microdissection-based DNA extraction method); lane 10: PCR master mix (β-actin PCR, negative control). 
Table 8. Summary of the compared DNA extraction methods and results of LV-PCR amplification. The 
preparation part shows a comparison of the standard extraction method and the novel microdissection-based one 
in relation to the extraction amounts of the ancient material. The analysis part presents a summary of the 
obtained aDNA LV-PCR results according to the applied extraction method. The nested paraffin-embedding 
procedure combined with most precise material extraction made the working performance highly sensitive, 
reducing contaminations compared to the traditional method using pulverized whole bone tissue pieces. 
 
Sample Preparation Analysis 
 Starting amount of 
sample material for 
DNA extraction 
DNA concentration 
after extraction 
procedures 
Fragment amplification via low-volume PCR 
on chemically structured object slides 
Laser-based DNA 
extraction method  
(∼60 pg of target DNA 
present in 1 µl total 
reaction volume) 
Powder-based DNA 
extraction method  
(50-100 pg of target 
DNA present in 1 µl 
total reaction volume) 
 
Laser-
based 
DNA 
isolation 
method 
Powder-
based 
DNA 
isolation 
method 
Laser-
based 
DNA 
isolation 
method 
Powder-
based 
DNA 
isolation 
method amelogenin 
106/112 bp  
β-actin 
297 bp 
amelogenin 
106/112 bp 
β-actin 
297 bp 
Mummy1 female + - +/- (2:4) 
Mummy2 female + female - 
Mummy3 male + - - 
Mummy4 
Several 
150-350 
µm 
osteon 
islets 
1 g of 
bone 
powder 
∼ 60 
pg/µl 
2.1 – 
10.0 
ng/µl 
male + male +/- (1:5) 
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c) Performance on LOC chips. Comparable to amplification reactions performed on the multi 
LV-PCR microdevice, LV-PCR has been performed on LOC chips as well. Amelogenin PCR 
has been performed on extracted microdissected material of sample mummy4. Fragments of 
amelogenin gene amplification could successfully be detected via PAAGE (figure 44), 
verifying sample mummy4 to originate from a male individual as 106/112 bp fragments were 
obtained.  
 
Figure 44. PAAGE image data of LOC chip-performed LV-PCR amelogenin amplification of sample 
mummy4. M = molecular length standard (ReddyRun Superladder-low 100 bp ladder, Thermo Scientific, 
ABgene, Epsom, Surrey, UK). A) Overview of PAAGE data. No contaminating bands were detected, no side 
products and no genomic DNA smear, accounting for a highly sensitive analysis. Solely the molecular length 
standard showed a bad run having thick and split marker bands. B) Closeup view of obtained gender determining 
PCR products. Clear bands were detected. Lane 1: 100 pg human genomic male reference DNA showing male 
characteristic 106/112 bp fragments (performed on multi LV-PCR microdevice); lane 2: 100 pg human genomic 
female reference DNA showing female characteristic 106 bp fragments (performed on multi LV-PCR 
microdevice); lane 3: negative control (performed on multi LV-PCR microdevice); lane 4: 60 pg male DNA of 
sample mummy4 showing male characteristic 106/112 bp fragments (performed on LOC chips). 
Sequencing of PCR products from a microdissected mummy sample. Sequencing analysis 
was performed on amelogenin and β-actin PCR products, amplified from the microdissected 
male mummy sample mummy4, exemplarily for all of four mummy samples. Sequencing 
results were aligned to human nucleotide sequences, recalled from the human genomic 
database of NCBI (www.ncbi.nlm.nih.gov). Sequencing 106/112 bp amelogenin PCR 
products showed sequence identities to amelogenin loci of 90% for the Y-fragmental 
sequence and 97% for the X-fragmental sequence. Sequencing the 297 bp β-actin PCR 
product showed sequence identities to the β-actin data of 96-98% (figure 45). Via the 
sequencing analysis, successfully the authenticity of PCR products could be verified. False 
positive PCR products originating from suboptimal PCR conditions as well as external 
contamination of extracted ancient DNA could clearly be excluded. 
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Figure 45. Sequencing results of β-actin fragments amplified from sample mummy4. Amplified 297 bp 
long fragments were sequenced from both sites using both primers, and were named sequence 1 and sequence 2. 
Sequence alignments were investigated using the particular operation at www.ncbi.nlm.nih.gov, housing 
references sequences of a huge amount of human genes. 
Typing mummies and scientific staff. To further verify absent external contamination of 
extracted aDNA, which might have been caused by people having been in close contact with 
any kind of mummy material, DNA typing was performed in two independent approaches. 
DNA typing reactions were accomplished using heterozygotic marker loci on extracted 
mummy material as well as genomic DNA of archaeologist/excavator, technical assistance 
staff, laboratory members and involved scientists, simply all people who have been 
knowingly in contact with laboratory equipment and consumables and any kind of mummy 
material used. In the following these typed individuals are referred to as ‘scientific staff’. For 
DNA profiling analysis, particularly mummy DNA originating from the laser 
microdissection-based DNA extraction method was used. DNA typing experiments were 
performed by STR marker analyses using three selected heterozygotic STR markers 
D7S1824, D9S302, D10S2325 and in addition the AmpF/STR SEfiler PCR amplification 
kit on all mummy samples, all people who worked in the laboratory and those who have been 
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in contact with examined bone samples, paraffin-embedded tissue blocks, tissue slides, 
laboratory working places and laboratory working tools like optical inverted microscope, 
DNA extraction equipment and PCR thermocyclers. Hereby, the focus was not on typing 
mummy material perfectly, but rather on obtaining allelic profiles of involved scientific staff 
for excluding extraneous contamination of mummy material. 
Typing via selected three heterozygotic STR markers D7S1824, D9S302 and D10S2325 
provided very usable results on typed scientific staff’s DNA material (figure 46 A). PCR 
analyses revealed mostly heterozygotic marker fragments, which could reliably be used for 
DNA typing as no allelic or loci drop out could be detected. On the contrary, typing mummy 
DNA material revealed just scattered marker peaks and none whole typing profile (figure 46 
B). As only 2 or 3 peaks were detectable, allelic and loci drop out effects were clearly visible, 
making a reliable DNA profiling analysis impossible. However, as these sparely detected 
peaks and thus the fragment’s lengths did not match any of the scientific staff’s genetic 
profile, cross-contamination could definitely be excluded. 
 
Figure 46. Genotyping performed via heterozygotic STR markers D7S1824, D9S302 and D10S2325. 
GeneScan 3.7 software electropherograms showing the PCR amplification results for the three STR loci 
selected and analyzed on an ABI PRISM 3130 XL Genetic Analyzer. A) Genotyping laboratory members as 
well as involved scientists, archaeologist/excavator and technical assistance staff, named “scientific staff 1-8”. 
B) Genotyping ancient mummy material, which was obtained through the laser microdissection-based DNA 
extraction method. 
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Typing present DNA material of scientific staff via the AmpF/STR SEfiler PCR 
amplification kit also produced usable results in all 12 STR loci, whereas mummy DNA 
material could just severely be typed (figure 47). Allelic profiles of scientific staff again 
showed no allelic drop out or loci drop out effects, but clear and unsoiled STR marker peaks, 
several hundred rfu in height, indicating reliable individual allelic genetic profiles obtained. 
Mummy material revealed just partly allelic profiles, accompanied with a lot of allelic and 
loci drop out events, while peak heights were consistently close to or even below the 
validation threshold of 50 rfu. Incomplete mummy typing profiles might be due to the very 
low amounts of mummy target DNA available and used for analyses. However, in amplifying 
also an amelogenin marker, at least the AmpF/STR SEfiler kit confirmed the determined 
genders of mummy samples. 
 
Figure 47. Except of DNA typing analysis using a multiplex STR PCR amplification kit. Peak data of seven 
out of 12 amplified STR marker loci are shown. Genotyping of ancient mummy material as well as 
archaeologist/excavator and most relevant involved scientists (named “scientific staff 1, 6, 8”) is shown, 
performed via the AmpF/STR SEfiler PCR amplification kit. Genotyper 3.7 software electropherograms 
showing an except of the AmpF/STR SEfiler PCR amplification kit results for six STR loci and the 
amelogenin locus analyzed on an ABI PRISM 3130 XL Genetic Analyzer. 
In these two autonomous DNA profiling approaches, external contamination could explicitly 
be excluded. As a result, we were able to widely exclude contamination and cross-
contamination of the ancient bone samples. Despite we did not obtain full allelic profiles from 
mummy sample material, the most important information obtained by those typing 
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experiments was that no cross-contamination was detectable at all. As shown by these results, 
typing of all people who have been in contact with mummy material worked quite fine and 
gave reliable results. Every DNA typing profile was individual and every marker peak 
combination was unique among all tested scientific staff and mummy samples (figure 46 and 
figure 47). As no peak combination of present material could clearly be detected in mummy 
typing profiles (table 9), contamination of ancient mummy samples by recent DNA of 
scientists, archaeologist, technical assistance staff and laboratory members could be 
eliminated successfully. Typing results received from mummy material clearly showed that 
cross-contamination from people involved in experiments did not occur and thus could widely 
be excluded. 
Table 9. DNA profiling. Results of typing DNA of mummy material compared to scientific staff’s genomic 
material. Characteristic fragment sizes of amplified STR markers are shown. 
 
 
DNA profiling using STR 
markers 
D7S1824  D9S302  D10S2325 
DNA profiling of several STR fragments using the 
AmpF/STR SEfiler PCR amplification kit: 
D3S1358 vWA D16S539 D2S1338 A D8S1179   SE33 
Scientific staff 1 116/148    180/188      258/314 17/ -        16/17      11/ -       19/25    X    14/15   29.2/32.2 
Scientific staff 2 126/131    188/200      238/254 - 
Scientific staff 3 126/136    168/172      263/267 - 
Scientific staff 4 116/131    171/176      262/266 - 
Scientific staff 5 131/136    163/200      273/281 - 
Scientific staff 6 142/153    167/188      262/ - 16/18      17/18       9/11       21/24   XY  12/ -       18/28.2 
Scientific staff 7 121/148    167/175      297/305 - 
Scientific staff 8 131/136    167/188      267/271 14/17      17/18       9/12       17/18   X     13/14  26.2/28.2 
Mummy1     - / -           - /179      270/ -   - / -       15/18       12/ -         - / -    X       - / -         - / - 
Mummy2     - /164    180/ -         270/ -   - / -       16/ -          - / -         - / -    X       - / -         - / - 
Mummy3 142/ -           - / -             - /313 17/ -         - / -          - / -         - / -    XY    - / -         - / - 
Mummy4     - / -           - /198      270/ -   - / -       18/ -          - / -         - / -    XY    - / -         - / - 
To enhance our analysis sensitivity, all aDNA PCR analyses were performed by virtual 
reaction chamber low-volume PCR, using 1 µl total reaction volume. One can easily imagine 
that there is a much higher impact probability between reactants and DNA template enclosed 
in small volume assays (1 µl) than in macroscopic samples like e.g. in 25 µl standard reaction 
volumes. Using this low-volume PCR method further enabled us to significantly reduce the 
starting amounts of extracted ancient DNA sample material needed for PCR reactions. This is 
an important reason for using virtual reaction chamber lab-on-a-chip systems dealing with 
reaction volumes in the micro- and nanoscopic range. As plastics were identified as potential 
sources of bioactive environmental contaminants, it will be an advising step to depart from 
plastic PCR-tubes to analysis devices fabricated of modified glass substrates. Moreover, it 
was also reported that processing agents from laboratory plastic ware could be leaking into 
biological media and solvents, particularly during storage (McDonald GR et al., 2008). Due 
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to these criteria, PCR-tubes, even when declared as “sterile”, were assumed to contain 
leaching agents and facilitate contamination of PCR reactions when heated. However, as 
reported several times, working with aDNA originating and extracted from soil buried bones 
and teeth is by itself associated with problems like low DNA quantity, high DNA 
degradation, the presence of PCR inhibitors and most importantly DNA contamination 
(Primorac D et al., 1996; Alonso A et al., 2001).  
Extraneous contamination can arise from adjacent treatments such as the handling of the 
remains by excavators and laboratory staff, airborne contaminants and contaminants present 
within laboratory reagents or on consumable items (Tuross N, 1994). Soil type and microbial 
community characteristics can adversely affect DNA recovery (Zhou J et al., 1996). The total 
DNA extraction from soil entails co-extraction of humic substances, mainly humic acid, as 
well as DNA originating from external organisms like bacteria and fungi (Tsai YL and Olson 
BH, 1992; Tebbe CC and Vahjen W, 1993; Kreader CA, 1996; Zhou J et al., 1996). These 
interferences can provide false-negative results in case of PCR inhibition (Zhou J et al., 1996; 
Zipper H et al., 2003) or false-positive ones (like non-specific products) in case of 
contamination, greatly reducing the information, which can be attained.  
The expansive variety of DNA extraction techniques being employed (as reported by 
Anderung C et al. (2008) and Rohland N and Hofreiter M (2007)), highlights that all of these 
procedures are affected by the problems and limitations concerning DNA quality, quantity 
and co-extracted PCR inhibitors as mentioned above. As an effort to minimize these 
interfering troubles as efficiently as possible, in the present study the surface of bone tissue 
sample fragments was carefully decontaminated. First by chemical cleaning with DNA-
degrading sodium hypochlorite, which was followed by a mechanical removal of the outer 
layers of the bone fragments before sample processing procedures. However, post mortem 
contaminations can hardly be removed completely as reported by Gilbert MTP et al. (2005 
and 2006). Nevertheless, there seems to be a significant correlation between the sector of 
extraction, outer versus inner sectors of bones, and the amount of DNA present in resulting 
samples (Kaiser C et al., 2008). The outer sectors, adjacent to the soil, were shown to have 
higher DNA concentrations than the inner ones, due to the presence of bacteria and fungi 
DNA. Furthermore, it was shown that the localization within the bone piece influences its 
degree of degradation. This is the result of varying degrees of protection against destructive 
environmental influences like temperature, humidity, pH and the geochemical properties of 
the soil including presence of microorganisms, UV irradiation and radioisotopes (Burger J et 
al., 1999). Since the outer surface is significantly more influenced by the direct contact to the 
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environmental soil, DNA is best preserved in the inner part of bones (Kaiser C et al., 2008). 
Based on laser microdissection of internal bone areas, the present study thus introduced a 
promising method for contamination-reduced bone tissue particle isolation and subsequent 
aDNA extraction. With respect to extracted aDNA quality, the grade of DNA degradation, 
and interfering destructive factors, the laser microdissection-based approach significantly 
excelled the traditional method. While the current DNA extraction operating procedure used 
whole bone tissue particles for pulverization and subsequent DNA extraction, the laser-based 
method concentrated on internal bone areas including osteon systems. The focus of bone 
particle isolation was on tissue areas containing these osteon systems in order to isolate 
fragments with the highest probability of preserved vascular cell material. Thus, several 
osteon areas were microdissected exclusively from the inner parts of the bones where surface 
contamination and inhibitor influences were least possible to occur. Despite higher DNA 
recovery and extraction rates in the classical extraction methods, the DNA quality was 
supposed to be considerably worse. This was most likely caused by present interfering 
substances and less authentic DNA provided by the pulverization method. For the higher 
DNA amount was little informative about the source of DNA and provided probably a 
mixture of desired mummy DNA and DNA of bacterial and fungal origin. In contrast, the 
advantages of the laser microdissection-based technique included a) minimization of 
contamination during handling of specimens, b) sample extraction exclusively from internal 
bone parts with a minimization of degradation effects and co-extraction of inhibiting 
substances and c) a reduction in the amount of starting material down to single osteon islets 
allowing maximum preservation of ancient material. 
X- and Y-chromosomal amelogenin fragments of 106/112 bp in length as well as a 297 bp-
sized fragment of the human multicopy gene β-actin were amplified by LV-PCR. In 
amplification reactions, particular attention was paid to the quality of extracted DNA, 
including possible effects of degradation or PCR inhibitors. In microdissection-based mummy 
samples, the amplification of amelogenin gene as well as β-actin gene fragments resulted in 
reproducible, constantly positive PCR products using only about 60 pg of DNA starting 
material (figure 43). When amplified on LOC chips instead of a multi LV-PCR microdevice, 
mummy DNA could successfully be detected as well in a reliable manner (figure 44). This 
successful amplification clearly qualified the complete lab-on-a-chip system for a reliable 
applicability on highly sensitive and „difficult-to-analyze“ sample material like e.g. necessary 
in the pathological research area. In contrast, PCR results of samples based on pulverized 
bone tissue showed just 50% success in amplifying amelogenin gene fragments (mummy2 
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and mummy4; figure 43 A and B) and no reliable positive amplification products for β-actin 
fragments using 100 pg of DNA starting material. These lower yields of PCR products may 
be due to poorer DNA quality, consistence or state because of degradation effects. Taking into 
account that also primer dimerization occurred during PCR, the failing amplification may 
more likely be attributed to DNA degradation than to present inhibiting substances. 
Moreover, here, especially the inconsistent amplification of 297 bp β-actin fragments was in 
agreement with a general amplification limit discussed for aDNA. Propagating amplification 
fragments longer than 200 bp are very unlikely due to degradation processes (Pääbo S, 1989). 
Here, amplification success correlated negatively with the length of the amplicon. This was 
supposed to be the result of contaminating outer bone layers, where extensive DNA 
degradation could have occurred. However, this larger β-actin fragment could be amplified 
reliably in microdissection-based samples, where the analyzed bone segments originated from 
the more preserved inner part of bone particles. 
Furthermore, sequencing of amelogenin and β-actin PCR products was performed on one 
male microdissection-based mummy sample (mummy4). This enabled us to confirm authentic 
PCR products and eliminate possible false positives, which may indeed show the right lengths 
of the wanted amelogenin and β-actin fragments while presenting a different sequence of 
DNA base pairs. Analysis of the sequencing data for both the 106/112 bp X- and Y-
chromosomal amelogenin fragments and the 297 bp β-actin fragment definitively identified 
them as human amelogenin and β-actin sequences once aligned to gene sequences from the 
human genomic database of NCBI (figure 45). Furthermore, sequencing results were also 
important to invalidate the possibly occurring phenomenon of jumping PCR, induced by 
damaged template DNA and resulting in the production of a chimeric sequence, as first 
reported by Pääbo S et al. (1990). Thus, via sequencing, the authenticity of the amplified 
DNA could be confirmed. Both, the successful amplification of a fragment significantly 
longer than 200 bp and the successful sequence alignment results of β-actin gene fragments 
highlighted the advantage of laser microdissection for ancient material extraction. 
Overall, we always obtained higher yields of PCR products by using laser microdissected 
samples than by amplifying samples being extracted via the classical method. This may be 
attributed to a better DNA quality present in microdissected samples due to less exposure to 
degradation effects. These results implicated that isolation of tiny target tissue material by 
laser microdissection combined with standard kit DNA extraction methods was sufficient for 
aDNA extraction and successful amplification. Combined with low-volume PCR using planar 
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microdevices, our method enabled the amplification of minute amounts of laser-
microdissected material in extremely small reaction volumes. 
Results of analyzing ancient bone tissue originating from Egyptian mummy material strongly 
highlighted the combination of laser microdissection and low-volume PCR as a promising 
new technique in ancient DNA analysis. The combination of several modules of the lab-on-a-
chip like e.g. laser microdissection, SPATS transfer and LV-PCR provided a wealthy 
platform for highly sensitive genetic analysis with minimum risk of contamination. Ancient 
mummy DNA could successfully be amplified in a highly sensitive and reliable analysis, 
while the risk of contamination could dramatically be minimized due to the application of 
novel techniques and technologies. Macroscopically, contamination effects could be 
eliminated via intelligent nested sample preparation followed by highly precise laser 
microdissection-based material isolation. The benefit of the laser microdissection-based 
extraction method was the chance of exact sample extraction, directly from the more 
preserved inner parts where authentic ancient DNA was most possible to occur, while 
circumventing co-extraction of PCR inhibitors or external bacterial or fungal DNA, 
interfering strongly with PCR analyses. Microscopically, contamination events could be 
eliminated through the utilization of highly sensitive virtual reaction chamber low-volume 
PCR on chemically treated PCR microdevices. The presented nanotechnological approach 
provided an adequate tool for reliable and highly sensitive DNA analysis, ensuring the 
optimum use of limited evidence material. This approach could adapt the preparative and 
extraction procedures to the low amount of preserved ancient DNA, thus offering the 
possibility to increase the amount of extracted, less degraded and less contaminated, authentic 
genetic material and decreasing the effect of destructive factors. In this approach, for the first 
time isolation, amplification and detection of ancient DNA in smallest sample amounts 
circumventing pulverization could be demonstrated. This new tool for aDNA analysis, which 
overcame contamination problems, DNA degradation and the negative effects of PCR 
inhibitors while reducing the amount of starting target material in the picogram range, was 
presented in a paper (“PCR analysis of minimum target amount of ancient DNA”, Woide D et 
al., 2010). The reported clash of new fashion technologies with ancient sample material is a 
fascinating starting point for revolutionizing and optimizing archaeological research on 
ancient sample material while employing high fashion lab-on-a-chip technology. 
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5.4  Critical assessment of the analytical power of the lab-on-a-chip 
Diagnostic testing especially for the forensic research area has emerged a lot of analysis 
methods due to various forensic relevant problems. Of particular importance are diagnostic 
tests for genetic diseases, microbial and viral infections, forensic analyses like blood typing or 
blood banking, as well as forensic human DNA identification. Typical target materials in 
forensic and pathological analyses are soft materials like e.g. pieces of dermal tissue, blood 
spots or other dried body fluids like saliva or sperm, but also hard materials such as bones and 
teeth. Preparing these samples for laboratory analysis is labor-intensive, time- and cost-
consuming, particularly when handling hundreds of samples per day during routine laboratory 
work. Additionally, sample material is a valuable property and the amount of target sample 
material used for analysis needs to be reduced to a minimum to be utilized as economically as 
possible. The lowest amount, which is aimed to be used for analysis, is surely the DNA 
content of just one single cell, comprising about 7 pg target DNA material. Due to the scarcity 
of material available and possible material contamination, the most important thing in DNA 
analysis is a sensitive, reliable and unfailing performance, while excluding risks of 
contamination during sample handling. 
Based on the needs to be able to reproducibly and reliably handle, process and analyze 
microscopic amounts of sample material and due to the tendency of standard laboratory 
analysis to become “smaller”, “faster”, “cheaper” and “more sensitive”, µTAS are becoming 
more and more relevant to be the right platform serving these purposes and revolutionizing 
human genetic analysis. After a longer developmental period, nowadays, micro total analysis 
systems are on their way to reach a state of applicability. Miniaturization of analysis systems 
yields an enormous saving in time and cost in regard to parallelization, automatization, waste 
of test tubes and biochemical reagents. Automation can render analysis more economic and 
reliable, and a smaller reaction volume favors low material consumption and implies an 
enhanced analysis sensitivity and homogeneity of detection. Furthermore, designed as 
disposables, microdevices can circumvent possible sample-to-sample cross-contaminations.  
However, the majority of developed lab-on-a-chip microdevices is fixed to just one specific 
application and can accept only one kind of sample material, thus lacking flexibility. Lab-on-
a-chips, combining all sample processing steps on one single device, are technically most 
challenging. And if realized, up to now they consist of complex 3-dimensionally architectured 
integrated systems, fixed to just one particular biological problem and additionally struggling 
with too expensive fabrication and sales costs to be used as disposables. However, an 
integrated system holds the distinct advantage of minimal manual sample handling, thus 
5. Applications of the Lab-on-a-chip System in Forensic Sciences 
 
 
125 
decreasing the risk of possible cross-contaminations originating from laboratory sources. Due 
to complexity, lab-on-a-chip systems with “sample-in-answer-out” capabilities are up to now 
sparely reported in literature (Burns MA et al., 1998; Roper MG et al., 2005; Easley CJ et al., 
2006 (b); Lien KY et al., 2007). And with a few exceptions (Chen L et al., 2007; Zhang CS et 
al., 2006; Panaro NJ et al., 2005; Pipper J et al., 2007) most of the reported miniaturized 
devices for nucleic acid amplification are integrated stand-alone systems replacing only the 
role of a conventional PCR thermocycler. Additionally, they are based on template DNA, that 
has already been processed off-chip by using established bench-scale procedures.  
As especially the forensic research area is in the need of practical, time, costs, labor and 
material saving micro total analysis systems, here, a unique modular lab-on-a-chip system 
with “open” applicability was introduced. Due to its modular character, the lab-on-a-chip 
provided a broad range of sample processing applications performed on separate devices, 
including sample material isolation, DNA amplification as well as product detection. The 2-
dimensional architecture of the presented lab-on-a-chip system’s operating chip platform gets 
the user away from fixed applications being performed. Due to its open accessible chip 
surface, it was flexible in application and capable of accepting a broad range of biological 
input materials. Those were liquids ones, such as purified DNA material and also whole 
blood, as well as solid ones like e.g. crude sample material like fixed microdissected tissue 
particles. However, using hard sample material like bone tissue pieces still needed 
preprocessing steps performed off-chip, as those procedures for DNA extraction were highly 
specific and could not be done on the microscale yet. Anyway, this µTAS provides a 
promising platform of enabling nanotechnologies for the forensic field of research due to 
several reasons. 1) Due to the modular character, the whole system or at least parts of it can 
easily be integrated into laboratory routine. 2) Benefitting from a planar “open accessible” 
chip design, it can accept a wide variety of sample materials, which was never realized and 
reported in literature before. Loading the sample onto the chip can either happen via laser-
microdissection and SPATS transfer for solid sample materials or via the automatic 
dispensing device BioSpot for liquid sample materials. 3) As the analysis chip is separate 
from all modular equipment providing the technical support, it can simply be used as a 
disposable. The CytoCycler chip-holder itself houses all electronic devices for temperature 
support and SAW actuation. LOC chips can easily be replaced for analysis, eliminating cross-
contamination between reactions in subsequently performed operations. 4) PCR product 
detection can be performed by a variety of individually selectable detection methods. Open 
access is provided to sample material and PCR droplets at any time due to the open planar 
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surface design of the amplification unit. Thus, detection can be conduced either on-chip like 
e.g. via real-time PCR or array technologies, or even off-chip in electrophoresis-based 
techniques. 5) It is predestined to work free of contamination due to a) sample loading based 
on laser microdissection and SPATS transfer and b) performed low-volume PCR. Sample 
isolation via laser microdissection and contamination-free particle transfer via the low-
pressure operated SPATS device is an important tool for validating the presented lab-on-a-
chip system for being capable of highly sensitive analysis. Several contamination-free 
applications have been reported, like e.g. isolation and transfer of single cells (Woide D et al., 
2009; Mayer V et al., 2009) as well as soft tissue material and ancient bone material (Woide 
D et al., 2010). Blank and negative controls, of e.g. co-microdissected and transferred PEN 
carrier-membrane, also validated a contamination-free transfer process. Due to low-volume 
PCR, the lab-on-a-chip is operating small-scale reaction volumes, which were profitable as 
increasing analysis sensitivity while reducing the amount of input sample material needed. In 
utilizing virtual reaction chamber PCR, for reliable analyses only 25 pg of DNA input 
material were needed, and reproducible PCR performances were obtained using just smallest 
microdissected tissue particles or 1% of whole blood. In general, such planar virtual reaction 
chamber-based microdevices bear the highest chance for being integrated into laboratory 
routine. As droplet-based virtual reaction chamber PCR needs just an easy scale-down of 
biochemical protocols applied to benchscale systems (Mukhopadhyay R, 2006), this 
flexibility cannot be matched by chamber- or flow-through-based architectures (Daw R and 
Finkelstein J, 2006). And scaling reaction volumes down is especially important for cost 
savings when pricy PCR amplification kits are used. 6) Each module can be operated 
independently and integrated into laboratory routine apart from the other units, but most 
importantly, all modules can be combined together in a whole workflow-process, providing 
the basis for complete automation. Thus, the presented lab-on-a-chip comes very close to the 
scientific demands for a micro total analysis system, as being applicable for many kinds of 
sample materials, utilizing smallest sample amounts, providing highly sensitive PCR analysis 
and detection, while excluding any risk of external contamination during sample handling. 
All in all, the presented lab-on-a-chip presents a step forward towards a universal micro total 
analysis system. It fulfills key features like cost savings and enhanced analysis sensitivity in 
applying low reaction volumes and disposable microchips. Major drawbacks are surely the 
bulky devices needed for operating chip performances as well as no highspeed analysis times. 
Certainly, due to low-volume PCR reaction times were faster than those of conventional 
thermocyclers, but not comparable to heating methods other than a Peltier element, like e.g. 
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via IR heating. Additionally, reaction volumes used were still in the microliter range and not 
in the nanoliter range as realized in several other devices, reaching from 280 nl (Easley CJ et 
al., 2006 (a), down to 200 nl (Lagally ET et al., 2004; Guttenberg Z et al., 2005), 100 nl 
(Neuzil P et al., 2006 (b)), 40 nl (Matsubara Y et al., 2004; Matsubara Y et al., 2005), 33 nl 
(Morrison T et al., 2006), 29 nl (Koh CG et al., 2003), 3 nl (Liu J et al., 2003), 0.45 nl 
(Marcus JS et al., 2006) and astonishing 85 pl (Nagai H et al., 2001). However, up to now, 
there is no definitive correlation between PCR volume and e.g. PCR cycling time. Only chip 
architecture and the mode of heating can transform the advantages of small-volume reaction 
systems into fast temperature transition and thus rapid analysis times and more efficient PCR 
amplifications. Thus, the detected 5 sec minimal cycling time per PCR cycle step provides a 
good basis for a fast analysis. However, the presented lab-on-a-chip system was not 
developed for the purposes, to be the fastest or the smallest one, but rather to provide highest 
flexibility in performed analyses and applied sample materials instead. Though, the biggest 
drawback can be attributed to the single reaction center presented on the chip surface. The 
design of the chip surface must be updated to provide several reaction centers. This would 
render the analysis chip to be capable of performing several reactions in parallel, as most 
importantly negative and positive controls are on demand to be included on-chip. 
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6.  Conclusion and Outlook 
Due to its universal applicability, a modular lab-on-a-chip like the presented one could 
definitely provide solutions and gain value in the scientific fields dealing with highly sensitive 
analysis, like e.g. in cytogenetics, forensics, legal medicine and pathology. Especially the way 
of contamination-free sample isolation via laser microdissection combined with highly 
sensitive LV-PCR amplification using smallest amounts of sample material provide tools of 
high-resolution analysis for scientific relevant questions, like e.g application on the single cell 
level e.g. in cancer diagnostics. This system is worldwide unique in its modular design, there 
are no competitive devices on the market combining these techniques. As up to now most 
developed microdevice chips are dependent on the capability of accepting either prepurified 
or completely liquid sample materials, the presented convergence of high fashion lab-on-a-
chip technology with „difficult-to-handle“-scientific relevant sample material represented an 
important step towards sophisticated micro total analysis systems’ application.  
However, as the developmental focus is especially on automation, working speed and high 
mobility of the devices for providing on-site analysis, some improvements would support an 
even better performance. Up to now, there are integrated systems reported, providing even 
faster analysis times, possibilities for parallel processing as well as smallest chip architectures 
in total being capable of being used as fast on-site portable analytic system. However, no 
modular system has been reported up to now providing any of these features. In the presented 
modular system, PCR performance is fixed to the heating rate capacity of the Peltier element 
and the architecture suffers from bulky devices like the microscope and the BioSpot while 
all modules require a huge power supply. Even if the miniaturization of bulky devices 
remains difficult, at least heating rates could be optimized via an even more sophisticated 
design of the heating device. Additionally, a definite improvement of the presented system 
would be an upgrade of chip architecture to provide multiple reaction centers for performing 
several reactions at a time. This would allow parallelization, high-throughput and automation 
as via automatization the reproducibility would also be enhanced to a big amount. As the 
system is totally software controlled, the first step towards automation is done building a base 
for further improvement. However, besides some drawbacks, the scientific progress described 
in this work presents a big step forward towards the generation of an ultimate micro total 
analysis device. 
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9.  Appendix 
9.1  Laboratory-internal operating procedures 
Laboratory-internal operating procedures (LOP) were written for general laboratory 
applications concerning the lab-on-a-chip system.  
LOPs were written for handling laser microdissection as well as the SPATS transfer system 
(chapter 9.1.1 and chapter 9.1.2), for the CytoCycler split into LOC chips (chapter 9.1.3) 
and LV-PCR (chapter 9.1.4), as well as for the BioSpot automatic dispensing device 
(chapter 9.1.5) and the Fluorescence Reader (chapter 9.1.6). 
LOP protocols are provided on a separate data medium (CD) enclosed to this work. 
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9.1.1 LOP of building adsorbing heads for the SPATS 
“Protocol for the fabrication of adsorbing head devices for the SPATS” 
A. Material 
• Universal compressed gas can (210g/400ml) + pistol adaptor for compressed gas can 
(Propan/Butan gas can with thread, Art. Nr. 52109, CFH Löt- und Gasgeräte GmbH, 
Offenau, Germany) 
• Glass capillary tube (Kapillaren zur Schmelzpunktbestimmung, open at both sides, 
AD 1,75 LG 100mm, 1000 pieces, Hirschmann Laborgeräte GmbH & Co.KG, 
Eberstadt, Germany) 
• Metal block device with fixed conventional micrometer step motor for high-precision 
XY-adjustment; metal block for bending of glass capillary tubes 
• Sharp/spiky item (e.g. needle or other) used for applying the adhesive 
• Glass Petri dish used as platform for applying the adhesive 
• Scalpel/tiny slotted screwdriver for adjusting screws of devices (screw threads) 
• Copper hole-rings (AGAR scientific Ltd., Stansted, Essex, U.K.; ordered from 
PLANO GmbH, Wetzlar, Germany) 
G2605C   1500µm   hole   copper   3.05mm 
G2600C   1000µm   hole   copper   3.05mm 
G2680C     800µm   hole   copper   3.05mm 
G2660C     600µm   hole   copper   3.05mm 
G2630C     300µm   hole   copper   3.05mm 
• Copper meshes (G2786C   2000   square mesh   copper   3.05mm, AGAR scientific 
Ltd., Stansted, Essex, U.K.; ordered from PLANO GmbH, Wetzlar, Germany) 
• UV lamp 220V 50Hz, 230V 60Hz (System Papst-Motor Typ 8550, Papst-Motoren 
GmbH & Co.KG, St. Georgen, Germany) 
• Adhesive = Norland optical adhesive (ultraviolet curing) 88, LOT 164 (Norland 
products Inc., Cranbury, NJ, USA) 
            (This adhesive, which is a single-package system, contains no solvent and cures by exposure to long 
              wave ultraviolet light (320-400nm). It is suitable for fast precision bonding to glass, metal, and many 
               plastics. Use it in any application that requires critical alignment or exact positioning.) 
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B. Operating procedure 
 
I. Bending of glass capillary tubes 
• Glass capillary tube is inserted into borehole of metal block (a centered, straight 
positioning should be achieved; use screw thread!) (figure 1 A, red arrow). 
• Start melting/bending of glass capillary tube by heating the desired kink using a 
compressed gas can; most precise and straight bending is achieved when heating from 
above (vertical heating is ideal for eliminating unwanted sloped kinks). 
• In an optimum way, bended glass capillary tube comprises a bending angle of exact 
90° (figure 1 B), a straight bending without narrowing or squeezing diameter of glass 
capillary tube or angling the course of the glass capillary tube. 
• Glass capillary tube needs to cool down before further processing! 
 
 
Figure 1. Bending of glass capillary tubes. A) Metal block for bending of glass capillary tubes to an angle of 
90°. Borehole in the upper part, centered (red arrow), provides fixation of glass capillary tube (screw thread); 
centered metal plate in front (anchored via 2 screws, blue arrow) supports achieving an exact bending of the 
glass capillary tube to an optimum angle of 90° (B). 
 
II. Attachment of hole-rings and meshes 
• Long end of glass capillary tube is fixed into a borehole of the small metal block, 
which is connected to micrometer step motor (use screw thread) (figure 2 B); bended 
short end of glass capillary tube is pointing bottom-up first, to apply the adhesive. 
• A tiny amount of adhesive is squeezed onto the surface of the glass Petri dish. 
• Apply a tiny amount of adhesive to bended short end of glass capillary tube, exactly at 
the cutting site/cut surface; use any spiky metal item for applying the adhesive. 
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• Hole-ring needs to be exactly attached to the cut surface of the glass capillary tube; 
hole of hole-ring and hole of cut surface should match perfectly. (Caution: diameter of 
glass capillary tube may not be narrowed by inclined/leaned hole-ring AND adhesive 
may not seal hole!). For attachment either the micrometer step motor plus supporting 
tip hole surface as ring-holder can be used, or attaching the hole-ring can be 
performed manually (figure 2 A, red arrow, and figure 2 C). 
• For curing of adhesive capillary glass tube needs to be exposed to an UV light source 
for 1-2 min. 
 
• Glass capillary tube needs to be readjusted into small metal block, connected to the 
micrometer step motor (using screw thread); bended short end of glass capillary tube 
points bottom-up for applying the adhesive. 
• A tiny amount of adhesive is applied to the outmost edge of hole-ring (use any spiky 
metal item for applying adhesive). (Caution: adhesive may not contact hole of hole-
ring, as in this case adhesive would seal mesh and interfere with low-pressure 
efficiency!). 
• Mesh needs to be exactly attached to hole-ring; shapes of both rings should match 
perfectly! (Do not move mesh extensively; avoid spreading adhesive!). 
• For curing of adhesive capillary glass tube needs to be exposed to an UV light source 
for 1-2 min. 
 
 
Figure 2. Working platform for applying hole-rings and meshes. A) Micrometer step motor fixed at a big 
metal block for XY-fine-positioning; small metal block with fitted supporting surface for attaching hole-rings 
and meshes (tip hole, arrow); UV curing adhesive; glass Petri dish as application platform for a tiny amount of 
adhesive; sharp/spiky item (metal tip) used for dosage and application of adhesive. B) Small metal block (fixed 
at the micrometer step motor) encompassing 2 boreholes for fixing the long end of bended glass capillary tube 
(screw thread); the short bended end of the glass capillary tube is facing the supporting surface (tip hole). C) 
Glass capillary tube after attaching hole-ring or mesh, respectively. D) Constituent parts of an adsorbing head 
device: glass capillary tube, hole-ring and mesh forming the sample take-up device. 
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9.1.2 LOP of LMD (laser microdissection) & SPATS transfer 
“Transfer of microdissected material via low-pressure SPATS device” 
A. Material 
• New adsorbing head (glass tube, hole ring, lattice/grid according to chapter 9.1.1) 
• Sample material fixed on PEN carrier membrane coated object slides (2 µm PEN-
slides; MicroDissect GmbH, Herborn Germany) 
• UVC light source (PCR Workstation, PeqLab Biotechnologie GmbH, Erlangen, 
Germany) 
• Laser control box (CryLaS FTSS 355-50, CryLaS GmbH, Berlin, Germany) 
• Softwares “Nanosauger 2.5/2.6/2.7” (XYZ High Precision, Darmstadt, Germany) 
• Color firewire camera (PixeLINK, Megapixel Firewire Camera, BFI Optilas, Munich, 
Germany) 
• Black & white CCD camera (Rolera-XR, QImaging, Surrey, BC, Canada) 
• Softwares “QCapture” or “QCapture Pro 6.0” (QImaging, Surrey BC, Canada) 
• Pressure-supplying pneumatic picopump (PLI-100 pressure control unit, Harvard 
Apparatus, Holliston, US) 
 
B. Operating procedure 
 
I. Preparations 
 
• Switch on computer, microscope power supply box 231 and microscope button. 
• Switch on laser control box → switch key to from “0” to “1”, a green light appears 
(left side) → now the laser lamp is getting pre-warmed → wait until the second green 
light turns on (right side) → now the laser can be started by pressing the red button 
located between both green lights (“Laser On/Off”) → when right green light turns to 
red, laser is ready to use. 
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II. Laser microdissection (LMD) 
 
• Decontaminate adsorbing head by using a UVC light source. 
• Make sure, that the arm of the transfer device is positioned out of the working area, on 
the right side of the XY-stage as a) this position favors an easy installation/fixation of 
the adsorbing head into the low-pressure supporting arm and b) the arm has enough 
space above to move up, as the software “Nanosauger” performs a calibration run of 
the XY-stage and the SPATS carrier arm when getting started. 
• Either use the color firewire camera for colored images, or switch on the black & 
white CCD camera for black and white images. 
• Run software “Nanosauger 2.5” (desktop) for fast working procedures (figure 1) and 
“Nanosauger 2.6” (desktop) for slow working procedures, both without using 
autofocus unit, or “Nanosauger 2.7” for working with implemented autofocus function 
(desktop). Softwares “Nanosauger” serve the color firewire camera, while for utilizing 
the black & white CCD camera additionally the software “QCapture” or “QCapture 
Pro 6.0” needs to be started. 
• Optionally the stage movement direction can be adjusted via clicking “Control Via 
Buttons” and then clicking “Inverted X-Direction” as well as “Inverted Y-Direction”; 
re-activate the box “Control Via Joystick”. 
• Speed of stage movement and up/down-direction of SPATS arm can be set by clicking 
“Control Via Buttons”, then the speed can be adjusted by moving the mode controller 
in the box “Speed” (settings 1-7); re-activate the box “Control Via Joystick”. 
• The SPATS arm can be move up/down by turning the joystick knob to the left and 
right; it can be moved left/right by pressing the arrow buttons in the box “Rotation”, 
the speed of sideways movement can be adjusted by clicking “Low Speed”, “Medium 
Speed” or “High Speed”; the length of the SPATS arm can be adjusted by turning the 
rotary knob located at the micrometer step motor. 
• Test, if lattice is centered to the view field of the microscope by approaching the 
adsorbing head to the 10x objective; if not, center grid for easier sample take-up. 
• For microdissection of single particles use the 40x objective; set microscope to “DL 
auf” (Durchlicht function is activated); laser can be switched on by operating the 
footswitch, or by activating the silver switch at the laser control box (“TRIGGER 
INT/EXT”) to “INT” position; set microscope to “AL auf” (Auflicht function is 
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activated) calibrate the laser beam by focusing it onto the level of the PEN-carrier 
membrane, adjust laser focus and cut energy → a thin focused cut line is desired. 
• Isolate single areas by keeping laser running and moving the microscope’s XY-stage. 
• To switch off laser, either loosen footswitch or turn silver switch (“TRIGGER 
INT/EXT”) to “EXT” position. 
 
 
Figure 1. Screenshot of software “Nanosauger 2.5”. Via the panel “XY Control unit” settings of the XY-stage 
can be changed. Activating the panel “Rotation” can move the SPATS device horizontally and various speed 
settings can be adjusted. The “Camera Properties” window allows taking pictures and provides several settings 
for optimized image taking. Via operating the “Nanosauger” panel, the low-pressure operation can be started 
(Suc Start/Suc Stop), stopped and a short impulse of high pressure can be applied by pressing “Clear”. 
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III. Single particle adsorbing transfer system (SPATS) 
 
• Use the 10x objective for controlled extraction/transfer via the SPATS device. 
• Switch on pressure-supplying pneumatic picopump and turn on compressed air. 
• Approach the grid/lattice of the adsorbing head to the surface of the isolated particle, 
start low-pressure process by clicking “Suck Start” (figure 1); check if particle is 
fixed to the grid and that the area of PEN-membrane is empty where isolation 
happened. 
• Move SPATS up and transfer particle to a tube, planar device or else; release particle 
by pressing “Suck Stop” and “Clear” for providing a short impulse of high-pressure. 
• Check particle release by having a look at the grid; for doing so, move adsorbing head 
back to the 10x objective and approach grid to objective lens. 
• To quit operations, move SPATS arm out of the working area, to the right side of the 
XY-stage; remove adsorbing head and store it accurately; switch off microscope, 
switch off microscope power supply box, turn off laser by pressing the red button at 
laser control box (“Laser On/Off”), switch off laser control box via moving the key 
from “1” to “0” position, quit software, turn off camera, shut down computer. 
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9.1.3 LOP of LOC chips 
“Application of LOC chips and of the LOC system” 
A. Material 
• LOC chips Cyto1, Cyto2, Cyto3 (Advalytix AG/Beckman Coulter Biomedical GmbH, 
Munich, Germany) 
• Ultrasonic cleaner (VWR International, Leuven, Belgium) 
• UVC light source (PCR Workstation, PeqLab Biotechnologie GmbH, Erlangen, 
Germany) 
• CytoCycler (PCR device incl. chip-holder, temperature control device, SAW control 
high frequency (HF) generator, particular software “CytoCycler” (Advalytix 
AG/Beckman Coulter Biomedical GmbH, Munich, Germany)) 
• HF generator (FC 1201 HF, Advalytix AG/Beckman Coulter Biomedical GmbH, 
Munich, Germany) 
• Software “CytoCycler” (Advalytix AG/Beckman Coulter Biomedical GmbH, Munich, 
Germany) 
• Tickopur (DR. H. STAMM GmbH, Berlin, Germany) 
• Acetone (Merck KGaA, Darmstadt, Germany) 
• EtOH 100% (Merck KGaA, Darmstadt, Germany) 
• PCR master mix (free of choice) and mineral oil cover (Sealing Solution, Advalytix 
AG/Beckman Coulter Biomedical GmbH, Munich, Germany) 
• Sterile 0.2 ml PCR tubes (Eppendorf AG, Hamburg, Germany) 
 
B. Cleaning of  LOC chips (1-2x) in ultrasonic cleaner 
 
• Clean chips with 70% EtOH, remove EtOH with paper towel (carefully tap the chip). 
• Wash chips for about 5 min in 2% Tickopur solution using ultrasonic cleaner. 
• Rinse chips thoroughly with H2Odd. 
• Clean chips for 2-3 min in H2Odd (ultrasonic cleaner); blow dry with N2. 
• Clean chips for 2-3 min in acetone (ultrasonic cleaner); blow dry with N2. 
• Clean chips for 2-3 min in 100% EtOH (p.A. grade) (ultrasonic cleaner); blow dry 
with N2. 
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• Incubate chips for 20 min using a UVC light source for decontamination. 
• Successful cleaning can be tested by performing a negative control reaction on cleaned 
chips followed by detection via PAAGE ⇒ PCR should reveal no PCR product! 
 
Important: as counting scale (graduation) at ultrasonic cleaner begins at “1” and not at “0” as 
written, add +1 min of time when starting the run (for 5 min put 6 min instead). 
 
C. General information concerning LOC chips 
 
• Currently, there are 4 different designs of LOC chips: Cyto1, Cyto2, Cyto2 plus 
microarray, Cyto3 plus microarray (figure 1 C-E). 
• Cyto1 = original design, July 2007; hydrophilic reaction points A and B comprising a 
diameter of 40 µm and a hydrophilic track width of 15 µm (figure 1 C).  
• Cyto2 = design for cell culture applications, January 2008; hydrophilic reaction point 
A comprises a larger diameter of 500 µm, instead of 40 µm as so far, for to let cells 
grow on the surface (the rest of the chip remained unchanged). Additionally, this chip 
charge was designed with a hydrophilic array field of 1x1 mm2 next to reaction center 
B, for supporting microarray applications (figure 1 D). 
• Cyto3 = totally new design, January 2009; hydrophilic track width was broadened to 
200 µm instead of 15 µm as so far, especially concerning main track between reaction 
centers A and B (between transducer 10 and 5), and all tracks leading to reaction 
center B (between transducer 3 und 7); diameters of almost all reaction points (A, B 
and centers in front of IDT 3 and 7) are comprising 500 µm instead of 40 µm (red 
circles in figure 1 E); additionally, an intermittent hydrophilic circle is surrounding 
reaction point B to keep the oil cover more fixed to the surface (same design as used 
for the AmpliGrid AG480F, but with 4 gaps of 500 µm width). This chip charge 
was also designed with a hydrophilic array field of 1x1 mm2 next to reaction center B, 
for supporting microarray applications. 
• Spotting of oligonucleotide probes for microarray applications was performed using a 
“Nadelspotter” which can spot 100 µm spots, while the minimal distance between 
spots should be 50 µm. The 1x1 mm2 array field (reaction point C) comprises 
dimensions of 1x1 mm2, thus 36 spots can be arranged in a 6x6 array. Spotting can 
also be performed in reaction spot B, while there only a 3x3 array is possible due to 
smaller diameter.  
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Figure 1. Design of LOC chips. A) Design and dimensions of chip charge Cyto1. B) Electromicroscopy images 
of hydrophobic/hydrophilic track system and reaction points. C) Layout of Cyto1: ∅ point A 40 µm, ∅ point B 
40 µm, track width 15 µm. D) Layout of Cyto2, with microarray: ∅ point A 500 µm, ∅ point B 40 µm, 1x1 mm 
array field (point C), track width 15 µm. E) Layout of Cyto3 with microarray: ∅ point A 500 µm, ∅ point B 500 
µm, 1x1 mm array field (point C), track width of red lined tracks 200 µm. 
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• Chips were manufacturer and provided by Advalytix AG/Beckman Coulter 
Biomedical GmbH, Munich, Germany; spotting operations were done there as well.  
• The basic material of each chip is LiNbO3. Each chip comprises 10 interdigital 
transducers (IDTs) with service connections and gold contact pads. Big IDTs for 
serving the main track should provide an aperture of 3 mm to be capable of moving 5 
µl of oil, the smaller ones for moving droplets an aperture of 1 mm. There must be at 
least 4 different SAW frequencies to operate 4 IDTs at a time. A homogeneous 
passivation using SiO2 enables chemical modification. The surface chemistry features 
hydrophobic and hydrophilic areas. Hydrophilic areas provide tracks for controlled 
droplet movement by surface acoustic wave operation (SAW) and distanced reaction 
centers, which enable independent temperature control. 
 
D. Installation of LOC chips into the CytoCycler device and setting frequencies/channels 
at the FC 1201 HF generator for the particular chip charge 
 
• The FC 1201 HF generator distributes according to the joystick settings high 
frequency signals in the range from 120-170 MHz to one of four channels. The 
maximal power/capacity comprises 35 dBm and is controlled continuously from 7 
dBm to maximum via the deflection of the joystick. The HF generator has 3 different 
switching-status options, marked via grouping into A, B and C (figure 2 A). The 
particular switching status is displayed in the upper middle of the front panel (figure 2 
A, blue arrow). States can be switched by tripping the left joystick button. By tripping 
the right joystick button, the generator switches to maximum power in the direction 
the joystick is moved along the main track. By pressing the “fire” button on top of the 
joystick, maximum power in the appropriated direction is provided, while the 
maximum corresponds to the set value. Each switching status operates 4 different HF 
channels and connected SAW transducers by moving the joystick (figure 2 A, red 
arrow). The relation of each transducer to the single groups in shown in figure 2 C. 
• When installing chips into the chip-holder of the CytoCycler, the temperature control 
device must be switched off – otherwise the temperature sensor and the whole device 
will get damaged! Additionally, the HF generator (SAW control box) may not be run 
without a chip installed! (HF channels may not be run with “open end” respectively 
without connected SAW LOC chip). 
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Figure 2. Operations on a LOC chip. A) Switching-status options A, B and C displayed at the panel (blue 
arrow). Joystick deflection shows operating HF channels (A, red arrow and B). C) The image shows the 
relation of transducers and switching status grouping. The arrows display the movement capacities/facilities 
of a droplet under the influence of the transducers of this group. 
 
• For installing a chip, the contacting lid for the high frequency support of the chip-
holder is opened by turning both screws and release the click-fastening mechanism 
(figure 3, red arrows); carefully remove SAW control lid and put in a chip preferably 
fixed to the left corner of the cavity for being optimally connected to IDTs by gold 
contacts and gold contact pins. 
 
 
Figure 3. Installation of LOC chips. Chips are inserted into the chip-holder via screw-operated “click-
fastening mechanism”. 
 
• Re-attach SAW control lid and fasten screws. 
• For each chip-charge, a report is provided telling the numbers of the chips, the number 
of single defect transducers as well as dedicated frequencies/channels for being tuned 
at the HF generator. 
• Those frequencies/channels and the power level then need to be set at the front panel 
of the HF generator due to the following scheme (figure 2 A): the four control 
elements on the left side are valid for area A on the chip, while the four control 
elements on the right side are valid for area B as well as area C. Always 4 transducers 
must be operable by joystick at a time. So an 8-channel HF generator is used, whereby 
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2 channels at a time should provide the same frequency. The joystick provides a 
switch to shift between the first 4 and the second 4 channels. The HF generator 
provides a PC-interface to enable software-controlled droplet movement. Thereby the 
upper left control element represents values for “up”, the lower left one for “down”, 
upper right one for “left” and the lower right one for “right” (figure 2 B); given 
directions are related to the tracks in the respective area in which the droplets are 
moved according to the acting IDTs. Thus, directions display the agitation facilities of 
a droplet being under the influence of these interdigital transducers. Currently droplet 
movement can only be carried out manually via joystick, but not yet via software. 
Important: changed values need to be saved, validated and transferred to the SAW 
control unit by activating the “Set” button. For details about the connection of IDTs 
and 1201 HF generator please refer to the “FC 1201 HF-Generator Manual” provided 
by Zeno Guttenberg (Advalytix AG/Beckman Coulter Biomedical GmbH, Munich, 
Germany) in 2006. Important: in case of a non-working joystick (shown by blinking 
lights at the front panel), the joystick needs to be re-adjusted. This can be done by 
opening the joystick covering at the rear side and measuring the co-current flow of the 
contacts for joystick deflections. The measured value should be set around 2.5 V. 
• The chip-holder is sometimes also named “CytoCycler”. It has a cavity for installing a 
single chip. The contacting lid for the high frequency support, which must be removed 
and reassembled for installing a chip, provides power connections for 10 transducers 
including 20 gold contact pins. 
 
E. Operating the CytoCycler for performing PCR 
 
• Install a new chip in the LOC chip-holder; important: the temperature control device 
may only be switched on when a chip is inserted – otherwise it might be damaged! 
• Start computer, switch on temperature control device (black heating device), run 
software “CytoCycler” (desktop). For a detailed description of the software and the 
different program cards please refer to the “CytoCycler Software Manual” provided 
by Zeno Guttenberg in 2006 (Advalytix AG/Beckman Coulter Biomedical GmbH, 
Munich, Germany). 
• The software provides different register cards, where programs for the load resistor 
heating (serving reaction point A) as well as the Peltier element (serving reaction point 
B and the array field C) can be saved; required register cards can be activated/marked 
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in the box “Status” (working procedure then happens from A1 to B3); for performing 
a normal PCR, simply register card B2 is required, where a complete PCR program 
can be typed in, saved and changed via “Save” or “Save as”. Saved programs can be 
changed and activated by “Load”→ “All Files“ → choose program. Single boxes in 
the cards, where the duration was set as “0” s, are going to be ignored. 
• Load resistor heating accepts temperatures from 20°(room temperature)-90°C, with a 
heating rate of 0.01-10 K/s; duration of temperature steps can be set to up to 16 h 
(60000 sec). The Peltier element accepts temperatures from 4°-105°C, with a 
heating/cooling rate of 0.01-5 K/s (cards A1, A2, B1) and a fixed heating rate of 3 K/s 
and cooling rate of 4 K/s. Cycling times can be chosen up to 200 s per temperature 
step, and times for pre-annealing or post-elongation up to 3000 s. Temperature 
increments can be set from 0.1-5 K, and time increments from 0.1-5 sec. The number 
of cycles can be adjusted from 0-60. 
• Load a saved program file: “Load” → “All Files” → choose program; parameters can 
be changed individually; run program by clicking “Start Process”; after chosen 
parameters have been checked by the software, a message box appears (“B2 
Kommentar”) to definitely start the reaction by clicking “Ok”; each program can be 
stopped by clicking “Abort Process”. 
• Before starting a PCR, each new chip which is installed into the chip device, needs to 
be pre-heated to 95°C for about 15 min C (during this procedure, the material of the 
chip expands due to the high temperature – this prevents the droplet afterwards, when 
starting the initial denaturation step of the PCR at 95°C, to be moved/deformed due to 
material stress); afterwards, let the chip cool down completely. 
• For performing PCR, first, add 1 µl of master mix onto reaction point B, then cover 
the reaction by adding 5 µl of mineral oil (Sealing Solution) to prevent evaporation 
and cross-contamination. Evaporation might inhibit the amplification reaction, as via 
evaporation the salt concentration of the reaction solution gets enhanced. 
• Start PCR by “Start Process”. 
• Let chip CytoCycler cool down after PCR is finished (wait until ventilation stops). 
• Transfer 1 µl PCR into a sterile 0.2 ml PCR tube for storage (e.g. add 1 µl of 6x gel-
loading-dye as well as 4 µl of water, then extract 6 µl volume from PCR tube for 
PAAGE application). 
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• Clean used LOC chips immediately with 70% EtOH and H2Odd, then store in water for 
a distinct period of time to remove dried PCR remains; continue with cleaning 
procedure (paragraph A of this LOP). 
• Insert a “dummy chip” into the cavity of the chip-holder serving as a placeholder, as 
CytoCycler device may never be assembled without a chip inside!! 
 
 
Figure 4. Screenshot of software “CytoCycler” (Advalytix AG/Beckman Coulter Biomedical GmbH, Munich, 
Germany). Several working sheets N-B3 comprising various PCR programs and protocols are independently 
addressable and operable. In the upper left corner a steady overview is provided concerning cycle number, 
temperature and activated working sheet. The temperature profile of the passed 20 minutes is shown graphically 
as well. 
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9.1.4 LOP of LV-PCR (low-volume PCR) 
“Low-volume (LV-PCR) for application on AmpliGrid AG480F and the LOC system” 
A. Material 
• AmpliGrid AG480F or LOC chips Cyto1, Cyto2, Cyto3 (Advalytix AG/Beckman 
Coulter Biomedical GmbH, Munich, Germany) 
• AmpliSpeed slide cycler (Advalytix AG/Beckman Coulter Biomedical GmbH, 
Munich, Germany) 
• UVC light source (PCR Workstation, PeqLab Biotechnologie GmbH, Erlangen, 
Germany) 
• CytoCycler (PCR device incl. chip-holder, temperature control device, SAW control 
high frequency (HF) generator, particular software “CytoCycler” (Advalytix 
AG/Beckman Coulter Biomedical GmbH, Munich, Germany)) 
• HF generator (FC 1201 HF, Advalytix AG/Beckman Coulter Biomedical GmbH, 
Munich, Germany) 
• Software “CytoCycler” (Advalytix AG/Beckman Coulter Biomedical GmbH, Munich, 
Germany) 
• Sealing Solution (Advalytix AG/Beckman Coulter Biomedical GmbH, Munich, 
Germany) 
• Sterile 0.2 ml PCR tubes (Eppendorf AG, Hamburg, Germany) 
• Purified DNA material or crude sample material for direct cell lysis, but not more than 
1 ng target DNA material – this might overload the reaction volume! 
• Master mix (MM) for performing PCR including buffer for DNA polymerase, dNTPs, 
MgCl2, oligonucleotids (primers), DNA polymerase: it is important to use an 
appropriate MM, which DOES NOT mix/fuse with the cover oil (Sealing Solution)!! 
Most suitable turned out to be PCR kits provided by QIAGEN GmbH (Hilden, 
Germany) like e.g. QIAGEN Fast Cycling PCR kit; QIAGEN Multiplex PCR kit; 
QuantiFast SYBR Green I PCR kit; QuantiTect SYBR Green I PCR kit). 
• Master mixes need to be calculated down to exactly 1 µl of total reaction volume per 
reaction; there are two possibilities: a) calculate master mixes (w/o DNA) to 1 µl per 
reaction point excluding volume of target DNA, as target DNA or the tissue 
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sample/cell respectively has already been placed at the reaction point and dried at 
room temperature; b) master mixes are calculated to 1 µl per reaction including 
volume of target DNA (standard procedure). Caution: drying sample material at room 
temperature on LOC chips worked always suboptimal and caused a lot of bubbling 
master mixes when applied to the sample; thus, just procedure b) should be used for 
LOC chips. On the AmpliGrid AG480F, both procedures worked comparable well! 
• AmpliGrid AG480F PCR: all cycling times for PCR need to be extended a bit, as 
slide cycler needs some time to reach the desired temperature (each temperature step 
about 20 sec longer); use higher concentration of polymerase (1U/µl); some kits 
perform better when scaled down, others worse (best: PCR kits by QIAGEN GmbH 
can be scaled down 1:1); primer concentration about 0.2 µM in PCR; use a DNA 
starting amount of about 100-200 pg, 1 ng at maximum; concentration of Mg2+ about 
1-5 mM; initial denaturation step as well as final elongation step each about 5-10 min. 
• 1 µl of PCR reaction master mix is generally covered with 5.0 µl of Sealing Solution. 
When using microdissected material, the PEN-carrier membrane might interfere 
amplification; thus, time of initial denaturation could be extended to 15 min. When 
droplets next to each other merge, less oil needs to be used (4.8-5.0 µl) (figure 1). 
 
 
Figure 1. Principle of low-volume PCR (LV-PCR). A) Schematic overview: 1 µl of hydrophilic master mix is 
placed on a hydrophilic reaction spot and kept in place by a surrounding hydrophobic ring; hydrophobic oil 
coverage prevents evaporation and is kept in place by a surrounding hydrophilic ring. B) Close-up of the droplet-
in-oil principle of LV-PCR on chip. C) LOC chip presenting a placed PCR reaction, comprising 1 µl droplet of 
master mix (red colored as containing blood) covered by 5 µl of mineral oil. 
 
B. Operating procedure 
 
I. Preparing the master mix 
 
• Clean room (use overshoes, gloves, lab coat): all PCR reagents are stored at -20°C in 
the freezer, EXCEPTING DNA!!! 
• 1 µl LV-PCR master mix for β-actin or amelogenin PCR respectively (QIAGEN Fast 
Cycling PCR kit): 0.5 µl 2x QIAGEN Fast Cycling PCR Master Mix (final 1x), 0.1 µl 
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10 µM forward primer (final 1 µM), 0.1 µl 10 µM reverse primer (final 1 µM), 0.0-0.3 
µl sterile water (Ampuwa, Fresenius GmbH, Bad Homburg, Germany) (depends on 
DNA amount/volume used or if DNA was dried on chip). Amelogenin primers (stock 
solution 100 pmol/µl) = ‘Amel1’ (5’-CCC-TGG-GCT-CTG-TAA-AGA-ATA-GTG-
3’) and ‘Amel2’ (5’-ATC-AGA-GCT-TAA-ACT-GGG-AAG-CTG-3’); β-actin 
primers (stock solution 100 pmol/µl) = ‘β-Actin up’ (5’-TCA-CCC-ACA-CTG-TGC-
CCC-ATC-TAC-GA-3’) and ‘β-Actin down’ (5’-CAG-CGG-AAC-CGC-TCA-TTG-
CCA-ATG-G-3’). 
• Calculate at least 1 negative control (just MM w/o DNA) and 1 extra reaction per 
reaction batch (as reserve, that there will be enough master mix for all reactions – 
note, that there are pipetting inaccuracies due to natural measurement error of pipets 
and MM sticking to filter tips and tubes!). 
• Important: mix reactants of master mix just by ‚agitating/stirring the pipet’, DON’T 
mix up and down!!! Extensive mixing might create smallest air bubbles in the master 
mix, which could lead to the generation of big bubbles in the reaction mix while 
heated to 95°C (Loss of reactants! Loss of volume! Change of concentrations!). 
 
II. Setting up a LV-PCR 
 
• Decontaminate AmpliGrid AG480F and LOC chips for 15-20 min using a UVC 
light source. 
• Position negative control first and then add DNA to the mix (in case that DNA has not 
been air dried at reaction points). 
• Add 1 µl MM per reaction point (volume can even be scaled down to 200 nl [1]), then 
cover droplets by using 4.8-5.1 µl of Sealing Solution to prevent evaporation and 
cross-contamination (figure 1). Evaporation might inhibit the amplification reaction, 
as via evaporation the salt concentration of the reaction solution gets enhanced. 
• Important item when pipetting: empty pipet just until the first pressure point is 
reached!!! Emptying pipet down to the second pressure point can cause bubble 
formation in maser mix and Sealing Solution due to the additionally blown off dead 
volume (enhanced pressure)!! 
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III. Standard PCR programs 
 
• β-actin and amelogenin PCR: 5-15 min at 95°C initial denaturation (depends on MM 
and required activation time of HotStart DNA polymerase), 35-40 cycles of 94°C for 
30 sec, 60°C for 30 sec, 72°C for 30 sec and final extension at 72°C for 1 min (cycling 
times and temperatures can be adjusted individually). 
• “Touch down PCR” for DNA typing using primers D7S1824, D9S302, D10S2325: 
10-15 min at 95°C initial denaturation (depends on MM and required activation time 
of HotStart DNA polymerase), 14 cycles of 94°C for 30 sec, 64°-50°C for 60 sec 
(temperature increment -1°C per cycle), 72°C for 30 sec, followed by 25 cycles of 
94°C for 30 sec, 50°C for 30 sec, 72°C for 30 sec, final extension at 72°C for 7 min. 
• AmpF/STR SEfiler PCR amplification system (Applied Biosystems, Darmstadt, 
Germany): 11 min at 95°C initial denaturation for HotStart AmpliTaq Gold DNA 
polymerase (5-15 min, depends on MM and required activation time of HotStart DNA 
polymerase), 28 cycles of 94°C for 1 min, 59°C for 1 min, 72°C for 1 min, followed 
by 60°C for 45 min final extension (for AmpliTaq Gold DNA Polymerase mediated 
non-template adenylation) or respectively 15 min (for KOD Xtreme DNA 
Polymerase = blunt ends, normal extension). 
 
C. Operating the AmpliSpeed (LV-PCR on AmpliGrid AG480F) 
 
• Switch on AmpliSpeed slide cycler; log in as ‘Administrator’; wait until self-test and 
calibration is done (display changes from “Self test” to “Idle”). 
• Load a saved program file: “File” → “Load” → “PROTOKOLLE” → choose program 
→ click “Ch. Dir”, which stands for “ok”. 
• For changing some parameters of the selected program: address/click on the parameter 
(e.g. time, temperature or cycle number) using the touch screen, change settings using 
the arrow buttons; when starting the changed program, automatically the software 
calls for saving the changed program – this can be confirmed, otherwise the changed 
program can be save using a new file name. 
• Position the AmpliGrid AG480F onto the heating area of the AmpliSpeed slide 
cycler and close the lid. 
• Run program by activating the “Start” button (arrow button). 
• After PCR has finished, stop program by clicking the “Stop” button (square button). 
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D. Operating the chip system (LV-PCR on CytoCycler) 
 
• Install a new chip in the LOC chip-holder (important: the temperature control device 
may only be switched on when a chip is inserted – otherwise it might be damaged) 
(see detailed description in the “LOP of LOC chips”, chapter 9.1.3). 
• Start computer, switch on black temperature control box, run software “CytoCycler” 
(desktop). 
• Load a saved program file: “Load” → “All Files” → choose program; parameters can 
be changed individually; run program by clicking “Start Process”; after chosen 
parameters have been checked by the software, a message box appears (“B2 
Kommentar”) to definitely start the reaction by clicking “Ok”; each program can be 
stopped by clicking “Abort Process”. 
• Before starting a PCR, each new chip which is installed into the chip-holder, needs to 
be pre-heated to 95°C for about 15 min C (during this procedure, the material of the 
chip expands due to the high temperature – this prevents the droplet afterwards, when 
starting the initial denaturation step of the PCR, to be moved/deformed due to material 
stress); afterwards, let the chip cool down completely. 
• First, add 1 µl of master mix onto reaction point B, then cover the reaction by adding 5 
µl of mineral oil (Sealing Solution) to prevent evaporation and cross-contamination 
(figure 1). Start PCR. 
• Let chip CytoCycler cool down after PCR is finished (wait until ventilation stops). 
• Transfer 1 µl PCR into a 0.2 ml sterile PCR tube for storage (e.g. add 1 µl of 6x gel-
loading-dye as well as 4 µl of water, then extract 6 µl volume for PAAGE 
applications). 
• Clean used LOC chips immediately with 70% EtOH and H2Odd, then store in water for 
a distinct period of time to remove dried PCR remains; continue with cleaning 
procedure (see “LOP of LOC-chips”, chapter 9.1.3). 
• Insert a “dummy chip” into the cavity of the chip-holder serving as a placeholder, as 
CytoCycler device may never be assembled without a chip inside. 
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9.1.5 LOP of BioSpot (PipeJet) 
“Application of BioSpot for automatic spotting of solutions onto the LOC” 
A. Material 
• BioSpot dispenser and software “BioSpot” (BioFluidix GmbH, Freiburg, Germany) 
• 0.2 ml sterile PCR tubes (Eppendorf AG, Hamburg, Germany) used as 
reservoirs/flasks for fluids (e.g. master mix, Sealing Solution, SSC washing solutions 
after hybridization/array amplification, etc...) 
• e.g. master mix solution (without DNA, to not contaminate tips/PipeJets of 
BioSpot), filled into 0.2 ml Eppendorf reaction tubes, for reaction center A or B 
• Sealing Solution (Advalytix AG/Beckman Coulter Biomedical GmbH, Munich, 
Germany), filled into 0.2 ml Eppendorf reaction tubes, for reaction point C 
• e.g. washing solutions (various concentrations of SSC), filled into 0.2 ml Eppendorf 
reaction tubes, for reaction center A or B 
 
B. Protocols 
 
I. Starting the Biospot (Nanodispenser) 
 
• Start computer, switch on hardware (piezo control unit & movement control), start 
software “BioSpot” (drive C:\\Program Files/BioSpot/software/BioSpot.exe or via 
shortcut “BioSpot” on desktop) → at first, automatically LOC-slide and PipeJets 
move to parking position (reference position) at x=0 or z=0 respectively (initial 
position). 
• Adjust speed/velocity of x- and z-axis in control window “Axis Control“: Xvel = 500, 
Zvel = 500, press “Set Axis Speed“ to validate changed settings; adjust the trackbar 
below for “Step width (mm)“ to smallest values as well (= 0.01 mm) ⇒ by adjusting 
these settings the motor gets prohibited of slippage/wheelspin when movement 
settings for x-position are changed from 0 to increasing values. In case of wheelspin, 
recalibrate the system by “Search Reference”. 
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II. Description of single active control windows (figure 1) 
 
• Window “(1) Axis Control and Axis Movement”: for movement of LOC-slide on x-
axis and of PipeJets on z-axis. For manual handling just the following settings are 
needed: “Move to Pos“ for moving the LOC-slide and PipeJets in desired positions 
on the x- or z-axis respectively. Simply set desired numbers and start application with 
“Move“ (black arrow buttons can only be used for movement when window “Enable 
Keyboard Control“ is activated, but are not needed necessarily. Buttons “Search 
Reference“, “Stop Search“ and “Move to Parking Position“ (x = 0, z = 0) are not 
needed for normal application as well). All of the following values given in table 1 
are valid for 0.2 ml Eppendorf reaction tubes, set into the various flasks. Initially 1.5 
ml flasks are set into the desired position A, B, C or D of the flask holder, into there 
0.5 ml reaction tubes are set, and into there, finally 0.2 ml reaction tubes. That “tube-
in-tube”-application is used to keep applied pipetting volumes as small as possible, to 
get PipeJets deeper into tubes and to not waste much fluid just for filling up the big 
1.5 ml tubes. Standard values for x- and x-movement are give in table 1. 
 
Table 1. Functions and values for using the BioSpot. 
 
LOC application Position x-axis [mm] Position z-axis [mm] 
Aspiration PJ1 (flask A) 280 33-37 
Aspiration PJ1 (flask B) 266.5 33-37 
Aspiration PJ1 (flask C) (best centered) 253.5 33-37 
Aspiration PJ1 (flask D) 240.05 33-37 
Aspiration PJ2 (flask A) 280 33-37 
Aspiration PJ2 (flask B) 266.5 33-37 
Aspiration PJ2 (flask C) (best centered) 253.5 33-37 
Aspiration PJ2 (flask D) 240.05 33-37 
Aspiration PJ3 (flask A) (best centered) 280 33-37 
Aspiration PJ3 (flask B) 266.5 33-37 
Aspiration with PJ3 using flask C and D is not 
applicable due to steric interference with 
cable/wire below the flask holder 
  
Dispensing PJ1 to reaction center A (H2O) 62 - 62.5 30 
Dispensing PJ2 to reaction center B (H2O) 114.2 (115) 30 (28) 
Dispensing PJ3 to reaction center C (oil) 164-166 25-28 
   
To check, if tip of PipeJet PJ1, PJ2 or PJ3 is 
centered to flasks A, B, C or D 
Flask position 28 
SPATS Position (for sample release) 700 - 
Fluorescence Reader 459 - 460 - 
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• Window “(3) Valve Control and Pump Control”: to open and close valves of single 
PipeJets and to connect pump with valves, or with air or valves with air (bypass). 
The valve, which is going to be used to “Aspirate”, must be open and connected to the 
pump (button “Valves (2)”), the other valves must be closed. The speed „PSpeed“ for 
„Aspirate“ or „Dispense“ respectively can remain unchanged at 20 ms. The volume 
„PVol“ can be adjusted: e.g. to 30 µl for H2O, master mix and washing solution (PJ1 + 
PJ2), to 40 µl for oil (PJ3). After „Aspirate“ valves can remain connected to the pump, 
avoiding a low-pressure to occur. The “Dispense” function is needed only to totally 
empty the valves and to dispense remaining liquids back into the flasks. 
• Window “(2) PipeJet Control”: various settings for automatic shooting of a 
definite volume using single PipeJets. There are just slight changes to be validated 
as most parameters are set as standard values and remain unchanged. Standard 
settings: Istroke = 36 µm, vdown = 200 µm/ms, thold = 10 µs, vup = 2 µm/ms, n = 5, 
delay = 100 ms. Just the “Istroke“ is recommended to be changed to 20 µm instead of 
36 µm, and the number “n“ from 5 to 20 repetitions, when 1 µl is going to be shot. 
Any changes in the settings need to be validated by “Set PJ“. A volume of about 1 µl 
is shot, when having aspirated a volume of about 30 µl with PJ1 or PJ2 and when 
starting the shoot-function by “Shoot PJ“. Buttons “Detect mode“ as well as 
„Dispense mode“ do not have a specific function defined by the software and can be 
neglected. 
• Window “(4) Batch Mode”: for programming and saving complex operations (in an 
excel-sheet). Thereby, a numerical code is applied. In the control window „(1) Axis 
Control and Movement“ x-position values indicate a movement of the LOC-slide, z-
position values indicate a movement of the PipeJets. In the control window „(3) 
Valve and Pump Control“ for valves V1, V2, V3 a “0“ indicates open valves and a “1“ 
means closed ones. For using the pump, at “PPos” a “0“ stands for “Bypass”, that is 
the connection of „Valve with Air“, “1“ indicates a connection “Pump with Air“ and 
“2“ means the connection “Pump with Valves“. Volumes for “Aspirate“ are indicated 
at “PVol“ using a “-“ for negative values, volumes for “Dispense“ using a “+” for 
positive values. Errors during the operation can be checked and detected by “Check 
Batch“. The operating process can be started with “Batch execute“ and can be paused 
with “Pause” or aborted with “Stop execution”. When the “Stop execution” function is 
activated, the total batch process stops immediately and the execution is cancelled. 
When pressing “Batch execute” again, the system will try to get back to the initial 
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starting positions of the actual batch file (the first line), and x-axis as well as z-axis 
will move simultaneously. Thus, to avoid PipeJets hitting the LOC-slide, use the 
“(1) Axis Control and Axis Movement” box to get the PipeJets (firstly) as well as 
the LOC-slide (secondly) manually back to the initial positions at z=0 and x=0, before 
starting “Batch execute” again. When “Pause” is pressed, a window “Batch Processing 
Paused” will appear. Now it is possible to change settings manually in window (1), (2) 
and (3), and to perform extra performances. However, the system will be back to the 
actual position in the batch mode and continue, after pressing “Ok”. So click “Ok” to 
continue. 
 
 
Figure 1. Screenshot of software “BioSpot” (BioFluidix GmbH, Freiburg, Germany). The software is used 
for operating the automatic dispensing device BioSpot. There are four single active control windows namely 
“(1) Axis Control and Axis Movement”, “(2) PipeJet Control”, “(3) Valve Control and Pump Control” for 
manually operated applications, as well as “(4) Batch Mode” for automatically operating protocols. (1) allows a 
regulation of speed and x-position of the slide rail and z-position of PipeJets. (2) allows an adaption of depth 
of penetration, displacement speed, release speed and holding time of the piezostack driven piston, as well as 
number of repetitions and delay time. (3) allows opening and closing of PipeJet valves, connections to the 
syringe pump as well as setting speed and volumes for aspiration and dispension and to start these operations. (4) 
allows programming complete sequences, which can be run automatically. 
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III. Manually performed spotting of 1µl of master mix onto reaction point A (PipeJet1,PJ1) 
 
• (1) “Move” LOC-slide to x-position 253.5 = flask C; “Move” PJ1 to z-position 33-37. 
• (3) “Connect” pump to valves, “Open” valve1, “Close” valves 2 and 3; PSpeed = 20, 
PVol = 30 µl; press button „Aspirate“ (watch, if fluid is aspirated into the tube); pump 
stays connected to valve1. 
• (1) “Move” PJ1 to z-position 0; “Move” LOC-slide to x-position 62 = reaction center 
A; “Move” PJ1 to z-position 30. 
• (2) Adjust the following settings at PJ1: Istroke = 20 µm, vdown = 200 µm/ms, thold 
= 10 µs, vup = 2 µm/ms, n = 20, delay = 100 ms; validate settings with „Set PJ1“; start 
spotting with “Shoot PJ1“; about 1 µl will be spotted onto the chip surface. 
• (3) After shooting, “Close” valve1 and “Connect” pump to air. 
• (1) “Move” PJ1 to z-position 0. 
• SAW-Control: 1 µl of fluid can now be move via SAW on the chip surface. 
• (1) “Move” LOC-slide to x-position 253.5; “Move” PJ1 to z-position 28-30. 
• (3) Release of fluid remains or of the over-aspirated volume from PJ1 back into the 
reservoir flask C: “Connect” pump to valves, “Open” valve1, activate button 
“Dispense“ as long as no liquid will be released any more or until the pump is out of 
range (“Plunger out of range“). In the case that there is still remaining liquid inside the 
tube, again aspirate some air using pump, and then dispense this volume via valve1: 
“Move” PJ1 to z-position 0, “Connect” pump to air, “Aspirate” (1-2x 30 µl), 
“Connect” pump to valves, “Move” PJ1 to z-position 28-30, “Dispense” (as long as all 
liquid is removed from the tube and pump reaches the initial position), “Close” 
valve1. 
• (1) “Move” PJ1 to z-position 0. 
• Trouble shooting: (3) when “aspirating“ about 30 µl, and then want to “Dispense“ just 
5 µl, unfortunately not 5 µl reached the chip surface, but only 1.5 µl. When 3x 
“dispensing” 5 µl, 11.5 µl reached the chip surface... thus, dispensing an exact volume 
did not work well..... 
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IV. Manually performed spotting of 1µl of master mix onto reaction point B (PipeJet2,PJ2) 
 
• (1) “Move” LOC-slide to x-position 253.5 = flask C; “Move” PJ2 to z-position 33-37. 
• (3) “Connect” pump to valves, “Open” valve2, “Close” valves 1 and 3; PSpeed = 20, 
PVol = 30 µl; press button “Aspirate“ (watch, if fluid is aspirated into the tube); pump 
stays connected to valve2. 
• (1) “Move” PJ2 to z-position 0; “Move” LOC-slide to x-position 115 = reaction center 
B; “Move” PJ2 to z-position 30. 
• (2) Adjust the following settings at PJ2: Istroke = 20 µm, vdown = 200 µm/ms, thold 
= 10 µs, vup = 2 µm/ms, n = 20, delay = 150 ms; validate settings with “Set PJ2“; start 
spotting with “Shoot PJ2“; about 1 µl will be spotted onto the chip surface. 
• (3) After shooting, “Close” valve2 and “Connect” pump to air. 
• (1) “Move” PJ2 to z-position 0. 
• SAW-Control: 1 µl of fluid can now be move via SAW on the chip surface. 
• (1) “Move” LOC-slide to x-position 253.5; “Move” PJ2 to z-position 28-30. 
• (3) Release of fluid remains or of the over-aspirated volume from PJ2 back into the 
reservoir flask C: “Connect” pump to valves, “Open” valve2, activate button 
“Dispense“ as long as no liquid will be released any more or until the pump is out of 
range (“Plunger out of range“). In the case that there is still remaining liquid inside the 
tube, again aspirate some air using pump, and then dispense this volume via valve2: 
“Move” PJ2 to z-position 0, “Connect” pump to air, “Aspirate” (1-2x 30 µl), 
“Connect” pump to valves, “Move” PJ2 to z-position 28-30, “Dispense” (as long as all 
liquid is removed from the tube and pump reaches the initial position), “Close” 
valve2. 
• (1) “Move” PJ2 to z-position 0. 
 
V. Manually performed spotting of 5µl Sealing Solution onto reaction point C 
(PipeJet3,PJ3) 
 
• (1) “Move” LOC-slide to x-position 280 = flask A; “Move” PJ3 to z-position 33-37. 
• (3) “Connect” pump to valves, “Open” valve3, “Close” valves 1 and 2; PSpeed = 20, 
PVol = 25 µl; press button “Aspirate“ (watch, if fluid is aspirated into the tube); pump 
stays connected to valve3. 
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• (1) “Move” PJ3 to z-position 0; “Move” LOC-slide to x-position 164 = reaction center 
C; “Move” PJ3 to z-position 28. 
• (3) “Connect” valves to air = “Bypass“, thus, automatically a droplet is generated at 
PJ3 due to declined low-pressure, which drops automatically onto the chip surface due 
to gravity; as soon as the droplet reaches the surface, immediately “Connect” the 
pump to valves, to generate the low-pressure again and to stop the dispensing directly. 
OR: “Close” valve3, “Connect” valves to air (“Bypass“), “Open” valve3, wait for 
droplet touching the chip surface, “Close” valve3. 
• (1) “Move” PJ3 to z-position 0. 
• SAW-Control: 5 µl of Sealing Solution can now be moved via SAW on the chip. 
• (1) “Move” LOC-slide to x-position 280; “Move” PJ3 to z-position 28-30. 
• (3) Release of fluid remains or of the over-aspirated volume from PJ3 back into the 
reservoir flask A: “Connect” pump to valves, “Open” valve3, activate button 
“Dispense“ as long as no liquid will be released any more or until the pump is out of 
range (“Plunger out of range“). In the case that there is still remaining liquid inside the 
tube, again aspirate some air using pump, and then dispense this volume via valve3: 
“Move” PJ3 to z-position 0, “Connect” pump to air, “Aspirate” (1-2x 25 µl), 
“Connect” pump to valves, “Move” PJ3 to z-position 28-30, “Dispense” (as long as all 
liquid is removed from the tube and pump reaches the initial position), “Close” 
valve3. 
• (1) “Move” PJ3 to z-position 0. 
• Trouble shooting: (3) when “aspirating” about 25 µl, and then want to dispense 4x 5 
µl, only 2.5 µl were dispensed... thus, dispensing did not work well with oil as well. 
• Trouble shooting: (2) the “Shoot PJ3“-function did not work very well with oil... 
during “Shoot PJ3” single oil droplets were spread over the chip surface and did not 
combine to an increasing droplet volume. Furthermore, it was not possible to “shoot” 
more than about 2 µl – it seems that in that case the PJ-valve ran empty/out of liquid, 
as the stored fluid in the tube could not flow fast enough into the emptied PJ tip.... 
especially when valve was still connected to pump; but when connecting the valve to 
air, too much liquid was released and no shooting was possible..... 
• (2) Additionally, parameter changes were tested, but did not succeed. Changes in “n“ 
= 20, 30, 40, 100 produced just a volume of maximum 2 µl when using “Shoot PJ3“. 
Changes in “delay“ of 100, 200, 500, 1000 and 2000 did not produce a larger 
dispensed volume than just 2 µl when using “Shoot PJ3“. 
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VI. To program automatic pipetting operations using the “(4) Batch mode” 
 
• Write a working procedure first: step-by-step, what to do (example in table 2). 
• Final instructions can then be typed into an Excel-sheet in the software according to 
the “Batch mode”-code (figure 2), or respectively, an already existing program can be 
loaded via “Open file” and then be changed (save changes via “Save file”). 
• Via “Batch execute” the list of orders will be run line-by-line. 
• The generated working sheet of the „Batch mode“ is saved with a .csv ending – this 
ending can simply be opened by Excel. 
• Working sheets generated in Excel can easily be saved as .xls as well as .csv ending 
files, and thus can easily be opened in the “Batch mode”. 
 
Table 2. Step-by-step operating procedure of moving PJ1 to reaction center A and PJ3 to reaction center C, 
which can be transferred to an Excel file and translated according to the “Batch mode”-code. 
 
 PJ1 = e.g. for master mix: use flask C (best centered) 
PJ3 = e.g. for Sealing Solution: use flask A (best centered) 
 Axis Control settings: 
(1) “Xvel“ / “Zvel“ = 500 steps/s; press “Set Axis Speed“ to validate new settings (Axis Control) 
(1) “Step width“ = 0.01 mm (Axis Control) 
 To “Aspirate” and “Dispense” the Sealing Solution/mineral oil (PipeJet3): 
(1) 1. “Move” LOC-slide to x = 280 mm to aspirate oil (Axis Movement) 
(1) 2. “Move” PJ position to z = 33 mm (Axis Movement) 
(3) 3. “Open” valve3 (V3) and keep the others closed (Valve Control) 
(3) 4. “Connect” pump to valves by pressing “Valves“ (Pump Control) 
(3) 5. Set “PVol“ to 25 µl (Pump Control) 
(3) 6. Press “Aspirate“ (Pump Control) 
(1) 7. “Move” PJ to the initial position, z = 0 mm (Axis Movement) 
(1) 8. “Move” LOC to x = 164 mm to dispense the oil in the reaction center C (Axis Movement) 
(1) 9. “Move” PJ to z = 28 mm (Axis Movement) 
(3) 10. To dispense the oil, “Connect” the valves to air by pressing “Bypass“ (Pump Control) 
(3) 11. Immediately after that the oil droplet reaches the chip surface, “Connect” the pump to valves by 
      pressing “Valves“ (Pump Control) 
(1) 12. “Move” PJ to z = 0 mm (Axis Movement) 
 To “Aspirate” and “Dispense” the master mix, H2O, or else (PipeJet1): 
(1) 13. “Move” LOC-slide to x = 253.5 mm to pipette the master mix (Axis Movement) 
(3) 14. “Open” valve1 (V1) and “close” valve3 (V3) (Valve Control) 
(1) 15. “Move” PJ to z = 33 mm (Axis Movement) 
(3) 16. Set “PVol“ to 30 µl (Pump Control) 
(3) 17. Press “Aspirate“ (Pump Control) 
(1) 18. “Move” PJ to z = 0 mm (Axis Movement) 
(1) 19. “Move” LOC-slide to x = 62 mm to dispense the master mix in the reaction center A (Axis 
       Movement) 
(1) 20. “Move” PJ to z = 30 mm (Axis Movement) 
(2) 21. Change PJ1 settings (PipeJet Control): 
      Istroke(20µm); vdown(200µm/ms); thold(10µs); vup(2µm/ms); n(20); delay(100ms) 
(2) 22. Press “Set PJ1“ to validate the modifications (PipeJet Control) 
(2) 23. Press “Shoot PJ1“ (PipeJet Control) 
(1) 24. “Move” PJ to z = 0 mm (Axis Movement) 
(1) 25. “Move” LOC-slide to x = 300 for SAW control and PCR performance (Axis Movement) 
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Operating procedure written into the Excel working-sheet: “Batch mode”-code (figure 2) 
 
To open a “Batch mode” file, press “Open file”. To save setting changes in a file or to save a 
new created one, press “Save file”. Saved files are stored in the folder “Methods” (drive 
C:\\Program Files/Biospot/Methods). 
 
For typing any instructions into an Excel-sheet, the following settings have to be considered, 
providing the “Batch mode”-code: 
 
A-D = (1) Axis Control and Axis Movement (target position of axis system) 
• X (A) and Z (B) = position of LOC-slide on x- and of PipeJets on z-axis 
• Xvel (C) and Zvel (D) = speed of x-axis and z-axis (500 steps/s = standard) 
 
E-J = (3) Valve Control and Pump Control (pumping behavior, valve position, valve 
            velocity, volume) 
• V1-3 (E,F,G) = valve 1-3 (1 = closed, 0 = open); keep all the valves closed until the 
aspiration or dispensing process is desired 
• PPos (H) = connection of pump/air/valves (0 = bypass (valves/air), 1 = pump/air, 2 = 
pump/valves) 
• PSpeed (I) = speed of aspiration/dispensing process (20 ms = standard) 
• PVol (J) = volume of aspiration/dispensing in [µl]: (-) = aspiration, (+) = dispensing,  
0 = standard (no pipetting activity) 
 
K-R = (2) PipeJet Control (stroke, downstroke velocity, holdtime, upstroke velocity) 
• PJ (K) = number of PJ, which is used to „shoot“ (1, 2 or 3) 
• Istroke (L) = penetration depth of piezo (5-36 µm, standard = 30 µm) 
• Vdown (M) / vup (O) = down-/upstroke speed of piezo during dispensing process 
(downstroke 100-250 µm/ms (standard = 200), upstroke 1-10 µm/ms (standard = 1; in 
use = 2)) 
• thold (N) = adjustment of piezo holding time (10-1000 µs; standard = 10 µs) 
• n (P) = number of repetitions of dispensing process (1-1000); 0 = standard = no 
“shooting” activity!!! 
• delay (Q) = delay time between each repetition (1-2000 ms; standard = 100) 
• Changes must be verified by pressing “Set PJ“ button 
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  A                                            B  
Figure 2. Programming operating procedures in “Batch Mode”. Operating procedures can be written into an 
Excel working-sheet. Parameters can be typed into the columns according to the desired operation to be 
performed. A+B) Operating procedures for pipetting 1 µl of fluid to reaction point A (A) or B (B) and 
dispensing 5 µl of Sealing Solution to reaction center C, expressed according to the “Batch mode”-code. 
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9.1.6 LOP of Fluorescence Reader 
“Fluorescence detection for applications like RT-PCR or microarray on the LOC 
system” 
 
A. Material 
 
• BioSpot device and software “BioSpot” (BioFluidix GmbH, Freiburg, Germany) 
• CytoCycler (PCR device incl. chip-holder, temperature control device, SAW control 
high frequency (HF) generator, particular software “CytoCycler” (Advalytix 
AG/Beckman Coulter Biomedical GmbH, Munich, Germany)) 
• Electronics (electronic control): LED power control box (self made), trigger signal 
break-out box (NI SCB-68 with the PCI ADC/DAC capture the trigger signal, 
activates the image capture and image processing process; Quick Reference Label, S-
Series Devices, National Instruments Germany GmbH, Munich, Germany) 
• Optics: - black & white CCD camera (Rolera-XR, QImaging, Surrey BC, Canada) 
                  - Filter sets (Interferenzfilter of BrightLine series, AHF Analysentechnik AG, 
                     Tübingen, Germany): excitation filter λmax = 498 nm (spread 35 nm = 464 
                     500 nm); emission filter λmax = 536 nm (spread 40 nm = 516-556 nm); both) 
                  - light source: blue LED (λmax = 470±2 nm LUXEON Rebel LXML-PB01 
                     0023, 3.4 V forward bias, 0.7 A operating current) 
• Software: “QCapture” or “QCapture PRO 6.0” (QImaging, Surrey BC, Canada), 
“LED_Switch.VI”, “Norbert.VI”, “Grand_NIVision_Intensity_Consec_Subtract_ 
Loopback_NewCamera.VI” (LabVIEW 8.6, National Instruments Germany GmbH, 
Munich, Germany) 
 
B. Operating procedure 
 
I. Start BioSpot (for moving LOC chip-holder to CCD camera (Fluorescence Reader)) 
 
• Prepare a test chip into the LOC chip-holder with a droplet in place (1 µl of water 
covered with 5 µl of mineral oil (Sealing Solution) at reaction center B) (see detailed 
description of chip installation in the “LOP of LOC chips”, chapter 9.1.3). 
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• Switch on BioSpot control device, start software “BioSpot” (desktop; see “LOP of 
BioSpot”, chapter 9.1.5). 
• Move CytoCycler (LOC chip-holder slide) to CCD camera (x-axis position = 460). 
• Leave “BioSpot” software open, stored in the background. 
 
II. Run “QCapture” (optimize chip position and camera settings) 
 
• Transfer CCD camera from the microscope and fix it to the holder (big golden screw). 
• Switch on CCD camera and connect to computer via firewire connection. 
• Start software “QCapture” (desktop; figure 1). 
• Click “Acquire” for activating window “Live Preview” (the software provides a live 
image of the chip surface). 
• Center camera image to the test droplet, optimize settings like magnification as well as 
focus (the image from the camera has to be focused sharply). 
• OR start software “QCapture Pro 6.0” (desktop; figure 2); click on the camera symbol 
for activating a settings box, where by clicking the “Preview” button a live preview is 
provided. 
 
 
Figure 1. Screenshot of software “QCapture”. Via activating the button “Acquire” (red arrow) a window 
opens providing a live preview image. 
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Figure 2. Screenshot of software “QCapture Pro 6.0”. Via activating the “Camera” symbol (red arrow), a 
window opens providing settings for the live preview. Operating the button “Preview” in these settings window 
provides then the live image of the camera. 
 
III. Run “LED_Switch” (check LED state) 
 
• Switch on LED power control box (red button at the grey self-made box). 
• Start software “LED_Switch” (desktop; figure 3). 
• Run program by clicking the white arrow symbol; activate the center switch for 
turning blue LED light on and off; adjust LED illumination (the focused light must be 
centered onto the middle of the test droplet); turn LED off. 
 
 
Figure 3. Screenshot of software “LED_Switch.VI”. The white arrow button, the red-circle button and the 
centered switch are needed to operate the LED light illumination. 
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• Stop program by clicking the red-circle button; quit software “LED_Switch” as well 
as the “QCapture” software. 
 
Important: after these preliminary steps the “QCapture” software as well as the 
“LED_Switch” software need to be stopped, as only one procedure at a time can have access 
to the camera as well as to the LED light source (so either “QCapture+LED_Switch” OR 
“Norbert.VI/Grand_NIVision...” can be run). 
Thereafter, the test chip can be removed out of the cavity of the CytoCycler device and a new 
chip has to be fixed in place, whereon the PCR shall take place. 
 
IV. Run LabVIEW program 
 
• Switch on CCD camera and connect to computer via firewire connection. 
• Switch on LED power control box (red button at the grey self-made box). 
 
During PCR, images taken via the LabVIEW programs are stored in folder D://pic (file name 
= OriginalXX.tiff / OriginalXX.jpeg) → after the PCR these images need to be stored in a 
separate folder, otherwise images will be overwritten by new saved images when image 
taking programs are re-opened and run again. The software “Grand_NIVision...” also 
generates images named ProcessedXX.tiff / ProcessedXX.jpeg – these pictures represent 
subtracted images showing the calculated difference in fluorescence intensity when 
subtracting the previous image from the actual image. During PCR, values of fluorescence 
intensity are stored continuously in the domain named “Array”; additionally, at the 
“Grand_NIVision...” software, an excel file is generated storing these values when the 
program is stopped.  
 
Assure that the trigger signal from the PCR CytoCycler is fed into the trigger signal break-out 
box which itself must be connected to the interface board placed in a computer slot. From the 
break-out box another two lines have to be connected to the LED power control box. They 
provide the trigger signal for the LED to be switched on and off. The LED power control box 
must be switched on as well (red button).  
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Run “Norbert.VI” (for manual image taking) 
 
• Start software “Norbert.VI” (desktop; figure 4). 
• Set exposure time (in milliseconds) to desired values like e.g. 100, 200, 400, 1000, 
and so on in the box “Exposure” (figure 4, red arrow 1). 
• Run program by clicking the white arrow symbol (figure 4, red arrow 2); now images 
can be taken manually at any time point by clicking the button “Take picture” (figure 
4, red arrow 3). 
• Run PCR (see issue V “Start CytoCycler”). 
• Stop program by clicking the red-circle button (figure 4, red arrow 4); quit software 
“Norbert.VI”. 
• Save images stored in folder D://pic to a separate folder, as otherwise they will be 
overwritten. 
 
 
Figure 4. Screenshot of software “Norbert.VI” for taking pictures manually. The white arrow button, the 
red-circle button and the “Take Picture” button are needed to operate the software, while exposure time needs to 
be set as well. Measured fluorescence intensities of taken images are shown in the box “Mean Intensity” and are 
stored consecutively in domains arranged in an array-like manner below the starting button. 
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or “Grand_NIVision_Intensity_Consec_Subtract_Loopback_NewCamera.VI” (for automatic 
image taking) 
 
• Start “Grand_NIVision_Intensity_Consec_Subtract_Loopback_NewCamera.VI”  
            (desktop; figure 5). 
• Set exposure time (in milliseconds) to desired values like e.g. 100, 200, 400, 1000, 
and so on in the box “Exposure” (figure 5, red arrow 1). 
• Run program by clicking the white arrow symbol (figure 5, red arrow 2); now images 
are taken automatically at distinct time points; time points depend on the position 
(front view: left = 1.step of PCR cycle, middle = 2.step, right = 3.step), where the 
trigger signal break-out box is connected to the backside of the temperature control 
box for performing 2-step or 3-step PCR: plug 2/middle = images taken at the end of 
the second temperature step during PCR (around 60°C), plug 3/right = images taken at 
the end of the third temperature step during PCR (around 72°C)). 
• Run PCR (see issue V “Start CytoCycler”); the program now waits for the trigger 
signals from the PCR CytoCycler. 
 
 
Figure 5. Screenshot of “Grand_NIVision_Intensity_Consec_Subtract_Loopback_NewCamera.VI” 
software for taking pictures automatically. The white arrow button and the red-circle button are needed to 
operate the software, while exposure time needs to be set as well. Measured fluorescence intensities of taken 
images are shown in the box “Mean Intensity” and are stored consecutively in domains arranged in an array-like 
manner below the starting button. 
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• Stop program by clicking the red-circle button (figure 5, red arrow 3); quit software 
“Grand_NIVision...”. 
• After the PCR, automatically an Excel file is generated showing a summary of 
measured values of fluorescence intensity. 
• Save images stored in folder D://pic to a separate folder, as otherwise they will be 
overwritten. 
 
V. Start “CytoCycler” (performing PCR) 
 
• Install new chip in LOC chip-holder device; switch on temperature control box, start 
software “CytoCycler” (desktop) and choose PCR program/settings (see “LOP of 
LOC chips”, chapter 9.1.3 and “LOP of LV-PCR”, chapter 9.1.4). 
• Pre-heat each chip for about 15 min to 95°C (during this procedure, the material of the 
chip expands due to the high temperature – this prevents the droplet afterwards, when 
starting the initial denaturation step of the PCR, to be moved/deformed due to material 
stress). 
• Run PCR using 1 µl of master mix, covered by 5 µl of Sealing Solution (see “LOP of 
LV-PCR”, chapter 9.1.4). 
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9.2  Table of oligonucleotides 
Table 10. Sequences and expected fragment sizes of oligonucleotides for PCR and array hybridization assays. 
Forward primers are marked with “F” or “fw”, while reverse primers are marked with “R” or “rv”. All 
oligonucleotides, primers as well as probes for hybridization arrays were ordered and purchased from Metabion 
GmbH, Martinsried, Germany. 
 
PCR primer Fragment size *Tm [°C] Oligonucleotide sequence 
Amel1 (1) 106 bp / 112 bp 65.0 5’-CCC-TGG-GCT-CTG-TAA-AGA-ATA-GTG-3’ forward 
Amel2 (1) 106 bp / 112 bp 64.0 5’-ATC-AGA-GCT-TAA-ACT-GGG-AAG-CTG-3’ 
reverse 
Amel1-f-Cy3 (1) 106 bp / 112 bp 65.0 5’-Cy3-CCC-TGG-GCT-CTG-TAA-AGA-ATA-GTG-3’ forward 
β-Actin up (2) 297 bp 71.0 5’-TCA-CCC-ACA-CTG-TGC-CCC-ATC-TAC-GA-3’ forward 
β-Actin down (2) 297 bp 71.0 5’-CAG-CGG-AAC-CGC-TCA-TTG-CCA-ATG-G-3’ 
reverse 
DYS392-fw 290-323 bp 60.0 5’-TAG-AGG-CAG-TCA-TCG-CAG-TG-3’ 
DYS392-rv 290-323 bp 59.0 5’-GAC-CTA-CCA-ATC-CCA-TTC-CTT-3’ 
DXS10134-fw 240-291 bp 60.0 5’-CCT-GGG-TGA-CAT-AGA-GAG-AC-3’ 
DXS10134-rv 240-291 bp 59.0 5’-CTT-TCG-TCC-CCG-AGT-TGG-T-3’ 
STR marker Fragment size *Tm [°C] Oligonucleotide sequence 
D7S1824-F (3) 163-199 bp 56.0 5’-Hex-GCA-CCT-GTT-TGA-TTC-AGT-CA-3’ 
D7S1824-R (3) 163-199 bp 60.0 5’-CCA-GCC-TGT-GTG-ACT-ATG-TG-3’ 
D9S302-F (3) 258-316 bp 63.0 5’-Fam-GGG-GAC-AGA-CTC-CAG-ATA-CC-3’ 
D9S302-R (3) 258-316 bp 58.0 5’-GCG-ACA-GAG-TGA-AAC-CTT-GT-3’ 
D10S2325-F (3) 119-154 bp 58.0 5’-Fam-CTC-ACG-AAA-GAA-GCC-TTC-TG-3’ 
D10S2325-R (3) 119-154 bp 60.0 5’-GAG-CTG-AGA-GAT-CAC-GCA-CT-3’ 
Array probes Fragment size *Tm [°C] Oligonucleotide sequence 
Amelo1(Y) 112 bp 64.0 5’-C6-Aminolink-(T)13-GA-GAA-ACC-ACT-TTA-TTT-GGG-3’ 
Amelo2(X) 106 bp 64.0 5’-C6-Aminolink-(T)13-CT-TGA-GAA-ACA-TTT-GGG-ATG-3’ 
Amelo3(Y) 112 bp 64.0 5’-C6-Aminolink-(T)13-AC-CAC-TTG-AGA-AAC-CAC-TTT-3’ 
DYfw 290-323 bp 68.0 5’-C6-Aminolink-(T)13-TA-GAG-GCA-GTC-ATC-GCA-GTG-3’ 
DYrv 290-323 bp 67.0 5’-C6-Aminolink-(T)13-GA-CCT-ACC-AAT-CCC-ATT-CCT-T-3’ 
DXfw 240-291 bp 68.0 5’-C6-Aminolink-(T)13-CC-TGG-GTG-ACA-TAG-AGA-GAC-3’ 
DXrv 240-291 bp 67.0 5’-C6-Aminolink-(T)13-CT-TTC-GTC-CCC-GAG-TTG-GT-3’ 
AMfw 106 bp / 112 bp 70.0 5’-C6-Aminolink-(T)13-CC-CTG-GGC-TCT-GTA-AAG-AAT-AGT-G-3’ 
AMrv 106 bp / 112 bp 69.0 5’-C6-Aminolink-(T)13-AT-CAG-AGC-TTA-AAC-TGG-GAA-GCT-G-3’ 
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(1)
 Primers Amel1 and Amel2 for amplifying 106/112 bp fragments of the human sex determining gene 
amelogenin were reported by Shadrach B et al. (2004). Amelogenin is a protein of dental enamel whose DNA 
sequence is present on human X- and Y-chromosomes (Lau EC et al., 1989), generating different lengths 
products in males and females. Most commonly used amelogenin primer sets span a 6 bp deletion on the X-
chromosome, resulting in a 112 bp fragment from the Y-chromosome and a 106 bp fragment of the X-
chromosome. Therefore male individuals show X/Y PCR products of 106/112 bp while females give X/X single 
amplification products of 106 bp. 
 
(2)
 Primers β-Actin up and β-Actin down for amplifying a 297 bp fragment of the human multicopy gene β-actin 
were reported by Taylor TB et al. (1997).  
 
(3)
 Primer-pair sequences of D7S1824, D9S302 and D10S2325 were taken from www.ncbi.nlm.nih.gov using the 
link to UniSTS primer database. 
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9.3  Material list including source of supplier 
Hardware 
• 3130xL Genetic Analyzer (Applied Biosystems GmbH, Darmstadt, Germany) 
• AdvaWash (Advalytix AG/Beckman Coulter Biomedical GmbH, Munich, Germany) 
• AmpliSpeed slide cycler (Advalytix AG/Beckman Coulter Biomedical GmbH, Munich, Germany) 
• BioSpot dispenser device (BioFluidix GmbH, Freiburg, Germany) 
• Black & white CCD camera (Rolera-XR, QImaging, Surrey BC, Canada) 
• Color firewire camera (PixeLINK, BFI Optilas, Munich, Germany) 
• CytoCycler PCR device incl. chip-holder, temperature control device, SAW control high frequency 
(HF) generator, particular software “CytoCycler” (Advalytix AG/Beckman Coulter Biomedical GmbH, 
Munich, Germany) 
• Electrophoresis Power Supply EPS 601 (Amersham Biosciences Europe GmbH, Freiburg, Germany) 
• Filter set ET482/35 and ET536/40 (Interferenzfilter of BrightLine series, AHF Analysentechnik AG, 
Tübingen, Germany) 
• GenePhor electrophoresis unit (Amersham Biosciences Europe GmbH, Freiburg, Germany) 
• HBO 100 high-pressure mercury lamp (HBO 100, Leistungselektronik JENA GmbH, Jena, Germany) 
• HF generator (FC 1201 HF, Advalytix AG/Beckman Coulter Biomedical GmbH, Munich, Germany) 
• Inverted optical microscope (Axio Obsever.Z1, Carl Zeiss GmbH, Jena, Germany) 
• Laser control box (CryLaS FTSS 355-50, CryLaS GmbH, Berlin, Germany) 
• LED (blue, λmax = 470±2 nm) (LUXEON Rebel LXML-PB01-0023, 3.4 V forward bias, 0.7 A 
operating current) 
• LED power control box (self-made) 
• Microarray scanner system (ProScanArray Microarray Analysis System, PerkinElmer Life and 
Analytical Sciences, Shelton, CT, USA) 
• PCR thermocycler (advanced Primus 96, PeqLab Biotechnologie GmbH, Erlangen, Germany) 
• PCR thermocycler (Cyclone25, PeqLab Biotechnologie GmbH, Erlangen, Germany) 
• Pressure-supplying pneumatic picopump (PLI-100 pressure control unit, Harvard Apparatus, Holliston, 
US) 
• Stratagene Real-time PCR cycler (Stratagene Mx 3000P, Stratagene, La Jolla, CA, USA) 
• Temperature control device (Advalytix AG/Beckman Coulter Biomedical GmbH, Munich, Germany) 
• Temperature measurement device (Präzisionsthermometer GMH 3710, Greisinger electronic GmbH, 
Regenstauf, Germany) 
• Trigger signal break-out box (NI SCB-68 with the PCI ADC/DAC, Quick Reference Label, S-Series 
Devices, National Instruments Germany GmbH, Munich, Germany) 
• Ultrasonic cleaner (VWR International, Leuven, Belgium) 
• UV lamp 220V 50Hz, 230V 60Hz (System Papst-Motor Typ 8550, Papst-Motoren GmbH & Co.KG, 
St. Georgen, Germany) 
• UV spectrophotometry (NanoDrop ND-1000, PeqLab Biotechnologie GmbH, Erlangen, Germany) 
• UVA-laser system (Laser control box, CryLaS FTSS 355-50, CryLaS GmbH, Berlin, Germany) 
• UVC light source (PCR Workstation, PeqLab Biotechnologie GmbH, Erlangen, Germany) 
Software 
• “BioSpot” (BioFluidix GmbH, Freiburg, Germany) 
• “CytoCycler” (Advalytix AG/Beckman Coulter Biomedical GmbH, Munich, Germany) 
• “GeneMapper ID v.3.2” (Applied Biosystems GmbH, Darmstadt, Germany) 
• “GeneScan 3.7” (Applied Biosystems GmbH, Darmstadt, Germany) 
• “Genotyper 3.7” (Applied Biosystems GmbH, Darmstadt, Germany) 
• “Grand_NIVision_Intensity_Consec_Subtract_Loopback_NewCamera.VI” (LabVIEW 8.6, National 
Instruments Germany GmbH, Munich, Germany) 
• “LED_Switch.VI” (LabVIEW 8.6, National Instruments Germany GmbH, Munich, Germany) 
• Microarray scanner software (ProScanArray Scanner Software, PerkinElmer Life and Analytical 
Sciences, Shelton, CT, USA) 
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• “MxPro – Mx3000P v3.00” (Stratagene, La Jolla, CA, USA) 
• “Nanosauger 2.5” (XYZ High Precision, Darmstadt, Germany) 
• ”Nanosauger 2.6” (XYZ High Precision, Darmstadt, Germany) 
• “Nanosauger 2.7” (XYZ High Precision, Darmstadt, Germany) 
• “Norbert.VI” (LabVIEW 8.6, National Instruments Germany GmbH, Munich, Germany) 
• “OriginPro 7.5 SR0” (OriginLab Corporation, Northhampton, MA, USA) 
• “QCapture Pro” (QImaging, Surrey BC, Canada) 
• “QCapture Pro 6.0” (QImaging, Surrey BC, Canada) 
Chemicals 
• Acetone (Merck KGaA, Darmstadt, Germany) (Cat. No. 1.00014.2500) 
• EtOH 100% (Merck KGaA, Darmstadt, Germany) (Cat. No. 1.00983.2500) 
• Tickopur TR 14 (DR. H. STAMM GmbH, Berlin, Germany) (Cat. No. 090328) 
• Xylene (Merck KGaA, Darmstadt, Germany) (Cat. No. 1.08685.2500) 
Consumables 
• 100 bp DNA ladder (New England BioLabs, Beverly, MA, USA) (Cat. No. N3231S) 
• 96-well plate (ABgene PCR Plates, Thermo Scientific, Epsom, Surrey, UK) (Cat. No. AB-0600) 
• Adhesive = Norland optical adhesive 88 (ultraviolet curing), (Norland products Inc., Cranbury, NJ, 
USA) (Cat. No. 100613-1) 
• AmpliGrid AG480F (multi LV-PCR microdevice) (Advalytix AG/Beckman Coulter Biomedical 
GmbH, Munich, Germany) (Cat. No. OAX04503) 
• Anode and kathode buffers: (-) Delect Cathode Buffer and (+) Delect Anode Buffer for 10% CleanGels 
and (+/-) DNA HyRes Buffer for HyRes CleanGels) (ETC GmbH, Kirchentellinsfurt, Germany) (Cat. 
No. 1002-11, 1002-11, 1002-21) 
• Copper collection grids (Copper meshes, 2000 square mesh copper 3.05mm, AGAR scientific Ltd., 
Stansted, Essex, U.K.; ordered from PLANO GmbH, Wetzlar, Germany) (Cat. No. G2786C) 
• Copper hole-rings, 3.05 mm (AGAR scientific Ltd., Stansted, Essex, U.K.; ordered from PLANO 
GmbH, Wetzlar, Germany) (Cat. No. G2600C/G2660C) 
• Cotton buds, sterile (Nuova Aptaca, Canelli (AT), Italy) (Cat. No. H087) 
• Delect Gel Buffer for 10% CleanGels and DNA HyRes Buffer for HyRes CleanGels (ETC GmbH, 
Kirchentellinsfurt, Germany) (Cat. No. 1002-11 and 1002-21 and xxx) 
• EDTA K treated blood collection tubes 1.3 ml (Monovettes, SARSTEDT AG & Co., Nümbrecht, 
Germany) (Cat. No. 41.1504.008) 
• GeneScan-500LIZ size standard (Applied Biosystems GmbH, Darmstadt, Germany) (Cat. No. 
4322682) 
• Glass capillary tube, transparent (Kapillaren zur Schmelzpunktbestimmung, open at both sides, outer 
diameter 1.75 mm, length 100 mm, 1000 pieces, Hirschmann Laborgeräte GmbH & Co.KG, Eberstadt, 
Germany) (Cat. No. 9201710) 
• Heparin-Natrium (B. Braun Melsungen AG, Melsungen, Germany) (Cat. No. 2047217) 
• Hi-Di Formamide (Applied Biosystems GmbH, Darmstadt, Germany) (Cat. No. 4311320) 
• LOC chips Cyto1, Cyto2, Cyto3 (Advalytix AG/Beckman Coulter Biomedical GmbH, Munich, 
Germany) 
• Microscope object slides (Carl Roth GmbH, Karlsruhe, Germany) (Cat. No. H871) 
• PCR tubes, sterile, 0.2 and 0.5 ml (Eppendorf AG, Hamburg, Germany) (Cat. No. 0030124.332 and 
0030121.023) 
• PEN mounted slides (ultra thin 2 µm polyethylene-naphthalate laser supporting carrier membrane 
(PEN), mounted on 0.17 mm thin microscope cover glass slides or on 1.00 mm thick standard 
microscope object slides; MicroDissect GmbH, Herborn, Germany) (Cat. No. MDG3P4A) 
• Plastic syringes 10 ml (Becton Dickinson GmbH, Heidelberg, Germany) (Cat. No. 110025158) 
• Primers, oligonucleotides, probes (Metabion GmbH, Martinsried, Germany; see list in appendix, 
chapter 9.2) 
• Polyacrylamide DNA gels (CleanGel 10% or CleanGel HyRes, ETC GmbH, Kirchentellinsfurt, 
Germany) (Cat. No. 1001-03 or 1001-27) 
9. Appendix 
 
 
185 
• Sealing Solution (Advalytix AG/Beckman Coulter Biomedical GmbH, Munich, Germany) (Cat. No. 
OAX04207) 
• Sterile water (Ampuwa, Fresenius, Bad Homburg, Germany) (Cat. No. 40676.00.00) 
• ReddyRun Superladder-low 100 bp ladder (Thermo Scientific, ABgene, Epsom, Surrey, UK) (Cat. No. 
SLL-100S/LD) 
DNA analysis kits 
• AmpF/STR SEfiler Allelic Ladder (Applied Biosystems GmbH, Darmstadt, Germany) (Cat. No. 
4373674) 
• AmpF/STR SEfiler PCR amplification kit (Applied Biosystems GmbH, Darmstadt, Germany) incl. 
AmpF/STR PCR Reaction Mix, AmpF/STR SEfiler Primer Set, AmpliTaq Gold DNA 
Polymerase 5U/µl, AmpF/STR SEfiler Control DNA 9947A (Cat. No. 4335129) 
• First-DNA All-tissue DNA kit (Gen-ial, Troisdorf, Germany) incl. buffers Lyse 1, Lyse 2, Lyse 3, and 
enzyme Proteinase K 20 mg/ml (Cat. No. D0502000) 
• KOD Xtreme Hot Start DNA Polymerase PCR system (Novagen, Merck, Darmstadt, Germany) 
incl. 2x Xtreme Buffer, Xtreme dNTPs (2 mM each), KOD Xtreme Hot Start DNA Polymerase 
1U/µl (Cat. No. 71975) 
• peqGOLD Tissue DNA Mini Kit (PeqLab Biotechnologie GmbH, Erlangen, Germany) incl. DNA Lysis 
Buffer T, DNA Binding Buffer, DNA Wash Buffer, Elution Buffer (10 mM Tris-HCl, pH 9.0), 
Proteinase K, RNase A (20 mg/ml), 10 mM TE Buffer, PerfectBind DNAColumns, 2 ml Collection 
Tubes (Cat. No. 12-3396-01) 
• QuantiFast SYBR Green I PCR kit (QIAGEN GmbH, Hilden, Germany) incl. 2x QuantiFast 
SYBR Green I PCR Master Mix (HotStarTaq Plus DNA Polymerase, QuantiFast SYBR Green PCR 
Buffer, dNTP mix, SYBR Green I, ROX passive reference dye), RNase-Free water (Cat. No. 204052) 
• QuantiTect SYBR Green I PCR kit (QIAGEN GmbH, Hilden, Germany) incl. 2x QuantiTect 
SYBR Green I PCR Master Mix (HotStarTaq DNA Polymerase, QuantiTect SYBR Green PCR 
Buffer, dNTP mix incl. dUTP, SYBR Green I, ROX passive reference dye, 5 mM MgCl2), RNase-Free 
water (Cat. No. 204143) 
• QIAGEN Fast Cycling PCR kit (QIAGEN GmbH, Hilden, GmbH) incl. 2x QIAGEN Fast Cycling 
PCR Master Mix (HotStarTaq Plus DNA Polymerase, QIAGEN Fast Cycling PCR Buffer, dNTP 
mix), 10x CoralLoad Fast Cycling Dye, 5x QIAGEN Q-Solution, RNase-Free water (Cat. No. 203743) 
• QIAGEN Multiplex PCR kit (QIAGEN GmbH, Hilden, Germany) incl. 2x QIAGEN Multiplex PCR 
Master Mix (HotStartTaq DNA Polymerase, Multiplex PCR buffer (6mM MgCl2), dNTP mix), 5x 
QIAGEN Q-Solution, RNase-Free water (Cat. No. 206143) 
• Silver staining system (DNA silver staining kit, GE Healthcare, Uppsala, Sweden) including 5x Fixing 
Solution (Benzene sulphonic acid (3.0% w/v in 24% v/v ethanol)), 5x Staining Solution (Silver nitrate 
(1.0% w/v), Benzene sulphonic acid (0.35% w/v)), 5x Sodium carbonate solution (Sodium carbonate 
(12.5% w/v)), 5x Stopping & Preserving Solution (Acetic acid (5% v/v), Sodium acetate (25% w/v), 
Glycerol (50% v/v)), Formaldehyde (37% w/v in water), Sodium thiosulphate (2% w/v in water) (Cat. 
No. 17-6000-30) 
